curriculum vitae - executivesearch.unm.educurriculum vitae . name: douglas michael ziedonis, md,...

1

Curriculum Vitae NAME: Douglas Michael Ziedonis, MD, MPH Associate Vice Chancellor for Health Sciences University of California San Diego (UCSD) Professor of Psychiatry, UC San Diego School of Medicine ADDRESS: Biomedical Sciences Building

9500 Gilman Drive La Jolla, CA 92093-0602

CITIZENSHIP: United States EDUCATION:

Davidson College Pennsylvania State University Medical School UCLA and West Los Angeles VA Medical Center UCLA Neuropsychiatric Institute (NPI) UCLA Department of Psychiatry & Brentwood VA UCLA & Brentwood VA Yale University Department of Epidemiology and Public Health

1977-1981 1981-1985 1985-1986 1986-1989 1988-1989 1989-1990 1993-1996

Davidson, NC Hersey, PA Los Angeles, CA Los Angeles, CA Los Angeles, CA Los Angeles, CA New Haven, CT

B.S., cum laude M.D. Internship General Psychiatry Residency Chief Resident Addiction Psychiatry Fellowship M.P.H. (NIH K Award while faculty)

BOARD CERTIFCATION & SUB-SPECIALIZATION CERTIFICATION: 01/1994 Diplomat in Psychiatry, American Board of Psychiatry and Neurology 04/1996 Addiction Psychiatry, Certification in the Subspecialty of Addiction Psychiatry American Board of Psychiatry and Neurology (ABPN)

Re-certifications / Maintenance of Certification (MOC) 04/2006, 04/2016 MEDICAL LICENSURES: 1987-present California 2007-present Massachusetts 1990-1999 Connecticut 1998-2009 New Jersey

2

EMPLOYMENT: 1990-1996 1996-1998 1998-2001 1998-2007 1999-2006 2001-2004 2002-2004 2004-2007 2006-2007 2007-2017 2012-2017 2014-2017

Yale University, Department of Psychiatry Yale University, Department of Psychiatry University of Medicine and Dentistry of New Jersey (UMDNJ) – now Rutgers University - Robert Wood Johnson Medical School (RWJMS), Dept. of Psychiatry Rutgers University, Center for Alcohol Studies Princeton Theological Seminary UMDNJ-RWJMS / Rutgers Department of Psychiatry UMDNJ / Rutgers - School of Public Health, Health Systems and Policy Division UMDNJ-RWJMS / Rutgers Depart. of Psychiatry & UMDNJ School of Public Health, Health Systems & Policy Division Temple University Graduate School University of Massachusetts Medical School (UMMS), Department of Psychiatry UMass Graduate School of Biomedical Sciences, 1. Program of Clinical & Population Health Research; 2. Program of Neuroscience Graduate School of Nursing, University of Massachusetts

New Haven, CT New Haven, CT New Brunswick, NJ New Brunswick, NJ Princeton, NJ New Brunswick, NJ New Brunswick, NJ New Brunswick, NJ Worcester, MA Worcester, MA Worcester, MA

Assistant Professor Associate Professor Associate Professor Visiting Professor Visiting Professor Associate Professor with Tenure Associate Professor Professor with Tenure Visiting Professor, Adjunct Faculty Professor with Tenure & Adjunct Professor 2017 – 2019 Professor & Adjunct Professor 2017 – 2019 Professor & Adj. Prof. 2017 – 2019

3

2017-present University of California, San Diego

La Jolla, CA Professor with Tenure

ACADEMIC HEALTH CENTER CLINICAL APPOINTMENTS & TITLE / POSITION:

Yale University 1990-1998 Connecticut Mental Health Center, New Haven, CT Medical Director, Substance Abuse Treatment Unit Outpatient Services, 1990-93 Director, Dual Diagnosis Treatment and Research Program, 1993-98 1990-1998 Hospital of St. Raphael, New Haven, CT Medical Director, Chemical Dependence Evening Partial Hospital & Outpatient 1990-1992 Gaylord Hospital, Wallingford, CT Psychiatric Consultant, Substance Abuse Inpatient and Partial Hospital Programs 1992-1997 St. Mary’s Hospital, Waterbury, CT Psychiatric Consultant, Behavioral Health Center 1997-1998 Waterbury Hospital, Waterbury, CT Psychiatric Consultant, Addiction Treatment Center, University of Medicine and Dentistry of New Jersey: Robert Wood Johnson Medical School 1998-2007 University Behavioral Health Care, Piscataway, NJ Director, Addiction Psychiatry Division, 1998-2006 Director, Addiction Services, 1998-2000 Director, Addiction Psychiatry PGY-V Residency Program, 1998-2006 1998-2007 Robert Wood Johnson University Hospital, New Brunswick, NJ Co-Director, UMDNJ Tobacco Dependence Program (UMDNJ School of Public Health)

Director, Addiction Psychiatry Treatment and Consultation Services University of Massachusetts Medical School / UMass Memorial Health Care 2007-2017 UMass Memorial Health Care (UMass Memorial Medical Center), Worcester, MA

Chair, Department of Psychiatry, 2007 – 2017 Chief, Mental Health Service Line (Group Practice & Hospital), 2009 – 2017 Director, UMass Center of Excellence in Addictions, 2007 – 2017

2007-2017 UMass Memorial Behavioral Health Services (UMMBHS) President, UMMBHS 2007 – 2017

University of California San Diego Health (UCSD Health) 2017-present Executive Governing Board, UCSD Health Associate Vice Chancellor for Health Sciences Medical Staff & Faculty Program Management Office, Co-Director (2018 – present) Health Sciences Student-Run Free Clinic – HS oversight (2017 – 2019) Centers for Integrated Health – HS oversight Executive Director, UCSD Center for Mindfulness

4

Career Highlights Summary / Administrative Roles: • Past 13 years include a progression of senior leadership roles and responsibilities at UCSD

and UMass, including Associate Vice Chancellor, Chief Academic Officer, President, Service Line Chief, Department Chair, Research Center Director, and Hospital Board of Trustee.

• Experienced at working in state public-university systems (@ UCLA, UCSD, Penn State, Rutgers, UMass), including commitment to serving state’s citizens, serving vulnerable and diverse populations, prioritizing community engagement, and working with state leaders

• Balanced commitment to excellence in all mission areas, including clinical, research, teaching, and community engagement

• Physician-Scientist with strong academic research career (118 grants, over 25 years of continuous NIH and other research funding, and 320+ publications and scholarly works).

• Excellence in mentoring & leading successful career development & leadership programs. • Visionary, strategic, and operations oriented depending on role and needs, including

operational strengths in finance, academics, philanthropy, facilities, and human resources. • First generation Latvian American with core values to enhance equity, diversity, and

inclusion (EDI) with a demonstrated record of EDI accomplishments. • Experience and success with State, County, Federal, and community-based organizations,

including in addressing critical health and public health issues, including health disparities, homelessness, addictions, mental illness, healthy aging, disabilities, and childhood obesity.

• Experience working with elected officials, including Governors and Legislative leaders. • Experienced leader with “one University” values of enhancing cross-campus partnerships

and increasing collaboration across member hospitals in health care system • Clinical system leader in times of health care change to managed care and value based care

who has led and practiced in a range of clinical settings University of California, San Diego (June 2017 to present) Associate Vice Chancellor for Health Sciences (including Chief Academic Officer role)

• Broad senior leadership responsibilities in all mission areas, including strategic planning coordination, all faculty & student matters, health system matters, campus wellness and health promotion, diversity, and coordination and evaluation to support all schools and departments in Health Sciences (Medicine, Pharmacy, and Public Health).

o Co-led Research Strategic Planning process (including crowdsourcing campaign). o Support for new UCSD Dissemination & Implementation Science Center (DISC).

• In Chief Academic Officer role, oversaw Medical Education and relied on an outstanding Dean and team of leaders through the successful 2018 LCME re-accreditation.

• Led development of a new UCSD School of Public Health initial proposal and with a great team oversaw the successful two-year approval process to become an approved UC Regent School through engaging the full UCSD campus, including Deans, 100s of faculty, students, & staff from Health, Engineering, Business, Social Sciences, Humanities & Arts, SIO, etc. http://senate.ucsd.edu/media/288495/sph-pre-prop-review-docs-10-2017.pdf

o Oversight of cross-campus Institute for Public Health. • Oversight roles related to inter-professional education and online education (with campus). • Oversee and support Health Sciences Deans, AVCs, Associate Deans, and Directors of

Faculty, Student, and Staff matters related to Academic Affairs, Faculty Affairs, Employee Relations, Ethics & Compliance, Diversity, Human Resources, and Wellness.

http://senate.ucsd.edu/media/288495/sph-pre-prop-review-docs-10-2017.pdf

5

• Initiated the first Equity, Diversity, and Inclusion Summits to support strategic planning and create new initiatives, partnerships, and share best practices, including faculty, staff, and students. Supported initiatives focused on LatinX/Hispanics and American Indians.

• Oversee and co-lead the UCSD Healthy Campus Network (HCN) which includes over 100 faculty, staff, and student leaders joining to create a culture of health that addresses health disparities through increased communication and elevating everyone’s efforts.

o New programs including diabetes prevention, healthy beverage initiative / water conservation, student food scarcity, and enhancing Student Mental Health.

• Oversee Health Sciences International (HSI) and expanded global partnerships in all mission areas, visiting students, and co-lead campus wide workgroup focused on making recommendations for a possible UCSD Global Affairs Office to support global initiatives.

• Clinical system leadership – core member of UC Health Executive Governing Board, which oversees all our health system strategy, finances, and operations with specific leadership roles, related to academic integration, inter-professional education, faculty and clinician management, Chair/Chief Leadership Training, Professionalism, Compliance, & Wellness.

• With CFO and VC, have monitored finances, expenditures, funds flow, and prioritize growth investments, including major capital investments and physical plant growth.

• Initiated and co-lead a COVID19 emotional support initiative (UCSD mindful compassion) for Health Sciences & Campus to support the front-line and staying at home workforce.

University of Massachusetts (January 2007 – June 2017)

• President of UMass Behavioral Health Services – oversight of network of 25 community-based behavioral health program sites, including oversight & support for CEO of Community HealthLink & led enhancing integration of faculty leaders, academic activities, and research partnerships.

• Chair of Psychiatry - led tremendous growth in all mission areas: faculty size grew 70% to 375, 15-fold increase in clinical & translational research, 5 new Divisions, new endowed chairs, and expanded State Agency partnerships. Developed an innovative career development office, and enhanced education resources, centralized office, and integrated innovative technologies.

• Board of Trustees Marlborough Hospital – provided oversight of general community member hospital with 67 beds, emergency room, cancer center, and medical / surgical services.

• Population Health Leader – Massachusetts led transient to Value Based Care. Leader on team developing multiple ACOs, “systemness,” doubling group practice (3,000), and I oversaw behavioral health expansion (tele-health, primary care links, caseworker certification).

• CTSA / Research Career Development Lead - developed and led a K Award writing group in which about 50 faculty awarded an NIH, VA, or other career development award.

• UMass Wellness Initiative - initiated and led our UMass Memorial system Wellness Initiative (for 35,000) working with 5 hospitals and HR offices engaging 30% year 1 and 60% by year 2.

• AAMC Council on Deans Fellowship (2013 – 2014) - three selected nationally, included the AAMC Executive Development for Deans program.

• Inter-professional Education and Career Development Lead – while serving on faculty in Schools of Medicine, Nursing, and Biomedical Science developed inter-professional training

• Addiction Center of Excellence Director – led the development of the COE, which included an extensive network of researchers, educational programs, and engagement with community.

6

UNIVERSITY SERVICE (including Administrative Role Workgroups): University of California (UC) – UC system level (10 UC Campuses) 2017- 2018 University of California Health (UC Health) Leadership Group

• UC Regents Health Services Committee 2017-2018 UC Deans Leadership Group 2017-Present Conflict of Interest Workgroup. University of California, Office of the President (UCOP) 2017-Present UC Opioid Crisis Curriculum Workgroup for all UC Medical Schools (UCSD) 2018-Present UC Health Campus Network (HCN) Advisory Team 2019-Present UC Physician Well-Being Collaborative 2018-Present California Institute for Regenerative Medicine (CIRM) Board Member, Alternate (UC system representative to this California State Agency) University of California San Diego (UCSD) – Full Campus Level 2017-2020 UC San Diego School of Public Health, SPH (UC Regents approved 2019)

• Led development of SPH initial proposal and with team led oversight of 2-year approval process, including Academic Senates and UC Regent reviews

• Chair, Executive Council for School of Public Health Proposal (whole UCSD campus) • Chair, SPH Proposal Advisory Committee (full campus faculty, staff, and students)

2017-Present UCSD Institute of Public Health, Sponsor & Supervisor 2017-2019 Chancellor’s Strategic Academic Program Development (SAPD) Steering Committee 2017-2018 Strategic Academic Program Development Initiation Core Project Team 2017-Present Research Career Development K Award Writing Group, Developer & Leader 2017-present UCSD Community Stations Advisory Group, Advisor

• Qualcomm Institute, School of Engineering, Design Lab, etc) 2017–present UCSD Healthy Campus Network (HCN), Sponsor, Advisor, and Co-Director 2017-Present UCSD Interfolio & Faculty 180 IT Project

• Co-Chair Executive Steering Group • Co-Leader – Health Sciences Workgroup

2017- present Equity, Diversity, and Inclusion Advisory Council 2017-present Drug-Free Schools and Communities Act Leadership group 2017-Present Real Estate Focus Group Coordinating Group 2017-Present UC San Diego Compliance, Audit, Risk and Ethics (CARE) Committee 2017-Present Innovation & Entrepreneurship Workgroup - Technology Transfer Subgroup UCSD Health Sciences & UCSD Health:

UCSD Health Sciences Councils, Cabinets, Committees, and Workgroups: 2017-present Affiliation Partnership Council

• UC San Diego & San Diego Veterans Affairs Health Care system • Co-lead with Chief of VA San Diego Health Care system

2017-2018 Health Sciences Integrated Strategic Planning Workgroup, co-lead 2018-2020 Health Sciences Deans Meeting (Medicine and Pharmacy Deans with VC & AVC HS)

7

2017-2019 Health Sciences Expenditure Commitments Committee (ECC) o Weekly review of all faculty / physician hires in Health & Health Sciences

2017-2019 Vice Chancellor / Chief Financial Officer Finance Meeting 2017-2019 Skaggs School of Pharmacy & Pharmaceutical Sciences Budget & Educational Workgroup 2017-Present Health Sciences Financial Operations Meeting 2017-Present Chief Information Officer (CIO) Advisory Group 2017-Present Health Sciences Faculty Council 2017-Present Council of Health Sciences Chairs 2017-Present Health Sciences Research Council 2017-Present Council of Clinical Chairs 2017-2018 Health Sciences Academic & Educational Leaders Cabinet, Chair 2017-2019 Health Sciences VC Cabinet Faculty Issues Meeting 2017-Present Health Sciences Faculty Engagement and Wellness Workgroup, Chair 2018-Present Health Sciences / Cross Campus Managing Disruptive Behavior Workgroup, Chair 2017-Present Academic Personnel Process Workgroup 2017-Present Health Sciences Compensation Plan Advisory Committee – Chair 2017-Present Health Sciences Compliance Advisory Group (CAG), Co-Leader 2017-2019 Health Sciences VC Cabinet Educational Issues Meeting 2017-2019 Student-Run Free Clinic (medical, dental, other students) – Oversee and Supervise 2017-2018 Liaison Committee on Medical Education (LCME)-ISS Task Force – LCME review 2018 Sponsor & Lead on Integrating Strategic Plan & QI Process 2017-Present Health Science International Leadership Group 2017-Present Health Sciences Equity, Diversity, and Inclusion Strategic Planning & Summits – Lead 2017-Present Academic Resource Center (ARC) Steering Committee – Oversight 2017-Present Psychiatry Senior Faculty Meeting 2017-Present Addiction Special Interest Group 2019-Present Dissemination & Implementation Science Center (DISC) – Senior Administrative Advisor 2019-Present Sanford Institute for Empathy and Compassion, Executive Council 2018-Present Center for Open Dialogue Leadership Group - Director 2020-Present UCSD Mindful Compassion Initiative for Emotional Support during COVID19 Developed initiative and Co-Lead with Sanford Institute Director UC San Diego Health: 2017-Present Executive Governing Board, UCSD Health 2017-Present Medical Staff & Faculty Program Management Office (PMO) Steering Committee 2017-Present Co-Director, Faculty and Physician Management (Program Management Office) 2017-Present Disruptive Faculty and Physician Management Group 2017-Present Health Information Services Executive Committee 2018-Present UCSD Centers for Integrated Health – Oversight 2019-Present UCSD Center for Mindfulness – Executive Director 2017-Present UCSD Pain Consortium Committee 2017-Present UCSD Opioid Crisis Workgroup - Co-Leader with SOM Dean 2019-Present UC San Diego Health Board of Advisors for Health Sciences Advancement

8

University of Massachusetts Worcester Campus, 2007 – 2017 Schools of Medicine, Graduate Nursing School, and School of Biomedical Sciences University Committee Service 2007-2017 Executive Council (Lead Council for UMass Worcester – includes the Medical School,

Graduate School of Biomedical Sciences, and Graduate School of Nursing) * Vice-Chair 2011-2013 * Chair 2013-2015 2007-2017 Clinical Research Advisory Committee 2007-2010 National Children’s Study-UMass Research Liaison Committee 2007-2017 Compensation Committee 2007 UMass Academic Health Center Strategic Planning Task Force 2007 Co-Chair, Faculty and Leadership Development Committee 2007 Research Workgroup of the UMass Academic Health Center Strategic Planning Effort 2007-2017 Director, UMass Center of Excellence in Addictions 2007-2009 Clinical and Translational Sciences Award Initiative Advisory Committee 2007-2009 Clinical and Translational Sciences Award Initiative Aims and Themes Writing Group 2007-2009 Clinical and Translational Sciences Award Initiative Bench to Bedside Writing Team 2007-2009 Clinical and Translational Sciences Award Initiative T2 Core Writing Group 2008-2017 Chairs’ Strategic Council 2008-2011 New Campus Facility Executive Team 2008-2011 Albert Sherman Center Executive Committee 2008 Leadership Council Subcommittee on Research Core Facilities 2008-2012 Steering Committee, Learner-centered Integrated Curriculum (LInC) 2009 Faculty Forward (internal leadership for AAMC initiative) Task Force 2009 Office of Federal Contracts and Compliance (OFCCP) Recruitment Task Force 2009-2012 Steering Committee, Center for Health Quality, Outcomes & Economic Research 2010-2017 UMass Center for Clinical & Translational Science - Training and Faculty Development - Reviewer: Pilot Project Grants, Global Initiative Grants, and K12 Grants 2010 UMMS Distinguished Service Award Committee 2010 Co-Chair UMMS/UMMHC Shared Identity Steering Committee 2010 Empowering Research Faculty Task Force 2010 UMMS Postdoctoral Recruitment Process Committee (focus on Diversity & Inclusion) 2010-2012 UMMS Faculty Recruitment Process Committee (focus on Diversity & Inclusion) 2011 Expedited Process, Training Process, and Outreach and Advertising workgroup

(subcommittee of Faculty Recruitment Process Committee) 2011 LCME “Self-Study” UMass Medical School (LCME site visit 2012) LCME Self-Study Guide Leadership Group - Sub-committee on Student Health Services, Financial Aid, and Academic Counseling 2011 Empowering Research Faculty Committee 2011 Chancellor's Award for Distinguished Service Committee 2011-2017 Advisor, UMMS Center for Integrated Primary Care 2011-2017 Transplant Quality Council 2011 Deep Sequencing Core and Bioinformatics Core Planning Group 2011-2017 Neuroscience Steering Committee

9

2012 Dean’s Tenure Committee to review tenure system at UMMS 2012 Chancellor’s Medal for Distinguished Service Selection Committee 2012 Commonwealth Care Alliance Workgroup 2012-2015 Co-Chair, CTSA Clinical Research Scholar (K12) Award Committee 2013-2017 Center for Integrated Primary Care Advisory Board (UMMS) 2013-2017 Community Health Improvement Plan (CHIP) Committee 2013-2017 Stewardship Group for Joint Campus Strategic Planning 2013-2017 UMass/VA Joint Venture Steering Committee 2014-2017 Opioid Conscious Curriculum Advisory Committee 2014-2017 Talent Strategy Work Group 2014-2015 UMass Neurology Department’s Internal Review Committee 2015-2016 Metrics to Assess Efficacy of Mentoring Learning Committee 2016 Campus Read Planning Committee 2016-2017 UMMSs Executive Council’s Ad Hoc Workgroup on Underrepresented Minorities (URM) 2016-2017 NEASC Midterm Accreditation Workgroup (New England Assoc. of Schools & Colleges) 2016-2017 Diversity Summit III leadership group 2016-2017 Prioritization Workgroup on Under Represented Minorities (URM) in Health Care Among

Faculty and Students at UMMS 2017-2017 UMass Neuro-therapeutics Institute Internal Review Committee Search Committees (UMMS/ UMMHC) 2007-2008 Chair, Chair of Neurology Search Committee 2007-2008 Quantitative Health Sciences Chair Search Committee 2008 Vice Provost for Faculty Affairs (VPFA) Search Committee 2008-2009 Cancer Clinical Center of Excellence Director Search Committee 2008-2009 Bedford VA Mental Health Service Line Manager Search Committee 2009 Institutional Leader of Bioethics Search Committee 2009 Director, Diabetes Center of Excellence Search Committee 2009 Associate Vice Chancellor for Diversity and Equal Opportunity Search Committee 2009-2010 Director, University of Massachusetts Institute for Health Policy Search Committee 2009-2010 Quantitative Health Sciences Chair Search Committee 2010 Radiology Chair Search Committee 2011 Chief Medical Officer Search Committee 2011 Bedford VA Mental Health Service Line Manager Search Committee 2011 Co-Chair, Chief Information Officer Search Committee 2012-2013 Commonwealth Medicine Chief Academic Enhancement Officer Search Committee 2012-2013 Urology Search Committee 2012-2013 President Search Committee 2013 Marlborough Hospital CEO Search Committee 2014-2016 Chair of the Department of Neurosurgery Search Committee 2016-2017 Executive Director of Corporate & Foundation Relations Search Committee, Interviewer Building Construction / Renovation Committees Service: 2012 - 2013 UMMS Albert Sherman Center building ($400M Research & Education) 2008 - 2010 UMass Ambulatory Care Center (ACC) Building (Clinical Research & Care) 2010 - 2013 Department of Mental Health’s Worcester Recovery Center and Hospital

10

UMass Memorial Health Care (UMMHC) 2007-2017 President of UMass Memorial Behavioral Health Services (UMMBHS)

• Oversaw complex network of community based mental health service sites, including oversight and support for CEO of Community Healthlink (CHL) with locations across Massachusetts for all ages, including all levels of care from residential services to outreach into the community / homes. Many multi-culturally focused programs and integrated with primary care. $70M budget

2013-2017 Board of Trustees Marlborough Hospital

• Active oversight of general community hospital with 67 beds, emergency room, cancer center, and medical / surgical services. $80M budget

2015-2017 UMMHC Population Health & Accountable Care Organizations (ACOs)

• Co-leader on Longitudinal Care Team, including Steering Committee (A3 Stakeholder Group) & Obesity-Diabetes Self-Management Pilot Project Team

• Lead and oversight Behavioral Health Initiatives

2007-2017 Chair of Department of Psychiatry (Clinical Service described here) • Co-led the development of a unified system approach (with CEO and 5 UMass

system hospital Presidents) across 5 hospitals to address behavioral health care, including better links with academic activities, improved access to care, increase bed occupancy across the system, and better coordinated services.

• oversaw extensive clinical services network throughout Massachusetts in our UMass Memorial Health Care (UMMHC) system, and the University of Massachusetts Medical School’s (UMMS) clinical RFR awarded contracts with other state agencies (Department of Mental Health, Public Health, Youth Services, and Executive Office of the Trial Courts), and contracts with other hospitals, VA, and community agencies.

• Led development of 5 new specialty Divisions & new partnerships with the VA Health Care system, Joint Ventures, community agencies, & other Departments.

• Managed and/or oversaw complex budgets including Department of Psychiatry, ($54M with medical school, group practice, and state contracts; $30M Service Line) with many funds flow from State lines, Clinical Revenue, State and Other Contracts, VA Partnerships, Group Practice, & Hospitals.

2007- 2017 Chief of UMass Memorial Medical Center’s Behavioral Health Service Line

• University & Memorial Hospital Locations. 52 beds and other services, $30M. Consultation/Liaison Service in two hospitals, Outpatient Psychiatry Services with numerous specialty programs in numerous sites, Outpatient integrated care within primary care programs, Population Health / ACO collaborations, Emergency Mental Health Service, and professional services for other hospitals (Marlborough Hospital, Clinton Hospital) and with non-UMMHC partners in community hospitals (not-for-profit and for-profit) and outpatient programs.

• Chief of Tobacco Addiction Treatment Consultation Service with consultation clinical services and Tobacco Addiction Rounds for residents & medical students.

11

2007-2017 UMMHC Wellness Initiatives for Employees & Families • In 2007, began initiative to better address tobacco, including creating a tobacco

free campus, clinical consultation service, treatment guidelines for the medical center, pharmacy protocols for new patients who smoke, new policies, and program to help employees who want to quit tobacco use.

• In 2014, Initiator and co-leader of Wellness Initiative which included 5 hospitals and HR offices. We engaged 30% of the workforce in first year and 60% in the second year. Mindfulness support programs developed.

UMass Memorial Health Care (UMMHC) Committee Service: 2007-2017 Leadership Council 2007-2017 Clinical Performance Council 2007-2017 Group Practice Advisory Committee 2007-2017 UMass Memorial Behavioral Health System, Chair of the Board of Directors 2007-2017 Advisory Board, UMMHC Primary Care Strategy Integration 2007-2017 Primary Care Integration System Advisory Board 2007-2017 Community Healthlink, Inc., Board of Directors 2007-2012 Resource Group – Large Capital Projects Committee 2007-2009 UMass Memorial Strategic Planning Task Force 2009 Medical Group Contingency Steering Committee 2010 Behavioral Health Planning Committee 2011 Total Health Management (Wellness) 2011-2014 Co-Chair, Behavioral Health Strategic Plan Implementation Stakeholders 2011-2017 UMass Memorial Cancer Center of Excellence 2011-2017 Center for Advance Primary Care Advisory Committee 2012-2017 Inspired Change Initiative Executive Leadership Group 2012-2013 McKinsey Operations Transformation Engagement Group 2012-2013 Co-Chair, Primary Care Executive Committee 2013 Master Facility Planning Committee 2014-2017 Wellness Advisory Committee 2014-2017 Medical Services Council 2016-2017 Physician Compensation Philosophy Workgroup 2016-2017 Community HealthLink, Inc Engagement Workgroup 2016-2017 Group Practice Faculty Engagement Workgroup, Initiator & Co-leader University of Medicine & Dentistry of New Jersey (UMDNJ) 1998-2007 UMDNJ - University Behavioral HealthCare (Piscataway, NJ) 1998-2006 Executive Committee (Leadership Committee for all UBHC activities) 1998-2006 Addiction Services Leadership Committee (Chair 1998-2000) 1998-2006 Medical Staff Committee 1998-2000 Chair, Addiction and Dual Diagnosis Training Committee 1998-2000 The Mercer County Addiction Science Center Building Committee UMDNJ / Rutgers University: Cancer Institute of New Jersey (CINJ) 2004-2006 Population Science Leadership Group

12

2004-2006 Director, Addiction Research Program at the CINJ 2004-2006 Primary Mentor, CINJ Faculty Development Award (Drs. Foulds and Steinberg) UMDNJ – School of Public Health 2002-2006 Health Systems & Policy Division 2002-2006 Co-Director, Tobacco Dependence Program UMDNJ - Robert Wood Johnson Medical School (formerly UMDNJ RWJMS; now Rutgers RWJMS): 1998-2006 Chairman’s Advisory Committee, Department of Psychiatry 1998-2006 Chairman’s Executive Committee, Department of Psychiatry 1998-2006 Chair, Addiction Psychiatry Fellowship and Post-Doctoral Student Training Committee 1999-2006 Interdisciplinary Training Committee 2000-2006 Chair, Medical School’s Curriculum Committee’s Subcommittee on Substance Abuse 2000-2006 Medical Student Well-being / Impairment Committee 2002-2006 Faculty Well-being / Impairment Committee 2002-2006 House Staff Well-being/Impairment Committee PROFESSIONAL ORGANIZATIONS: 1982-present American Medical Association (AMA)

1982-1984 Delegate/Representative to AMA Conventions 1983 Co-Chair, Committee on Representation on the State Level

1982-1985 Pennsylvania Medical Society

1982-1985 Medical Student Section Governing Council Chair 83-84, Secretary 1982-83

1983-1984 Council on Medical Practice 1984-1985 Chair, Medical Student Well-Being Committee 1984-1985 Committee on the Impaired Physician

1984-present Alpha Omega Alpha Honor Medical Society (AOA) 1984-present American Psychiatric Association (APA)

1987-1990 Committee of Graduate Education 1987-1990 Committee of Residents and Fellows, Area VI Representative 1994-2000 Practice Guidelines Work Group on Nicotine Dependence 1998-2000 Task Force on Nicotine Dependence, Chair, 1999-2000 1999 Drug Abuse Research Scholars Program Technical Assistance Faculty 1999-2006 Chair, Addressing Tobacco in Psychiatric Populations Work Group 2002-2006 Practice Guidelines Work Group on Substance Used Disorders 2003-2006 Committee on Training and Education in Addiction Psychiatry 2014-present Chair, APA Workgroup on Tobacco Use Disorder 2015-present Corresponding Member, Council on Addiction Psychiatry

1985-1990 Southern California Psychiatric Society

1987-1989 Government Affairs Committee

13

1988 Alcohol and Substance Abuse Committee 1986-1989 Psychiatric Residents Committee

1987-2007 American Association of Directors of Psychiatric Residency Training (AADPRT)

1987-1990 Executive Committee 1988 Critical Incidence Task Force

1988-present American Academy of Addiction Psychiatry (AAAP)

1989 Co-Chair, Members-in-Training Committee 1990-1993 Board of Directors 1998-2000 Board of Directors 1990-1992 Program Committee

1990-1994 Chair, Public Information Committee 1998-2000 Co-Chair, Public Policy and Public Information Section 1999-2002 Chair, Public Information Committee 1988-present American Society of Addiction Medicine (ASAM)

1991-2005 Family and Generations Issues Committee 1997-2001 Workgroup on Co-occurring Mental and Substance Use Disorders

1988-1998 Association for Medical Education and Research in Substance Abuse (AMERSA)

1988-1993 Membership Committee & Fellowship Training Committee 1989-1996 Program Committee, Chair 1993-1994; Co-Chair 1991-1993 1993-1995 Member at Large, Executive Committee

1990-1999 Connecticut Psychiatric Society 1994-2008 Group for the Advancement of Psychiatry (GAP) 1994- 2008 Committee on Alcoholism and Addictions 1996-2004 Society for Research on Nicotine and Tobacco (SRNT) 1998-2000 Public Policy Committee 1999-2007 New Jersey Psychiatric Society 2007-2017 Massachusetts Psychiatric Society 2007-2017 American Association of Chairs of Department of Psychiatry 2013-present American College of Physician Executives 2013-present American Association of Medical Colleges (AAMC) 2013-2014 Council of Dean’s Fellow 2014-present Liaison Committee on Medical Education (LCME) Survey Team 2014-present Group on Faculty Practice (GFP1-GFP) Committee 2014-present Group on Student Affairs (GSA1-GSA) Committee 2014-present World Association of Business Coaches (WABC) - Registered Corporate Coach (RCC)

14

HONORS AND AWARDS 1982-1984 National Institutes of Health – National Research Service Award 1984 Alpha Omega Alpha (AOA) Honor Medical Society - Pennsylvania State University

Medical School 1985 American Heart Association, Stroke Council – Medical Student Scholarship Award to

Study Cerebrovascular Disease 1985 Pennsylvania State University Medical School – Roche Clinical/Research Psychiatry

Award 1987-90 American Psychiatric Association – Committee of Residents and Fellows Selection 1992 National Institute of Mental Health's (NIMH) New Clinical Drug Evaluation Unit (NCDEU)

– New Investigator Award 1993 College on Problems of Drug Dependence (CPDD) – Fellowship Award 1993-1998 National Institute on Drug Abuse – Scientist Development Award for Clinicians (SDAC) 1994 Congress on International Neuropsychopharmacology (CINP) – Rafaelsen Award 1994 Group for the Advancement of Psychiatry – Alcoholism and Addictions Committee

Selection 1994 American Psychiatric Association Practice Guidelines Work Group on Nicotine

Dependence 1995 Governor's Blue Ribbon Commission on Addiction Services – Co-Chair Selection by

Governor 1997 Association for Clinical Psychosocial Research – Fellow 1998 Best Doctors in America 1999 American Psychiatric Association – Task Force on Nicotine Dependence, Chair American Psychiatric Association Council on Addictions 2001-2005 Robert Wood Johnson Foundation/RAND – Advisor, Co-Occurring Disorder Project 2002 Substance Abuse and Mental Health Service Agency (SAMHSA) – Advisor 2002 America’s Top Psychiatrists 2002 President Bush’s New Freedom Commission on Mental Health – Advisor

15

2002 American Psychiatric Association; Substance Abuse Treatment Guidelines 2002-2012 Best Doctors in America 2004 SAMHSA Co-Occurring Disorders Center for Excellence – Senior Fellow 2006 Best Doctors 2006: New York Area 2006 Norman H. Edelman Clinical Science Mentoring Award, UMDNJ 2006-2010 National Institute of Mental Health (NIMH) – Mental Health Services Research in Mental

Health Specialty Settings – Review Committee (SRSP) 2007 President Bush’s Cancer Panel 2007-2009 Institute of Medicine (IOM) Committee on Gulf War and Health: Smoking Cessation in

Military and Veteran Populations, Institute of Medicine of the National Academies 2009 Establishment of the annual “Douglas Ziedonis Career Development Mentoring Award,”

University of Massachusetts Medical School / UMass Memorial Health Care’s Department of Psychiatry

2009 Special Commission on Oxycontin and Heroin (Governor Deval Patrick, Massachusetts) 2010 Distinguished Fellow of the American Psychiatric Association 2011 Women’s Faculty Award for Outstanding Mentoring to Women Faculty, UMMS 2013-2014 Council of Deans Fellow, Association of American Medical Colleges (AAMC) - three selected nationally each year 2015 MISSION Program admitted into the Substance Abuse and Mental Health Services

Administration (SAMHSA), National Registry of Evidence-Based Practices (NREPP) 2015 Massachusetts Commission for the Deaf and Hard of Hearing’s Outstanding

Organization of the Year Award (Department of Psychiatry – DeafYes! Program) 2016 Open Dialogue Program admitted into the Substance Abuse and Mental Health Services

Administration (SAMHSA), National Registry of Evidence-Based Practices (NREPP) 2017 American Psychiatric Association’s Academic Gold Award (MCPAP for Moms)

16

CONTRACTS AND GRANTS: PROGRAM OF RESEARCH: My independent program of research focuses on better understanding and treating co-occurring

addiction and mental illness (co-occurring disorders), especially tobacco addiction and serious mental illness. Since starting my faculty research career at Yale, I have been funded continuously on a total of 118 research grants, including as PI on 28 research grants (in bold, including NIH, Foundation, Philanthropy, Federal & State Agencies); as Co-I on 68 grants; as mentor on 17 NIH or other research career awards (in italics); & as PI/Co-PI on 2 Center Grants.

The overarching questions guiding my program of research are: 1. What impact does co-occurring mental illness & addiction have on clinical course and outcomes? - including biological, psychological, and social / environmental factors 2. What clinical, organizational, and public health interventions can improve outcomes for individuals with co-occurring disorders? 3. Can non-pharmacological interventions help individuals with behavioral health problems and their families discover personal capacities to move past mere symptom reduction to pursue and find their own meaning and purpose in life?

My three specific areas of research focus: (1) Tobacco Use Disorders and Psychiatric Co-morbidity Focus on schizophrenia, behavioral interventions, and dissemination & implementation science studies of my Addressing Tobacco Through Organizational Change model; (2). Drug Addiction (stimulants & opioids) with & without Co-morbidity Focus on depression, psychosis, and pain comorbidities, including addiction clinical trials, laboratory studies of craving, and at risk populations of being homeless, during pregnancy, and health disparities. Studies of our MISSION and MCPAP for Moms models (3) Recovery-Oriented Psychosocial Interventions Develop and study non-pharmacological interventions to help indivduals & families, including Dual Recovery Therapy, Open Dialogue, & Mindfulness-Based Interventions.

My approach involves three primary research methods: (1) Quantitative & qualitative research (mixed methods) to understand clinical problems and system barriers, including translational impact with genetics & neuroimaging. (2) Behavioral therapy development and clinical trials methods to develop and evaluate treatments, including treatment manuals, fidelity scales, and training programs (3) Dissemination & Implementation science research methods to identify, develop, and evaluate strategies to integrate evidence based practices into public health, clinical, and community settings using organizational change and .

The international and global impact of this research has been to increase awareness and understanding of co-occurring mental illness and addiction (especially tobacco); develop new products used globally (manuals, teaching aides, fidelity measures); change practice guidelines and policies; developed 2 research programs are recognized as “nationally effective programs” by SAMHSA NREPP (MISSION and Open Dialogue); and reduced health disparities.

This work has resulted in authoring 315 original research articles, reviews, books, chapters, clinical practice guidelines, behavioral therapy & organizational change manuals, etc.

Have had global research collaborations in Asia (China, Korea, Japan) and Europe (Latvia, Finland, Lithuania, Norway, UK, Denmark, and Italy).

17

CURRENT RESEARCH GRANT ACTIVITIES: 15 Grants: 5 as Principal Investigator (PI), 3 Co-PI, and 1 as mentor on Research Career Award

Title Granting agency

Amount of total award

(with indirect costs)

Time period of contract/grant

Role (e.g. PI, co-investigator,

project leader, etc.)

Testing an Organizational Change Model to Address Smoking in Mental Healthcare

National Cancer Institute (NCI). R01 CA202699

$1,336,109 (UCSD’s component)

03/2016 – 02/2021 UCSD PI: D. Ziedonis PI: R. Schnoll (UPenn)

Computerized phenotype for opioid overdose

NIH/CTSA Collaborative with MUSC, Univ Kentucky, Dartmouth & UCSD

8/6/2019-6/30/2021 UCSD Site PID: Hogarth Co-I: Ziedonis

Open Dialogue: Development and Evaluation of a Social Network Intervention for Severe Mental Illness (ODDESSI)

National Institute for Health Research (NIHR) United Kingdom

UCSD Contract Pending. $2,322,109 total project

07/2017 – 07/2022 CO-I: D Ziedonis PI: S. Pilling (University College London)

Study of Physician Well-being and the EHR Work Across Specialties

American Medical Association

$100,000 02/2020-01/2022 PI: Tai-Seale Co-PI: Ziedonis

Adapting the Open Dialogue Model in the United States: Developing and Piloting an Organizational Change Approach & Behavioral Therapy Manual

Foundation for Excellence in Mental Health Care

$505,348 11/2012- 06/2020 PI: D. Ziedonis

Open Dialogue Dissemination & Implementation Science

Doris Bry Trust $3,000,000 04/2018 endowment started

PI: D. Ziedonis

Open Dialogue Dissemination & Implementation Science

Doris Bry Trust $260,000 07/2019 endowment started

PI: D. Ziedonis

Healthy Beverage Initiative

University of California (UC) Office of the President

$140,000 2019-2020 Index: PEDUHBI

PI: Melendrez Co-PI: Ziedonis (evaluation / research lead)

Diabetes Prevention Program (pilot with evaluation)

UC Office of the President

$24,500 08/19-08/21 PI: Ziedonis Co-PI: Post-Doc: M. Gholami, PhD

Childhood Obesity Initiative (COI) Prevention Services (with evaluation/research collaboration with SD County)

San Diego County Health and Human Services Agency & Board of Supervisors

$804,000 2019-2022 Contract #: 560830

PI: Melendrez / Pediatrics Co-PI: Ziedonis

18

Healthy Food Access – CALfresh Healthy Living Program / SNAP

USDA & SD County Health and Human Services Agency

$1,344,000 2019 - 2022 PI: Melendrez Co-PI: Ziedonis Lead on evaluation

“Examining Attrition in Substance Abuse Treatment Through the Health-related Quality of Life Lens” Clinical Research Scholar KL2 Research Career Development Award

NIH / National Center for Research Resources & the National Center for Advancing Translational Sciences UMMS

$420,000 04/ 2017- 03/2022 Co-Mentor: D. Ziedonis PI: E. Pivovarova

A System of Safety (SOS): Preventing Suicide through Healthcare System Transformation

National Institute of Mental Health (NIMH) R01MH112138

$5,034,504 9/5/2016-6/30/2021 Co-PIs: Boudreaux & Kiefe

Consultant: D. Ziedonis

Rapid Access to Perinatal Psychiatric Care in Depression Program (RAPPID): An Innovative Stepped-Care Approach for Obstetrics and Gynecology Clinics

Center for Disease Control (CDC) 1U01DP006093-01

$2,500,000 09/2015-09/2020 Consultant: D Ziedonis PI: N. Byatt;

HOPEnDialogue: An International collaborative multicentre research to support the Open Dialogue Learning Community and evaluate the effectiveness of Open Dialogue in various mental health care contexts around the world

Foundation for Excellence in Mental Health Care

UCSD Contract Pending

07/19-07/21 Consultant: Ziedonis PI: Raffaella Poccobello & Giuseppe Salamina

PAST RESEARCH GRANTS (103 grants; PI on 25 grants):

Title Granting agency

Amount of total award

(include indirect costs)


Role (e.g. PI, co-investigator, project

leader, etc.)

Research Center of Excellence for Systemic and

Psychosocial Research

Massachusetts Department of Mental

Health

$8,100,000 01/01/07- 5/31/17 PI: D Ziedonis

Advancing STOP: Self-regulation/CBT Therapy for Opioid Addiction and Pain

NIDA R34DA041549-01A1

$696,000 07/01/2017-04/30/2020

Co-I / Consultant: D Ziedonis PI: A. Wachholtz

Innovative Smartphone Application for Quitting

National Institutes on Drug Abuse (NIDA).

$1,090,478 2014 -2019 Co-Mentor: D. Ziedonis

http://www.missionmodel.org/manuals-1/?encryptedParam=AM4-82IKQro.Y9JpxED3suU6uGJOqkX9G0QIe9OPorM7BWIdVL_AUlE.

19

Smoking among Seriously Mentally Ill

K99DA037276-01/ R00DA037276-03

PI: R. Vilardaga

“Treatment of Trauma and Addiction in the Deaf Community” Clinical Research Scholar K12 Research Career Development Award

NIH / National Center for Research Resources and the National Center

for Advancing Translational Sciences

$429,659 03/2014 – 02/2019

Primary Mentor: D. Ziedonis (switch to co-mentor with move to UCSD) PI: M. Anderson

The BRIDGE QUERI Center of Excellence/ Implementation Science Center (MISSION)

Veterans Affairs (VA) HSR&D QUERI Center of

Excellence

$3, 975,000 2015 – 2019 Consultant/ Co-I: D Ziedonis Co-PIs: D. Smelson / M. Gifford

Mindful Physician Leadership Program

Physicians Foundation Leadership Grant

$150,000 2/15/16 – 2/14/18 PI: D Ziedonis (06/01/17 grant PI role transitioned to N. Byatt)

Open Dialogue: an innovative approach to treat psychiatric crises. Evaluation of the transferability in Italian mental health departments

Italian Ministry of Health (Italy) Ministero della Salute

499,800 € (~$529,393)

01/2015 – 12/2017 D. Ziedonis role: Scientific Consultancy / Co-I Evaluation PI: Raffaella Poccobello Project Co-PIs: Giuseppe Salamina & Chiara Rossi

“Rapid Access to Psychiatric Care in Perinatal Depression Program (RAPPID)” Clinical Research Scholar KL2 Research Career Development Award

NIH / National Center for Research Resources and the National Center for Advancing Translational Sciences KL2TR000160

$775,358 2013 - 2018

Primary Mentor: D. Ziedonis (switch to Co-mentor with move to UCSD) PI: N. Byatt: KL2

Testing A Couple-based Program for Alcohol Risk Reduction in the National Guard

National Institute on Alcohol Abuse and Alcoholism (NIAAA) R34AA023589-01

$783,199 04/2015 - 03/2018 Consultant: D. Ziedonis Co-PIs: Epstein E & Smelson D

Mind and Health: Developing a Neural Marker for Mindfulness, a Pathway to Health

National Center for Complementary and Alternative Medicine (NCCAM) 5R34 AT006963-02.

$740,250 2013 - 2017 Co-I: D. Ziedonis Co-PIs: C. Fulwiler & J. King

Assessment and reduction of the burden of major mental disorders and life-style related cognitive dysfunction

National Research Programme of Latvia, Programme Biomedicine for Public Health (BIOMEDICINE).

225,000.00 € (~$253,618)

2014-2017 Scientific Advisor / Co-I: D. Ziedonis PI: E. Rancans (Riga Stradins University)

Improving Functional Outcomes for Veterans with PTSD and Tobacco Use

VA Rehab Research & Development. I21RX-001756-01A1.

$191,709 07/1/15-06/30/17 PI: Kelly. Co-I Ziedonis

20

Imaging - Science Track Award for Research Transition (I-START). Behavioral and Neural Response to Cocaine Cue-Reactivity

National Institutes on Drug Abuse (NIDA). R03DA029179.

$239,213 2012 – 2015. PI: D. Smelson Co-I: D. Ziedonis

National Center for Homelessness Among Veterans (MISSION grant)

Veterans Affairs Office of Patient Care Services

$7,600,000 2009 - 2017 Site PI: D. Smelson; Site Co-I: D. Ziedonis

Adapting Alcohol Behavioral Couple Therapy for Service Members in Post-Deployment

National Institute on Alcohol Abuse and Alcoholism (NIAAA) R34AA023027

$726,289. 05/2014- 04/2017 Co-I: D. Ziedonis Co-PIs: Epstein E & Smelson D

Methamphetamine associated psychosis and schizophrenia: a comparative imaging pilot study

Shanghai Jiao Tong University School of Medicine/Shanghai Mental Health Center (SJTUSM/SMHC)

$10,000

10/2015 - 10/2017 SMHC PI: D. Liu. UMass PI: D. Ziedonis

Naltrexone-bupropion combination treatment for smoking cessation and weight loss in patients with schizophrenia


$10,000 10/2015-10/2017 UMass PI: X. Fan; Co-I: D. Ziedonis; SMHC PI: M. Zhao.

Co-morbid Opioid Addiction and Chronic Pain

National Institute on Drug Abuse (NIDA) 5 K23 DA030397-03

$635,560 08/2011-07/2017 PI: A. Wachholtz; Co-Mentor: D. Ziedonis

Cognitive enhancement treatment to improve negative symptoms in patients with schizophrenia


$10,000 10/2015-10/2017 SMHC PI: Z. Yi UMass PI: T. Giuliano; Co-I’s: D. Ziedonis, X. Fan

Mindful Physician Leadership Program (initial pilot project and mixed methods study)

Physicians Foundation Leadership Grant

$75,000 05/2014-08/2015 PI: D. Ziedonis

Addressing Tobacco Through Organizational Change: Pre-Intervention Pilot Study at Shanghai Mental Health Center

Shanghai Jiao Tong University School of Medicine / Shanghai Mental Health Center (SJTUSM/SMHC)

$10,000 05/2013- 05/2015 UMass PI: D. Ziedonis; SMHC PI: M. Zhao

University of Massachusetts Center for Clinical Translational Science-Education CTSA

National Center for Advancing Translational Science-Education (NCATS) 5 Ul 1 TR0000161-04.

$20,000,000 07/01/2010-03/31/2016.

PI: K. Luzuriaga Co-I: D. Ziedonis (Faculty Career Development Training Program)

MISSION-Vet HUD VASH Implementation Study

Veterans Affairs HSR&D QUERI Grant # SDP 11-235

$1,098,800 2011 – 2015 PI: D. Smelson

21

Co-PI: Matthew Chinman Co-I: D. Ziedonis

VICTORY: A Videoconferencing Tobacco Cessation Research Study

IH/ National Institute of Drug Abuse (NIDA) 1R56DA036798-01A1

$228,750. 09/15/2014-12/31/2015

PI: S. Kim; Co-I: D. Ziedonis

Neuroimaging Youth with Callous-Unemotional CD and Co-morbid Substance Abuse

National Institute on Drug Abuse (NIDA) K01 Gina Vincent, PhD 5 K01 DA026502-04

$900,000 08/01/2010-07/31/2015

PI: G. Vincent; Secondary Mentor: D. Ziedonis

Tobacco Dependence Treatment for Asian Americans

National Institute on Drug Abuse (NIDA) 5 K23 DA021243-05

$845,925 04/15/2009-09/31/2014.

PI: S. Kim; Primary Mentor: D. Ziedonis

RCT for Smoking Cessation in 10 Medical Schools.

National Cancer Institute (NCI) R01CA136888-05

$572, 221 07/06/2009-05/31/2014

PI: J. Ockene; Co-I: D. Ziedonis

Biomarker assessment for treatment response in schizophrenia.

Shanghai Jiao Tong University School of Medicine/Shanghai Mental Health Center

$10,000 05/13-05/15 SMHC PI: J. Wang UMass PI: X. Fan & Co-I: D. Ziedonis

Innovative Intervention Strategies for Metabolic Problems in Schizophrenia: Developing Innovative Intervention Strategies for Psychopathology, Cognitive Deficits, & Metabolic Problems in Patients with Schizophrenia

National Institute of Mental Health (NIMH) 5K23 MH082098-05

$228,928 06/12/2008 - 05/31/2014

PI: X. Fan. Primary Mentor: D. Ziedonis

The Remote Brief Intervention and Referral to Treatment for Alcohol Misuse (R-BIRT)

National Institute on Alcohol Abuse and Alcoholism (NIAAA) R41AA022035

$342,811 09/25/2012-02/28/2015

PI: E. Boudreaux; Co-I: D. Ziedonis Small Business Technology Transfer (STTR) with Polaris

Aripiprazole as adjunct treatment to improve prolactin elevation in patients with schizophrenia

Shanghai Jiao Tong University School of Medicine/Shanghai Mental Health Center (SJTUSM/SMHC) (internal funding)

$10,000 05/2013-05/2015 UMass PI: X. Fan; UMass Co-I: D. Ziedonis; SMHC PI: J. Sheng

Addressing Tobacco Through Organizational Change: Pre-Intervention Pilot Study at Tianjin Mental Health Center (TMHC)

Tianjin Medical University/Tianjin General Hospital/Tianjin Mental Health Center (TMU/TGH/TMHC)

$10,000 01/2013 – 05/2015 UMass PI: D. Ziedonis; TMHC/TMU PI: J. Li

22

A splitting brain: Imbalanced neural networks in schizophrenia

National Nature Science Foundation of China

$2,000,000 2008-2014 China PI: Tao Li; UMass PI: N Zhang; Co-I: Ziedonis

Addressing Tobacco Through Organizational Change in China

UMass Medical School Global Initiative

$50,000 09/2009-12/2013 PI: D. Ziedonis

Addressing Tobacco Through Organizational Change Intervention and Evaluation

Connecticut Department of Public Health

$225,000 ($2.1M total grant ith ComuniCare PI: J. Dauer)

12/01/2009 - 12/31/2013.

UMass PI: D. Ziedonis

A Multi-Site Feasibility Study of Interventions Designed to Enhance HUD-VASH Services

VA National Center on Homelessness Among Veterans Award

$300,000 09/2010 – 09/2013 PI: D. Smelson; Co-PI: G. Gonzalez; Co-I: D. Ziedonis

Development of a Structured Toolkit to Assist HUD-VASH Case Managers in the Housing Placement and Treatment of Homeless Veterans with Clinical Needs

VA National Center on Homelessness Among Veterans Award.

$200,000 02/2011 – 09/2013 PI: D. Smelson Co-I: D. Ziedonis

Memantine-enhanced Buprenorphine Treatment for Opioid-Dependent Young Adults

National Institute of Drug Abuse (NIDA) 5R01DA027138-02

$2,100,000 07/01/2009-06/31/2013

PI: G. Gonzalez Co-I: D. Ziedonis

Developing Technologies to Enhance Treatment Engagement

VA National Center on Homelessness Among Veterans Award

$275,000 04/2011 – 04/2013 PI: D. Smelson; Co-I: D. Ziedonis

A Mindfulness and Acceptance- Based Smoking Cessation Treatment for Veterans with Posttraumatic Stress Disorder VA Career Development Award

Veterans Health Administration, U.S. Department of Veterans Affairs VISN 1 V1CDA2010-01

$187,283 07/01/2010-06/30/2012

PI: M. Kelly; Primary Mentor: D. Ziedonis

Addressing Tobacco through Organizational Change in a VA Mental Health Clinic

VISN 1 (VA New England) Innovation Grant

$9,337 (pilot study)

11/1/14-04/30 PI:Kelly Co-I: Ziedonis (primary mentor)

Maintaining Independence and Sobriety Through Systems Integration Outreach and Networking: Manual & Workbook Dev Project

VA National Center on Homelessness Among Veterans

$175,000 09/2010 – 02/2012 PI: D. Smelson Co-PI: G. Gonzalez; Co-I: D. Ziedonis

A Mobile Enabling Technology to Enhance Adherence to Behavioral Therapy.

National Institute of Drug Abuse (NIDA)/ American Recovery and Reinvestment Act (ARRA) RC1- 08428.

$1,100,145 10/01/2009-09/03/2012

PI: E. Boyer Co-I: D. Ziedonis

23

Critical Time Intervention (CTI) for Men with Mental Illness Leaving Prison

National Institute for Mental Health (NIMH) R01 MH076068-01A1

$3,486,675 10/2006 – 09/2011 PI: J. Draine (University of Pennsylvania) Co-I: D. Ziedonis (while at UMDNJ)

Adolescent Trauma and Addiction. NIDA

National Institute of Drug Abuse (NIDA) K23 DA14009-01.

$850,000 07/2006-07/2011 PI: L. Fortuna; Primary Mentor: D. Ziedonis

Addressing Tobacco through Organizational Change

National Institute of Drug Abuse (NIDA) R01 DA020705

$1,400,000 04/20/2006- 03/31/2011

UMass site PI: Ziedonis and co-developer of idea to study my ATTOC model Overall PI: J. Guydish (UCSF)

Treatment of Cocaine Addiction with Integrative Meditation

National Institute of Drug Abuse (NIDA) R21DA025149-01A1

$412,500 04/01/2009-03/31/2011

PI: K. Chen; Co-I: D. Ziedonis

Kratom as a Barrier to Drug Treatment of Opioid Analgesic Addiction.

National Institutes of Health (NIH) SF 424 (R&R)

$72,319 04/01/2009-03/31/2011

PI: E. Boyer Co-I: D. Ziedonis (UMMS)

Addressing tobacco through organizational change in Veterans Administration Substance Disorder Programs.

VA HSR&D Merit Review RRP

$100,000 2010-2012 PI: D. Kalman Co-I: D. Ziedonis (mentor)

Disseminating Tobacco Cessation Activities in ICCD Clubhouses

Legacy Foundation Grant

$148,930 12/01/2008-11/30/2010.

PI: C. McKay; Co-I: D. Ziedonis (mentor)

Addressing Tobacco Through Organizational Change in the Community Based Outpatient Clinics

Veterans Affairs (VA) HSR&DRRP 08-253

$75,000 09/2009-09/2010 PI: D. Smelson Co-I: D. Ziedonis

Medically Unexplained Physical Symptoms (MUPS) in Primary Care Research Center (Developing Center Grant)

National Institute of Mental Health (NIMH) P20-MH-074634-01

$2,911,462 09/2005 – 08/2010 PI: J. Escobar; Co-I: D. Ziedonis (while at UMDNJ)

Maintaining Independence and Sobriety through Systems Integration, Outreach and Networking: Evaluation of the MISSION Program

Center for Substance Abuse Treatment (CSAT) / Substance Abuse and Mental Health Services Administration (SAMHSA) T116576.

$1,968,071 11/2004 – 12/2009 PI: D. Smelson Co-PI: A. Kline; Co-I: D. Ziedonis

Evaluation of the SAMHSA National Co-Occurring

Substance Abuse and Mental Health Services

$750,000 10/01/2005- 03/31/2010

UMass PI: D. Ziedonis; Overall PI: J. Hornik

24

Disorder State Initiative Grant

Administration (SAMHSA) GS-10F-0148P

(Advocates for Human Potential)

Clinical Trial Network Community Treatment Provider Research Core (University of Pennsylvania / Delaware Valley Node in the Clinical Trial Network)

National Institute of Drug Abuse (NIDA)

$133,333 09/30/1999 – 08/31/2009

PI: D. Ziedonis (Robert Wood Johnson Medical School)

Nicotine Intake in Smokers with Schizophrenia

National Institute of Mental Health (NIMH) R01 MH076672.

$1,568,392

08/2006 – 07/2009 PI: J. Williams; Co-I: D. Ziedonis

Addressing Tobacco in Mercer County (Intervention and Evaluation)

New Jersey Department of Health and Senior Services

$240,000 07/01/2006 – 06/30/2009

PI: D. Ziedonis (role transferred to M. Steinberg with 07 move to UMass)

Nicotine Dependence Treatment Program and Evaluation


$907,000 11/01/2000 – 06/30/2009

PI: D. Ziedonis (role transferred to M. Steinberg upon 07 move to UMass)

Treatment Issues for Smokers with Schizophrenia

National Institute of Drug Abuse (NIDA) K23 DA018203-01

$597,725 07/2004 – 06/2009 PI: M. Steinberg; Primary Mentor: D. Ziedonis

Imaging of nicotine sensitization in humans: a translational application of fMRI


$370,00 04/10/2008-03/31/2009

PI: J. DiFranza Co-PI: J. King; Co-I: D. Ziedonis

A Brief Community Linkage Intervention for Dually Diagnosed individuals

VA HSRandD Merit Review Grant # IIR-020-145.


Phase 2, Double-blind, Placebo-controlled trial of Selegiline Transdermal System (STS) as an Aid for Smoking Cessation

National Institute of Drug Abuse (NIDA) / VA CSP-1022

$451,491 10/2006 – 09/2008 Site PI: D Ziedonis (role transferred to J. Williams with 07 move to UMMS)

Treatment of Addiction to Nicotine in Schizophrenia (Behavioral Therapy Development Study)


$1,513,905 07/2003 – 06/2008 PI: D. Ziedonis (role transferred on 4/07 to J. Williams with my 07 move to UMass)

Qigong Therapy for Treating Cocaine Addiction

National Center for Complementary and


25

Alternative Medicine (NCCAM) R21 AT001350

Time-Limited Case management for Chemically Addicted Mentally Ill

Veterans Administration Award

$864,434 05/2005 – 05/2008 PI: D. Smelson; Co-PI: A. Kline; Co-I: D. Ziedonis

Coping and Recovery in Serious Mental Illness

National Institute of Mental Health (NIMH) K23

$750,000 07/2003 – 06/2008 PI: P. Yanos Primary Mentor: D. Mechanic Secondary Mentor: D. Ziedonis

Tobacco Treatment Initiated in the Emergency Department

National Institute of Drug Abuse (NIDA) K23 DA016698.

$800,000 07/2003 – 2008. PI: E. Boudreaux Primary Mentor: D. Ziedonis

Cue-elicited Craving and Genetics in Cocaine Dependence

National Institute Drug Abuse (NIDA) R03 DA020434-01

$155,500 09/2005 – 09/2007 PI: D. Smelson; Co-I: D. Ziedonis

Modifying Motivational Enhancement Therapy (MET) for use with Addiction Severity Index (ASI) data

National Institute of Drug Abuse (NIDA) R01 DA15978-01

$931,724 10/2002-07/2007 PI: D. Ziedonis

Re-Entry Career Award. Enhancing Motivation in Drug Addiction Treatment


$280,000 06/2005 – 07/2007 PI: A. Cordal; Mentor: D. Ziedonis

Tobacco Dependence Program (Center)

NJ Department of Health and Senior Services

$7,091,202 07/01/2000 – 06/30/2007

PI: J. Fould; Co-PI: D. Ziedonis

Engaging and Treating Tobacco Dependence Amongst the Medically Ill for Cancer Prevention

Cancer Institute of New Jersey (CINJ) Faculty Development Award

$180,000 01/2005 – 01/2007 PI: M. Steinberg; Primary Mentor: D. Ziedonis

Tobacco Dependence Treatments for Cancer Prevention

Cancer Institute of New Jersey (CINJ) Faculty Development Award.

$180,000 01/2005-01/2007 PI: J. Foulds; Primary Mentor: D. Ziedonis

Using Peer Counselors to Address Tobacco among Mental Health Consumers

American Legacy Foundation, Small Innovative Grant Program

$100,000 2005 – 2007 PI: J. Williams Co-PI: D. Ziedonis

The Efficacy of Aripiprozal in Decreasing Cue-Elicited Craving in Withdrawn Cocaine Dependent Patients

Bristol Myer Squibb $49,100 2003 – 2005 PI: D. Smelson Co-I: D. Ziedonis

Minority Supplement for Treatment of Addiction to Nicotine in Schizophrenia

National Institute of Drug Abuse (NIDA).

$40,000 09/2004 – 09/2006 PI: D. Ziedonis

26

Nicotine Dependence Treatment in Psychiatric Comorbidity

National Institute of Drug Abuse (NIDA) K23 DA14009-01

$700,000 07/2001-07/2006 PI: J. Williams; Primary Mentor: D. Ziedonis

Minority Supplement for Modifying MET


$40,000 05/2003-09/2005 PI: D. Ziedonis

Mental Illness Research and Education Clinical Center (MIRECC)

Veterans Affairs Central Office

$9,000,000 01/01/1999 – 12/31/2004

PI: L. Siever (Bronx VA / Mt. Sinai); Co-I: D. Ziedonis

Consultant versus Fully Integrated Treatment for Co-Occurring Disorders

KD1 TI12549-01 Substance Abuse and Mental Health Services Admin (SAMHSA) / Center for Substance Abuse Treatment (CSAT)

$1,150,000 10/01/2000 – 08/30/2004

PI: D. Ziedonis

Clinical Trials Network Center Grant (Delaware Valley Node)

National Institute of Drug Abuse (NIDA

$11,000,000 1999 – 2004 Co-I: D. Ziedonis PI: G. Woody (Univ Pennsylvania)

A Study of the Efficacy of Seroquel in Decreasing Cue-Elicited Craving and Relapse in Withdrawn Cocaine Dependent Patients

Astra Zeneca $89,250. 2002 – 2004 PI: D. Smelson; Co-I: D. Ziedonis

The Efficacy of Risperidone as an Anti-Cocaine Craving Agent in Withdrawn Cocaine Dependent Patients

Janssen Research Foundation.

$59,100 2002 – 2004 PI: D. Smelson; Co-I: D. Ziedonis

Evaluation of the Transitional Treatment Interventions-Time-limited Case Management

Veterans Administration Millennium Funding

$414,000 2000 – 2003 PI: D. Smelson Co-I: D. Ziedonis

Office Based Treatment for Addictions: Therapy Development Study

Robert Wood Johnson Foundation

$460,000 09/01/2000 – 12/31/2003.

PI: S. Adtjian; Co-PI: D. Ziedonis

Inherited Susceptibility to Alcoholism

National Institute of Alcoholism and Alcohol Abuse (NIAAA) RO1 AA 11639

$600,356 07/01/1999 – 06/30/2003

PI: P. Manowitz; Co-I: D. Ziedonis

Buprenorphine / Naloxone vs Clonidine for Outpatient Opioid Detoxification, National Multi-Site Study within the Clinical Trials Network of NIDA

National Institute on Drug Abuse (NIDA)

$291,769 11/01/2000 – 08/31/2002

PI: D. Ziedonis

27

Adapting Behavioral Marital Therapy to Treat Drug Abusers

National Institute of Drug Abuse (NIDA) R01

$550,000 07/01/1999 – 06/30/2002

PI: E. Epstein (Rutgers University Center for Alcohol Studies); Co-I: D. Ziedonis

Risperidone vs Haloperidol in Treating Individuals with Schizophrenia or Schizoaffective Disorder Who Continue to Use Alcohol and/or Cocaine

Janssen Research Foundation

$107,844 06/1999 – 05/2001 PI: D Ziedonis

The Efficacy of Risperidone in Decreasing Cue-Elicited Craving in Withdrawn Cocaine Dependent Schizophrenics


$43,500 02/1999 – 01/2001 PI: David Smelson Co-I: D. Ziedonis

The Dynamic Assessment and Referral System for Substance Abuse (DARSSA)

National Institute of Drug Abuse (NIDA) R41 DA021455-01

$145,852 4/01/06-9/31/07 PI: E. Boudreaux; Consultant: D. Ziedonis

The Efficacy of Olanzapine versus Haloperidol in Decreasing Cue-Elicited Craving and Relapse in Withdrawn Cocaine Dependent Schizophrenics

Lilly Pharmaceutical $59,000 01/1999 – 12/2000 PI: D. Smelson; Co-PI: D. Ziedonis

Nicotine, Nicotine Patch, and the Impact on Pulmonary Isoenzymes: a Pilot Study

Rutger’s University $15,000 01/01/2000 – 12/31/2000

PI: M. Iba (EOSHI Rutger’s University) Co-PI: D. Ziedonis

New Jersey State Government, Trenton. Addressing Tobacco Project


$148,687 05/1/2000 – 06/30/2000

PI: J. Slade Co-PI: D. Ziedonis

Research Training in Mental Health Epidemiology

National Institute of Mental Health (NIMH)

$1,455,574 1995 – 2000 PI: K. Merikangas Co-I: D. Ziedonis

Yale Medications Development Research Center

National Institute of Drug Abuse (NIDA) P50DA09250

$7,386,870 1994 – 1999 PI: T. Kosten Co-I: D. Ziedonis

Pharmacotherapy for Schizophrenic Cocaine Abusers (Core Project in Yale Medications Development Research Center)

National Institute of Drug Abuse (NIDA) (Center PI: T. Kosten, NIDA P50DA09250, $7,386,870)

$1,250,100

1994 – 1999 PI: D. Ziedonis

Risperdal versus Haloperidol in the Treatment of Substance Abusing Schizophrenics


$156,600 1997 – 1999 PI: D. Ziedonis

28

Yale Psychotherapy Development Research Center

National Institute of Drug Abuse (NIDA) P50DA09241-01

$7,742,207 1994 – 1999 Center PI: B. Rounsaville; Co-I: D. Ziedonis

Connecticut Department of Mental Health / Yale Medication Effectiveness Research Program

National Institute of Mental Health (NIMH) R24 MH54446

$2,317,916 1994 – 1999 PI: S. Woods Co-I: D. Ziedonis

Therapy for Drug Abusers with Psychiatric Co-morbidity

National Institute of Drug Abuse (NIDA) RO1-DA09127-01A1

$508,212 1995 – 1999 PI: D. Ziedonis

Drug Abuse and Psychiatric Co-Morbidity

NIDA K20-DA0193 Scientist Development Award for Clinicians.

$573,692 1993 – 1999 PI: D. Ziedonis

Medication Development Research Center

National Institute of Drug Abuse (NIDA) P50DA09250

$7,386,870 1995 – 1998 Center PI: T. Kosten; Co-I: D. Ziedonis

Nicotine Dependence and Psychiatric Patients Smoking Cessation Treatment Development, (Pilot Project in the Yale Psychotherapy Development Research Center)

National Institute of Drug Abuse (NIDA) Center (PI: B. Rounsaville, NIDA P50DA09241-01, $7,742,207).

$55,000. 1997 – 1998 PI: D. Ziedonis Pilot Project

Yale Faculty Alcohol and Drug Training Cadre Program.


$597,378 1992 – 1997 PI: R. Shottenfeld; Co-I: D. Ziedonis

29

PAST STATE & FEDERAL EDUCATIONAL & CLINICAL RFR AWARDED CONTRACTS:

• As Chair at UMMS provided oversight of over $25M annual clinical and training RFR awarded contracts from state agencies (DMH, DPH, etc) and additional Federal Contracts

• At UMMS, served as PI on five clinical RFR awarded contracts: the DMH Area Medical Directors, Lemuel Shattuck Hospital Psychiatric Services, and the Comprehensive Psychiatric Services of Central Massachusetts.

Past State & VA Agency Educational and Clinical Service RFR Awarded Grants:

Title Granting agency Amount of Total award


Role

Comprehensive Psychiatric Services – Worcester Recovery Center & Hospital (new 10-year contract)

MA Department of Mental Health

$78,964,320 (10 years)

begins 07/2017 PI (PI role to new interim Chair transitioned with move to UCSD)

Comprehensive Psychiatric Services - Central Massachusetts


$53,302,993 01/2007 – 06/2017 PI

Lemuel Shattuck Hospital Psychiatric Services

MA Department of Public Health

$1,568,181 07/2009 – 06/2019 PI (until move to UCSD)

Worcester State Hospital Child Psychology Services


$1,706,855 01/2007 – 06/2017 PI

DMH State Area Medical Directors


$16,429,272 01/2007 – 06/2017 PI

Child & Adolescent Services at Worcester Recovery Center and Hospital

MA Department of Mental Health Continuing Care Unit1

$44,474,866 01/2007 – 06/30/18

PI: 2007 – 2009 Chair oversight until move to UCSD

Child & Adolescent Services at Worcester Recovery Center and Hospital

MA Department of Mental Health Continuing Care Unit2

$44,025,462 01/2007 – 06/2018 PI: 2007 – 2009 Chair monitor & oversight until move to UCSD

Tobacco-Free Community Capacity Building / Community Partnership


$564,000 7/1/11 – 6/30/2020

Mentor to PI; Chair monitoring & oversight until move to UCSD

Children's Trauma Evidence-Based Practice Resource & Referral Service


$100,000 7/1/2016 – 6/30/2018

Chair monitoring & oversight until move to UCSD

Let's Talk - Recovery for Parents


$169,885 10/2016 - 06/2019 Chair monitoring & oversight until move to UCSD

Mobile Forensic Psychology Evaluation Team


$7,504,309 7/2010 – 06/2018 Chair monitoring & oversight until move to UCSD

30

Massachusetts Center of Excellence for Specialty Courts

Executive Office of Trial Courts


Evaluation of the Efficiency of the Juvenile Drug Court


$25,000 7/1/16 – 9/30/17 Chair monitoring& oversight until move to UCSD

Adult Drug Court Fidelity Monitoring Services


$51,865 10/16 – 9/30/17 Chair monitoring & oversight until move to UCSD

Validation of Detention Placement Instrument


$131,410 5/16 – 06/2018 Chair monitoring& oversight until move to UCSD

Reentry Service Delivery & Evaluation for Western Massachusetts


$278,059 10/2015 – 09/2017 Chair monitoring & oversight until move to UCSD

MISSION Implementation and Other Models of Diversion & Recovery for Traumatized Veterans


$1,378,682 7/1/13 – 6/30/17 Chair monitoring & oversight until move to UCSD

MISSION Court Related Enhanced Service for Treatment



MISSION Model on Cape Cod - Barnstable Drug Court

MA Executive Office of the Trial Court


MISSION Boston Metro for Chelsea & Quincy Drug Courts

MA Executive Office of the Trial Court


MISSION Forward: Training & Leadership of MISSION Model Delivery


$333,974 09/2013 – 2017 Chair monitoring & oversight

MISSION Housed: Training & Leadership of MISSION Model Delivery


$931,620 11/2013- 06/2017 Chair monitoring& oversight until move to UCSD

Educational / Training Grant Funding in Public Sector Clinical Programs:

Forensic Training MA Department of Mental Health.

$4,606,859 01/2007 – 06/2017 Chair monitoring & oversight

Psychiatry Residency Training MA Department of Mental Health


GME Enhancement Under the Veterans Access, Choice, and Accountability Act (VACAA) of 2014

Veterans Affairs Health Care Office of Academic Affiliations

$250,000 04/01/16 - 09/30/18 PI: Mattocks Co-I Ziedonis until move to UCSD

31

EXTERNAL PROFESSIONAL ACTIVITIES: PRESIDENTIAL NATIONAL-LEVEL ADVISORY & LEADERSHIP ROLES: 2002-2003 Consultant, President Bush’s New Freedom Commission on Mental Health

o Co-lead Co-Occurring Disorders Subcommittee & Co-Author of “Co-Occurring Mental Illness and Addiction” (Minkov, K. and Ziedonis, D.M.)

o Acknowledgement in Achieving the Promise: Transforming Mental Health Care in America President’s New Freedom Commission Report (2003)

2007 Advisor, President Bush’s Cancer Panel STATE-LEVEL LEADERSHIP ROLES: 1992-1998 Connecticut’s Department of Mental Health and Addiction Services (DMHAS)

Co-Chair, Dual Diagnosis Task Force 1992 – 1998; Co-Chair, Budget Option Subcommittee, 1992-1994 Co-Chair, Treatment Outcome Subcommittee, 1993-1994

1995-1996 Co-Chair Connecticut Governor's Blue Ribbon Commission on Addiction Services 1996-1998 Connecticut Governor’s Alcohol and Drug Policy Council Outcomes Monitoring, Youth and Family, and Treatment Committees 1998-2001 New Jersey State MICA Task Force and County MICA Task Forces 1999-2001 New Jersey Department of Mental Health’s MICA Critical Pathways Workgroup 1999-2003 State of New Jersey, Governor’s Council on Addictions, Leadership Forum Group 2000 New Jersey Department of Health Task Force on Addictions

2002- 2004 Co-Chair NJ Division of Addiction Services: Advisory Committee on Quality Standards 2002-2005 New Jersey Department of Mental Health Task Force on Co-Occurring Disorders

2007-2017 Massachusetts Department of Mental Health’s Senior Leadership Meetings with Commissioner and Deputy Commissioners

2009 Governor’s Special Commission on Oxycontin and Heroin (Governor Deval Patrick) 2014-2015 Massachusetts Hospital Association Trustees Advisory Council 2018-present California Institute of Regenerative Medicine, CIRM (Board Member – Alternate)

32

NATIONAL GRANT REVIEW PANELS, STUDY SECTIONS, COMMITTEES: 1993 Peer Reviewer, Substance Abuse and Mental Health Services Administration’s (SAMHSA)

Center for Substance Abuse Treatment (CSAT). Treatment Improvement Protocol (TIP): Screening, Assessment, and Treatment Planning for Patients with Co-Existing Mental Illness and Alcohol and Other Drug Abuse

1993 Technical Review Committee, National Institute of Drug Abuse (NIDA) 1994 Group Consultant Reviewer, NIDA Epidemiology and Prevention Review 1994 NIDA Concepts Review Meeting "Study of Psychiatric Co-Morbidity" 1997-1999 Ad Hoc Reviewer, National Institute of Drug Abuse, Clinical Treatment Research 1997-1999 Reviewer, National Institute of Drug Abuse Special Emphasis Panel:

Co-Occurring Disorder Treatment Research 1999 Reviewer, National Institute of Drug Abuse and National Cancer Institute, Special Review

Committee; Meeting: Transdisciplinary Tobacco Use Research Centers 1999 Reviewer, National Institute of Drug Abuse, Behavioral Therapy Development SRC 2000 Peer Reviewer, US Department of Health and Human Services Public Health Service:

Clinical Practice Guideline: Treating Tobacco Use and Dependence Project 2000-2001 Reviewer, National Institute of Mental Health (NIMH) Special Emphasis Panel:

Interventions ZMH1 ITV-D (01) 2001-2002 Work Group and Co-author, Center for Substance Abuse Treatment’s Co-Occurring

Disorder Treatment Improvement Protocol (TIP) 2001-2006 Advisor, Robert Wood Johnson Foundation / RAND Institute, Co-Occurring Disorder 2002 National Institute Health (NIDA, NIMH, NCI) Nicotine Dependence and Medication Development Experts Panel 2002-2004 Consultant & Co-organizer, Robert Wood Johnson Foundation, National Initiative

Advisory Panel: Addressing Tobacco Individuals with Mental Illness or Addiction. 2002-2004 Work Group Leader, SAMHSA Co-Occurring Disorder Treatment Improvement Protocol 2002-2004 Expert Consultant, Substance Abuse and Mental Health Service Agency (SAMHSA), Co-

Occurring Mental Illness and Addiction Report To Congress 2002-2004 Advisor, Substance Abuse and Mental Health Service Agency (SAMHSA), Co-Occurring

Disorders Initiative National Registry of Effective Programs 2004-2009 Senior Fellow, SAMHSA Co-Occurring Disorders Center for Excellence (COCE) 2005 NIMH Tobacco Use and Cessation in Psychiatric Disorders Workgroup 2005 SAMHSA Policy Academy 2006 Technical Report Consultant, National Association of State Mental Health Program

Directors (NASMHPD) Smoking Policy and Treatment at State Psychiatric Hospitals 2006 NIH (NIDA, NIAAA, NIMH) Methodology of Conducting Pharmacologic Clinical Trials in

Patients with Alcohol/Drug Dependence, and Psychiatric Co-Morbidity Workgroup 2006 Reviewer, National Institute on Drug Abuse. NIDA-K: The Training and Career

Development Review Committee and Special Emphasis Panels (SEPs) 2006 Robert Wood Johnson Foundation, Smoking Cessation Leadership Center 2006-2010 Reviewer, National Institute of Mental Health NIMH Mental Health Services in MH

Specialty Settings Review Committee (SRSP) 2006 Expert Advisory Group, American Legacy Foundation “Bringing Everyone Along:

Reaching Smokers with Mental Health and Substance Abuse Disorders” Project 2007 Content Review Expert, National Development and Research Institutes, New York

initiative to integrate tobacco use interventions into addiction treatment programs. 2008-2010 Advisory Board, Center for Behavioral Health Services Criminal Justice Research

33

2008-2009 Institute of Medicine (IOM) Committee on Gulf War and Health: Smoking Cessation in Military and Veteran Populations, Institute of Medicine of the National Academies

2011 SAMHSA Pharmacotherapy Expert Consensus Panel on Pharmacological Treatment of Co-Occurring Disorders, Westat Corporate Headquarters, Rockville, MD

2011 Special Emphasis Panel, NIH / NIDA Consultant/ Telereviewer. RO1/R34 Review/ZDA1GXM-A

EDITORIAL POSITIONS: 1982-1984 Pennsylvania Medical Society – Insider (Co-Editor) 1987-1990 American Psychiatric Association’s Psychiatric Residents Newsletter (Co-Editor) 1987-1991 The Jefferson Journal of Psychiatry (Editorial Board) 2005-2007 Journal of Substance Abuse Treatment (Editorial Board) 2008-2009 Neuropsychiatry Reviews (Editorial Board) 1992-2012 The American Journal of Drug and Alcohol Abuse (Editorial Board) 2011-2012 Journal of Dual Diagnosis (Editor, Special Edition 2012) 2011-2017 The Scientific World Journal (Editorial Board) 2004-2017 Journal of Groups in Addiction and Recovery (Editorial Board) 2007-present Journal of Dual Diagnosis (Editorial Board) 2014-present General Psychiatry [formerly - Shanghai Archives of Psychiatry] (Editorial Board) JOURNAL REVIEWER: About six times per year serve as a reviewer on a variety of Journals (initial date), including, Archives of General Psychiatry (1988), Drug and Alcohol Dependence (1990), The American Journal of Drug and Alcohol Abuse (1990), The American Journal on Addictions (1993), Journal of Clinical Epidemiology (1993), Schizophrenia Bulletin (1995), Schizophrenia Research (1996), Biological Psychiatry (1997), Nicotine and Tobacco Research (1998), American Journal of Geriatric Psychiatry (1998), Neuropsychopharmacology (1998), Journal of Psychotherapy Practice and Research (2000), Health Psychology (2000), Journal of Substance Abuse Treatment (2000), Administration and Policy in Mental Health and Mental Health Services Research (2006), Journal of Family, Systems and Health (2009), Human Genetics (2011), Social Psychiatry and Psychiatric Epidemiology Journal (2011), Molecular Psychiatry (2014), PLOS ONE (2017) BOARD OF DIRECTORS / ADVISORY BOARDS NATIONAL ORGANIZATIONS: 2011-2017 National Network of Depression Centers, Board of Directors 2011-2019 Skyland Trail National Advisory Board 2013-2018 RiverMend Health Scientific Advisory Board on Addictions 2014-2018 RiverMend Health Scientific Advisory Board on Obesity & Eating Disorders 2018-Present MINDS Foundation (non-profit NGO) - Advisory Council

34

DEPARTMENT OF VETERANS AFFAIRS (VA) HEALTH CARE SYSTEM ACTIVITIES VA San Diego Healthcare System 2017 – current

o Co-leader of Affiliation Partnership Council o Strategic Planning Collaboration meetings o Medical Education Collaboration meetings o Tobacco Use Disorder Academic Partnership Group

VA Central Western Massachusetts Healthcare System (formerly Northampton) 2007 - 2017

- Leader in academic partnership development for UMass Medical School (UMMS) & VA. - From no partnership with the VA, led the UMMS Psychiatry Department to have an active

role and be the lead UMass Department with the Central Western VA and Bedford VA. - Psychiatry resident training activity & faculty recruitment in Worcester CBOC since 2011. - Co-leader in transitioning Worcester CBOC to be on UMass Worcester - University campus.

VA Bedford 2007 - 2017

- Advisor, Center for Health Quality, Outcomes and Economic Research (HRS&D Center 07-14) - Leader in academic partnership development for UMass Medical School and Bedford VA

VA Boston 2007 – 2011 Worcester Community Based Outpatient Clinic (2007 - 2011) Established new academic partnership for UMass Department of Psychiatry VA New Jersey 1998-2007 Senior Consultant - Dual Diagnosis Program and Services (Addiction Psychiatry Residency)

Consultant Research Psychiatrist: Tested care coordination selected as "Promising Practice" VA West Haven CT / Yale University 1990 -1998 VA / Yale University Addiction Psychiatry Residency Program – Faculty supervisor Research Collaborator, MIREC on Co-Occurring Disorders VA Brentwood / Wadsworth (Greater Los Angeles) - UCLA (1985 -1990) Director, Dual Diagnosis Treatment & Research Program (1989 -1990) VA National Level Activities: Co-Occurring Disorders / Smoking Cessation 1998 -2006

• Cooperative Studies Review Committee – Multi-Center VA studies on smoking cessation • VA at the Vanguard: National Committee identifying strategies to address smoking veterans • Data Use Agreement Project with VA Central Office to use the EPR/SHEP Datasets.

Collaboration with VA Central Office, Thomas Craig (Chief Medical Officer/Office of QI). • VA Dual Diagnosis Task Force – Committee Member

35

GLOBAL HEALTH INITIATIVES (research, education, and clinical systems):

• Active in global initiatives throughout career, including at Davidson College, Penn State, UCLA, Yale, Rutgers / UMDNJ, UMass and UC San Diego.

o Initiatives include training, consultation, and research • The Global Health Initiatives are aligned with local diversity & multicultural projects

University of California, San Diego

• Health Sciences International (HSI) o Oversee HSI and support HSI Director at integrating strategic planning efforts with

other missions and engage with UCSD Campus Global Activities o https://medschool.ucsd.edu/international/Pages/default.aspx o HSI is a comprehensive center focused on education & training, research

collaborations, health care system consultations and technical assistance, health care at UCSD, and affiliations / School collaborations. Provides comprehensive support for students and faculty traveling globally or coming from abroad to UCSD, including MOU development for global partnerships with other Universities and agencies. Provides global leadership training programs at UCSD. Current formal partnerships in Mexico, Columbia, Argentina, Libya, Kuwait, Mozambique, Saudi Arabia, India, China, South Korea, and UAE. Support faculty doing academic work with colleagues in many countries that the office supports. Support clinical care.

• UCSD Campus Wide Global Initiative – working with the consultation of the American Council on Education’s Internationalization Laboratory, co-leading a campus wide effort to determine what centralized global office structure, scope of work, coordinating function, strategic planning collaboration, prioritization, etc should be done. Education, Research, Clinical Services, and Community-engagement/policy are missions for inclusion. Co-lead Workgroup focused on developing the initial plan and then engaging leadership and faculty. Current priorities include a focus with Mexico, China, and India.

University of Massachusetts Medical School Department of Psychiatry:

• Created and Sponsor Global Mental Health Office in Department of Psychiatry at UMass. http://www.umassmed.edu/psychiatry/globalini-tiatives/

Created and Sponsored China Mental Health Program at UMass http://www.umassmed.edu/psychiatry/globalinitiatives/chinaconnectionwelcome.aspx

Specific Global Health Project Examples (since 2007): Russia Collaborations 2007-2017

National Peace Foundation’s Russian Delegation Visit on Trauma, Addiction & Recovery - Primary Host (12/14/2007- 12/22/2007)

Moscow - Vavilov Institute of General Genetics, Russian Academy of Sciences Evgeny Rogaev PhD faculty at UMMS had trainees at UMass Psychiatry

https://medschool.ucsd.edu/international/Pages/default.aspx

http://www.missionmodel.org/manuals-1/


36

China Collaborations 2009 - 2019 Chengdu:

UCSD Health Sciences International (2018) o Sichuan University & West China Hospital (SU/WCH) Meetings

UMass MOU with SU/WCH (05/26/2009) • Completed research: (1) Addressing Tobacco Through Organizational

Change in China; (2) Neuroimaging First Break Psychosis, Tao Li (PI) o Shanghai: Shanghai Jiao Tong University School of Medicine / Shanghai Mental

Health Center (SJTUSM / SMHC) UCSD Collaborations – Visiting Scholar / Health Sciences International 2019 • Editorial board – General Psychiatry (Shanghai Archives of Psychiatry) UMass MOU (1/2013) - Min Zhao, MD, PhD (SJTUSM/SMHC)

o Shanghai: Tongji Hospital/ Tongji Hospital of Tongji Universty Collaborative visits and faculty exchange with Dr. Zhou (family therapy)

o Tianjin: Tianjin Medical University/Tianjin General Hospital/Tianjin Mental Health Center (TMU/TGH/TMHC). UMass MOU

o Beijing: Peking University Health Science Center. UMass MOU o Guiyang: Guizhou Medical University

Dr. Zhou – Visiting Professor at UMass with interests in mindfulness. Henan: Henan Province Mental Hospital/Xinxiang Medical University

Zhengzhou - The First Affiliated Hospital of Zhengzhou University. Dr. Song – Visiting Professor to UMass Psychiatry.

o Changsha: The Second Xiangya Hospital of Central South University UMass - President of China Psychiatry Association (Dr. Jing Ping Zhao)

o Kunming: The First Affiliated Hospital of Kunming Medical University UMass Psychiatry Visit Fang Liu

Korea Collaboration – Chonbuk National University Medical School 2010-2017

UMass collaboration with Dr. Sangkeun Chung, Chair of Psychiatry, including focus on multi-cultural issues for Korean Americans and schizophrenia and tobacco use in Korea. Hosted Dr. Chung as a Visiting Scholar at UMass Medical School for 2 years

Kenya Collaborations – Moi University 2012 – 2017

MOU executed with AMPATH Consortium to work with Moi University School of Medicine in Eldoret, Kenya to help build service, education, and research capacity

Mental Health Work Group member Sponsored UMass Psychiatry Resident Clinical Rotation.

Finland Collaborations - University of Jyväskylä 2012 – 2017

Faculty visits and training at UMass and University of Jyväskylä Training with Norway (University of Tromsø).

Latvia Collaborations – Riga Stradins University (RSU) 2013 - Present

UCSD – Elmars Rancans Visiting Scholar from RSU, 2019 UMass MOU executed with Riga Stradins University; Key Collaborators/Designated

Liaisons: DZiedonis (UMMS) and Elmars Rancans, MD, PhD (RSU) (11/13). Baltic-American Foundation Training Grant on Open Dialogue in Latvia (2016)

37

United Kingdom Collaborations 2012 - present UMass and University of Nottingham: Collaborative training initiatives on recovery

& community based participatory research. Joint Partnership MOU with Shanghai Mental Health Center, China; University of Nottingham; and UMass.

UMass / UCSD and North East London NHS Foundation Trust / University College, London – collaboration in Open Dialogue

Denmark Collaborations – Open Dialogue Network 2015 - present

o Mentoring Bjarne Vind (AC-medarbejder, Boog rehabiliteringstilbud Skovvænget) on Open Dialogue. Skovvænget program PhD Thesis advisor.

Italy Collaborations – National Ministry of Health 2015 - Present ° Collaboration with leaders in the National Ministry of Health.

• UMass / Open Dialogue project in Italy (cities of Turin, Savona, Ascoli Piceno, Rome, Catania). Project implementing our fidelity tools and training materials.

• Open Dialogue materials translated into Italian. • Dr. Giuseppe Salamina & Raffaella Pocobello, PhD. Institute of Cognitive Sciences

and Technologies (ISTC), Consiglio Nazionale delle Ricerche (CNR). Japan Collaborations 2016 - present

• Public Health / MEBYO Initiative UCSD and Public Health initiatives with School of Health Innovation (MOU) and

Tokyo University. Open Dialogue Collaborations - Student exchange and Collaborations with Cross

Boundary Innovation Program, Osaka University and Graduate School of Human Sciences, Osaka University. Open Dialogue materials translated into Japanese.

Poland Collaborations 2016 - Present

o Collaborations with Regina Bisikiewicz leader of the Polski Instytutu Otwartego Dialogu. Training partnerships. Open Dialogue translated into Polish.

Lithuania Collaborations 2016 - Present

o Collaborations with Jan Hilbig, consultant psychiatrist of the Centre for Psychosocial rehabilitation at Vilnius municipal mental health centre.

Open Dialogue materials translated into Lithuanian Bangladesh Collaborations – Rural Mental Health (2016 -2017)

UMass - Collaboration with David Jordan (USA), Frank Crossan, PhD (Professor in the school of nursing at Glasgow Caledonia University in Scotland), and others at Caledonia University (where Professor Yunus is the Chancellor) and at the Yunus Nursing School in Dhaka. Working to develop rural mental health plan and nursing student exchange.

38

INVITED PRESENTATIONS: NATIONAL / INTERNATIONAL MEETINGS Invited Lectures / Grand Rounds Presentations: Present invited lectures approximately 2 to 6 times per year at Universities nationally and internationally on topics related to Mental Illness, Addiction, Tobacco, Wellness, Burnout/Resiliency, Mindfulness, Leadership, and Medical Education. Example locations for past Grand Rounds or lectures include: Harvard-McLean Hospital, Yale University, Boston University, University of Massachusetts, University of Pennsylvania, Columbia University, NYU, UCLA, UCSF, University of Washington, University of North Carolina, Penn State, SUNY, University of Maryland, University of Hawaii, University of New Mexico, MAYO Clinic, University of Louisville KY, University of Michigan, University of Chicago-Northwestern, Vanderbilt University, Medical College of Virginia, University of Missouri, Temple University, RWJMS-Camden, RWJMS-Piscataway, the Menninger’s Foundation, University of Florida, University of Miami, University of Wisconsin, University of Texas-Houston, Harvard / McLean Hospital, Harvard / Cambridge Health Care system, University of Washington, Seattle, etc. Specific examples can be provided. National Conference Presentations: Present at invited national conferences approximately 2 to 6 national / international meetings per year on topics related to Mental Illness, Addiction, Tobacco, Wellness, Burnout/Resiliency, Mindfulness, Leadership, Career Development, and Medical Education Example conferences are for NIAAA, NIDA, APA, CPDD, Veterans Affairs, NIH, SAMHSA, RWJ Foundation, Addiction Institute of New York, ASAM, Future Leaders of Psychiatry, AAMC, Chair Summits, IOM, IHI, National Conference of State Legislators, Cape Cod Symposium on Addictive Disorders, Healthy Kitchens/Healthy Living, AAAP, Joy of Medicine Conference, Healthy Aging Conference, and American Thoracic Society’s Annual Meeting. Specific examples can be provided. International Presentations: Present at invited international conferences approximately 2 to 5 times per year on topics related to Mental Illness, Addiction, Tobacco, Open Dialogue, Medical Education, and Leadership. Example locations are the Centre for Addiction and Mental Health in Toronto, Sichuan University in Chengdu, China, Peking University in Beijing, China, University of Jyvaskyla, Finland, Institute of Cognitive Sciences and Technologies, National Research Council, Rome, Italy; European Congress Symposium, Geneva, Switzerland; International Psychosis Conference, Lithuania; Riga Stradins University, Latvia; Baltic American Collaboration, Latvia; West China Hospital, Chengdu, China; International Open Dialogue Research Collaboration Conference, London, UK; Peer Supported Open Dialogue Conference, London, UK; International Congress on Addiction / Congrès International d’Addictologie de l’ALBATROS; Paris, France; World Congress of Latvian Scientists, Riga Latvia; Open Dialogue World Conference, Tokyo, Japan & Kyoto, Japan. Specific examples can be provided.

39

Contributions to Promoting Diversity

Throughout my 30-year career I have enhanced inclusive excellence that resulted in many personal, team, and institutional contributions to promote equity, diversity, and inclusion (EDI) amongst faculty, staff, and students, including increasing access, institutional and personal accountability, and creating a more welcoming and respectful climate. This work has enhanced recruitment and retention for women and URM, mentoring activities, research activities, teaching and curriculum, and community partnerships (locally and globally). These efforts include developing and implementing strategic plans and engaging large communities in a process to enhance inclusive excellence, including through existing and new organizational structures as well as conversations with individuals and groups. My contributions have considered many dimensions of human differences and diversity, including race, ethnicity, gender, sexual orientation, mental and physical disability, age, religion, military service, socioeconomic status, and organizational roles. Contributions in research studies have included attempts to better understand and help diverse populations or consider diversity dimensions, developing global initiatives across the world, in creating local multi-cultural clinical initiatives, and in serving on numerous community boards and developing community partnerships. As a senior leader (Associate Vice Chancellor, President, Chair, Division Director, and Board of Trustee) I have led culture change initiatives, system-wide discussions of critical diversity issues, and sponsorship. As a first-generation Latvian American who grew up bi-culturally with immigrant parents, I am very sensitized to the impact of cultural background, acculturation and immigration. Embracing cultural humility, diversity, and being inclusive has been core values. I have led multi-cultural initiatives in research, clinical services, education, and community for students, faculty, staff, and patients. Specific Examples of EDI Contributions during the past 13 years at UC San Diego & UMass include: • Initiator and leader for the first Equity, Diversity and Inclusion (EDI) Summits for UCSD Health

Sciences & Health with the goal to enhance strategic planning, awareness, and have individuals, teams, and the organization create action plans. I lead an Advisory Planning group of faculty, students, and staff that prepares the annual Summits, creates a catalog of best practices, provides training to teams and individuals, and has numerous workgroups on related activities. Examples of specific programs have been gender-focused and initiatives to enhance changes supportive for URMs, American Indians, Hispanics/LatinX, and African Americans.

• Serve on the UCSD Equity, Diversity, and Inclusion Advisory Council (Health Sciences representative) which is a campus-wide initiative for inclusive excellence. This Council advises the Vice Chancellor for EDI and the EDI office on creating a system strategic plan, new accountability meetings with each Vice Chancellor / Dean unit on UCSD campus, with a structure for public accountability on progress, new incentive plans for change, and specific program support.

• UC & UCSD Healthy Campus Network (HCN): Sponsor & Co-lead HCN and lead our work to address health disparities, inequities, and inclusive excellence, including using participatory action strategies of engaging those who would benefit from the service, “nothing for us without us” concepts, and particularly engaging the full range of diverse populations in the UC system and community.

• As a system leader at UMass, was co-leader in numerous system wide initiatives to enhance student, staff, and faculty diversity, address barriers, increase education and feedback, and expand programs within the institution. These efforts included serving on several Diversity & Inclusion Committees and sub-committees and working closely with Chief Diversity Officer, on several projects promoting

40

recruitment, retention, and mentoring of minority students and faculty. I initiated a leadership training on diversity and inclusion in-service, including use of Advancing Inclusion book.

• 2010, UMMS Postdoctoral Recruitment Process Committee (& Diversity/Inclusion) • 2010-2012, UMMS Faculty Recruitment Process Committee (& Diversity/Inclusion) • 2011, served on the Expedited Process, Training Process, and Outreach and Advertising

workgroup (subcommittee of Faculty Recruitment Process Committee. • The University of Massachusetts Medical School’s Executive Council Ad Hoc Workgroup

on Underrepresented Minorities (URM) in Academic Health Sciences • Leader in UMass Diversity Summit III leadership group, and Prioritization Workgroup on

URM in Health Care Among Faculty and Students at UMMS. • Reviewed existing student and faculty programs to determine which effective

(Health Sciences Preparatory, Pathway to Graduate Study, and BaccMD programs). • Developed and implemented a strategic plan to expand student scholarships for

URM medical students, including to biomedical science and nursing schools. • Created “diversity champions” in Psychiatry who inventoried educational programs

in cultural competence nationally and assessed efficacy & suitability to implement.

• Developed and added a “Diversity Section” to annual faculty evaluations to share about activities for students, faculty, patients, recruitment, research, multi-cultural community projects, etc. After our Department successful pilot of assessing contributions to diversity, Vice Provost of Faculty Affairs added this section all faculty evaluations at the University of Massachusetts Worcester Campus (all three schools).

• Led Psychiatry Department’s first Strategic Planning process, including diversity and inclusion • The Department’s Executive Committee and Leadership Team integrated Diversity as a value within

our Psychiatry Strategic Planning and included in Mission, Vision and Values statement. • Strategic plan led to range of successes in talent management (recruitment, retention,

advancement, leadership) and helping faculty from diverse backgrounds to report feeling connected and belonging. Enhanced multicultural research, curriculum, global partnerships, a Multi-Cultural Academic Interest Group, and changing monthly departmental meetings to be inclusive of faculty, staff; and students where the contributions were regularly recognized.

• Achieved a more diverse workforce and in sponsoring leaders from under-represented groups which transformed our department leadership from being only white and male to 50% women & 25% minority and recruiting 20% more women and 40% more URM joining faculty, staff, and trainees.

• Sponsored Vice Chair for Research on Executive Leadership in Academic Medicine (ELAM) award and mentored on her project: “Faculty Diversity at UMass: The Road Less Traveled” in which data was collected to better understand the current climate, barriers, and support systems available to our under-represented minority faculty, leading to initiatives for recruitment and retention.

• Establishment of the Career Development and Research Office (CDRO) helping faculty in general and with specific mentoring and outreach programs for women and minorities.

• Pipeline Program of engaging with the Central MA community and URM students in local colleges and high schools to participate in several student programs in Department, including a Brain Bee, summer internships, an academic interest groups, and research mentorship programs.

• Created a Global Mental Health Office and established new formal partnerships for research, training, and consultation work in many countries. This program also aligns with our multi-culturally oriented programs for refugees and immigrants from many different cultures.

41

Personal Activities in Mentoring, Research, Education, Clinical, and Other: • Mentoring: At the University of Massachusetts Medical School, honored with the Woman’s Faculty

Award for Outstanding Mentoring to Women Faculty. The range of my mentoring with faculty and students has been helping with their career development, learning research skills, developing teaching skills, and developing clinical skills. The many faculty members I have mentored have included over 50% women, many underrepresented minorities and many from other countries.

• Successfully mentored many women (and men) and URM who have very successful academic careers, including as primary mentor for faculty with NIH, VA or other research career awards. • Received NIH minority supplement awards for several students and faculty on my R01 grants

and have helped other faulty learn about this method to enhance their URM mentoring. . • Mentored faculty on Faculty Diversity Scholar Award focused on stigma and mental illness,

which has led to increased focus for that person’s career on internal / external stigma. • Served on an NIMH Minority Mentoring Program for junior faculty.

• Research on Diversity: Throughout my 30-year research career I have included multi-cultural

research through analysis of different human dimensions (gender, ethnicity, physical disability, mental illness / physical illness, etc) with most of my publications including diversity groups.

• As PI on the Center for Mental Health Services Research, we initiated a policy to review all grant proposals for efforts to embrace diversity and integrate cultural competence. This enhanced our applications, increased our recruitment of URM and women, led to advisory groups from the community we serve, & new areas of diversity research.

• Research & community work with Homeless Veterans (our MISSION model) resulted in policy changes, national training programs, and reduced homelessness.

• Research, post-doc program, and clinical services work resulted in our team being were awarded the Massachusetts Commission for the Deaf and Hard of Hearing’s Outstanding organization of the Year Award (Department of Psychiatry – DeafYes! Program).

• My research on mental illness and addiction disability also focuses on a common disability that results in stigma and most severe health disparities and other impacts.

• Education: Have taught classes and workshops on EDI issues for faculty, staff, and students.

• Developed a Spirituality Assessment lecture for all UMass medical students in 2007 that became a core ongoing lecture as part of the effort to enhance cultural competence.

• Clinical Services: Have focused on expanding clinical services to meet the needs of underserved populations considering the social and environmental determinants of health, health disparities, and racial justice, including community outreach, engaging the community in creating multi-culturally based clinical services (family based treatments, couples based treatments, etc) and for addiction services. Great impact on Tobacco Addiction services in New Brunswick NJ to engage the community (ex. Increased from 2% to about 30% patients who were Hispanic / Latino to match the population of the community through extensive community partnerships).

• Community Engagement – in all mission areas. Have served on boards of community-based

agencies that focused on URM populations.

42

Other Activities COMMUNITY SERVICE 1990-1998 South-Central Connecticut Mental Health Network

Dual Diagnosis Committee, Chair, 1990-1998 Annual Dual Diagnosis Conference Committee, Chair, 1990-1998 Clinical Services Committee, 1994-1998

1997-2000 Ethics and Morals Study Commission, Consultant Latvian Evangelical Lutheran Church in America 2007-2017 Central Massachusetts Addiction Consortium, Founding Chair 2007-2017 Pipeline Programs for Massachusetts High School Students

• “Brain Bee” – sponsor – about 50 to 100 high school students per year participate • Neuroscience and Mental Health Academic Interest Group – co-developer and

sponsor • Neuroscience and Mental Health Summer Internship Program – co-developer and

sponsor 2008-2009 St. Luke’s Roosevelt Hospital Center, NYC, External Reviewer, Psychiatry 5 Year Review 2009 Chair, University of Connecticut, Review Team, Department of Psychiatry, 5 Year Review 2009-2017 “Be Mentally Well” – developer and sponsor of twice yearly community education program 2010-2017 Community Engagement Workgroup – developer and sponsor 2011 Worcester Anti-Tobacco Task Force, The Worcester Division of Public Health and the

Central MA Tobacco-Free Community Partnership, UMass Department of Psychiatry 2011 Massachusetts Hospital Association – Tobacco-Free Hospitals Initiative. Webinar

Panelist: “Tobacco-Free: Patients, Policy, & Practicum” & resource developer 2012-2017 Member, Advisory Board for the Hector E. Reyes House in Worcester, Massachusetts 2013-2017 Worcester City Public Health Department Workgroup 2015 Member, Bullying Synergy Project Advisory Board, UMass Medical School 2016 Worcester MA District Attorney Joseph D. Early, Jr.’s Opioid Task Force 2017-present Healthy Campus Network – Campus & Community Programs in San Diego County 2019-present Childhood Obesity Initiative – (Co-PI with Blanca Melendrez, PI) on County community partnership program with 400 agencies across the County of San Diego. Program described: https://sdcoi.org/who-we-are/

https://sdcoi.org/who-we-are/

43

LEADERSHIP & MANAGEMENT TRAINING: UCLA Tavistok Authority and Leadership Training 1987-1990 Yale University School of Management 1997-1998 Leadership and Decision Making Center for Mindfulness, UMMS Mindful Leadership: March 2010 AAMC Philanthropy Workshop: Strategies, Best Practices February 2011 Crucial Conversations Training for Leaders, Worcester, MA September 2011 Intermountain Health Care - Introduction to Quality Improvement For Physicians - taught by Brent James, Salt Lake City, NV November 2011 Leadership Training Retreat: The Leader’s Toolbox March 2012 by Ralph Jacobson, Worcester, MA Institute for Healthcare Improvement (IHI), Quality Improvement May 2012 Leadership in Cultural Transformation May 2013 ThedaCare Corp., Appleton, Wisconsin AAMC Council on Deans Fellowship 2013 - 2014 AAMC 2014 Executive Development for Deans (Washington DC) January 2014 Building The 21st Century Physician Leadership Curriculum August 2015 Physician Foundation, Babson Executive Center Healthcare Value Network (HVN) Lean Principles from the Shingo Model November 2015 Gemba Visit – Theme: A System Design Journey September 2016 ThedaCare Center for Healthcare Value / Catalysis November 2016 CEO Site Visit Training Liberating Structures Immersion Workshop August 2017 Creating a Culture of Innovation EXECUTIVE BUSINESS COACHING PROFESSIONAL CERTIFICATIONS COMPLETED: 2015 World Association of Business Coaches (WABC)

Registered Corporate Coach (RCC) - “Business Coach Designation” Completed Corporate Coach Training Program (2015)

2014 Everything DiSC Coaching Assessment Certification Self-assessment, team, & 360 versions - IMPACT (2014 certification)

2015 Eq-I 2.0 (emotional intelligence) Coaching Assessment Certification Point of Leadership Training / Multi-Health Systems (MHS, 2015 certification)

2016 Pearman Personality Integrator Coaching Assessment Certification Point of Leadership Training / Multi-Health Systems (MHS, 2016 certification) 2017 Mayer-Salovey-Caruso Emotional Intelligence Test (MSCEIT) Coaching Assessment

Multi-Health Systems (MHS, 2017 certification) Black Belt Lean / Quality Improvement Certifications: 2013-2016 Center for Innovation and Transformational Change at UMMHC Lean Black Belt Certification (2016)

• Shingo Training & Six Sigma Training • Lean White Belt (2013), Yellow Belt (2013) & Green Belt (2014)

44

Education / Student Instructional Activities University of California, San Diego (UCSD) Associate Vice Chancellor for Health Sciences (2017-present)

• Oversight role has included all aspects of health sciences education and student matters, including support to all professional schools and departments in Health Sciences (Medicine, Pharmacy, & Public Health), and inter-professional education

o Chief Academic Officer role oversight of Medical Education Office (UME, GME, CME, and admissions/student affairs) through the successful 2018 LCME re-accreditation.

• Strategic Academic Program Development – Health Sciences representative to UCSD campus wide initiative led by the Chancellor to increase online Masters, Certification Programs, and Courses (2018-2019)

o Inter-professional Education: Oversee inter-professional education and collaborate with Deans to enhance coordination in Health Sciences and with campus

• New UCSD School of Public Health – (2017-2019) led the development of the UCSD School of Public Health initial proposal and with a great team oversaw the 2-year approval process in becoming an approved UC Regent SPH (2019). The process included engaging 100s of faculty, students, staff, and administrative leaders from Health, Engineering, Business, Social Sciences, Humanities & Arts, Scripps Institution of Oceanography, Qualcomm Institute, Design Lab, etc.

o Chair, Executive Council for SPH proposal & SPH Proposal Advisory Committee o http://senate.ucsd.edu/media/288495/sph-pre-prop-review-docs-10-2017.pdf

234 page proposal submitted in October 2017 • Masters in Public Health degree program (2018 start)

o Senior Administrative Advisor to the Director of the MPH program.

UNDERGRADUATE MEDICAL EDUCATION (UME): Active in medical student teaching / curriculum development and medical student well-being / mental health services in all institutions in past 30 years, including Penn State, UCLA, Yale, UMDNJ, UMass, and UCSD. Expertise on addiction, mental illness, spiritualty, well-being/resilience, leadership, mindfulness, and wellness education & curriculum for medical students. Active in International level / Global Medical Student Education, including invitations to international meetings focused on medical student training, including international student clerkships and cross-cultural meetings. Since serving as a Council of Dean’s Fellow for the American Association of Medical Colleges (AAMC), have been active on various AAMC groups: Liaison Committee on Medical Education (LCME) Survey Team (2014 - present) & AAMC Group on Student Affairs (GSA1) Committee – (2014-present). In addition, also AMA / ASAM Summit on Strategies for Integrating Knowledge about Substance Use and Related Disorders into the Curricula of Medical Schools in HHS Region I. Have been active in AMERSA focused on medical student education on addictions University of California, San Diego School of Medicine

Oversee Medical Education Office as Chief Academic Officer (2017-2018) through successful LCME review (April 2018)

New England Association of Schools and Colleges (NEASC) – UMass Medical Accreditations

o Leadership Workgroup

http://senate.ucsd.edu/media/288495/sph-pre-prop-review-docs-10-2017.pdf

45

o Midterm Accreditation Workgroup UMass Medical Student Education Activities at University of Massachusetts:

• Medical Student Curriculum Redesign at UMass (2007 -2017) • Leader in complete medical student curriculum redesign at UMass • Learner-centered Integrated Curriculum (LInC) Steering Committee 2008-2012 • Redesign and oversight of Medical Student Curriculum in Psychiatry • Co-Sponsored – Annual Complementary & Integrative Therapies Expo • Co-Sponsored – New Medical Student Electives, including addiction, mindfulness, complementary and alternative medicine, collaboration with Betty Ford Center • Faculty mentor, CAPSTONE Project (medical student scholarship program)

• Medical student selection process • Multiple Mini Interviewer for Admissions Office (2013 – 2014 recruitment year) • Associate Dean of Admissions Search Committee – 2014

• LCME site visit preparation and LCME visit at UMass (2011 – 2012) o LCME Self-Study Guide Leadership Group o LCME Self-Study Subcommittee on Student Health Services, Financial Aid, Academic

Counseling • Chair oversight of Medical Student Education in Psychiatry

o Core courses during the first two years and a 5-week clerkship for 3rd year medical students and 4-year student electives to UMMS and visiting students.

o Adapted and expanded our programs to include new clinical sites and integrated curriculum as the medical student class size expanded from 100 students per year to 150 with planning for the increase to 162 students per year.

o Created Vice Chair Education position and Office of Psychiatric Education & Training o Sponsored expansion of use of educational technology, SIMS Center for OSCE and

other training, Technology Training for Psychiatric Educators, Global Perspectives program, and Competencies / Milestones expansion.

Specific Medical Student Teaching / Course Curriculum Development Leadership: University of California, San Diego: 2017 – present

UC system wide Opioid Curriculum Workgroup – 1 of 3 UCSD representatives; developed a shared and portable curriculum across the 5 UC Medical Schools.

Mindful Leadership – graduate student course across campus Medical School Elective Course – Course Director for mindful leadership course open

for medical students, pharmacy students, and public health students (IPE) Lectures in Courses: Master’s Public Health (integrative medicine, addiction, health

services), Masters in Leadership (Value Based Care), Psychiatry (addiction)

University of Massachusetts Medical School: 2007-2017 Mind, Brain, Behavior II Course for Medical Students

• Addiction Lecture (2007 – 2017) • Spiritual Assessment: Coping with Illness Lecture (2007 – 2017)

Tobacco Addiction Rounds (TAR) for Medical Students on C/L rotation

46

• Developed Training Experience / Provide Clinical Supervision Mindfulness & Behavioral Health Senior Elective – faculty leader Complementary & Alternative Medicine Symposium – sponsor for annual event Addiction Training – systematic review of all four years and ongoing improvement plans Opioid Safe-prescribing Training Immersion (OSTI) – faculty small group leader (SIMS Center)

• Core educational experience of the Opioid Conscious Curriculum (OCC) Robert Wood Johnson Medical School: 1998 – 2006 Clinical Supervisor for Medical Students within the University Behavioral HealthCare System Third Year Medical Students Psychiatry Clerkship − Addiction Lectures Second Year Medical Students / Behavioral Science and Psychiatry Course, 1999-2004 ASAP Elective for MSII Medical Students, Faculty Sponsor, 1999-2001 First Year Medical Students – Case-Based Learning, 1998-2003 Yale University: 1990-1998 Substance Abuse Treatment Unit Seminar Series for Medical Students and Residents, Coordinator and Faculty, 1990-1993

Substance Abuse Seminar for all Third-Year Medical Students (during the core Psychiatry Clerkship), Seminar Coordinator and Faculty, 1990-1998

Substance Abuse / Dual Diagnosis Seminar for CMHC Outpatient Division (weekly seminar, September through April), Seminar Coordinator and faculty, 1994-1998

Clinical Supervisor for Medical Students, Psychiatric Residents, and Fellows, 1990-1998 University of California Los Angeles (UCLA): 1987-1989 Psychiatry Interviewing Course for First Year Medical Students, Instructor - 1987

3rd Year Med Student Clerkship Instructor: Affective Disorders & Biopsychosocial Model 1988-1989 Substance Abuse Seminar for First and Second Year Medical Students, Co-organizer, 1988-1989 Clinical Fundamentals Course for Second Year Medical Students, Instructor, 1989 Pennsylvania State University: 1984-1985 Physical Diagnosis Course for Medical Students, Instructor, 1984 Substance Abuse Seminar for Medical Students, Coordinator, 1984-1985

47

GRADUATE MEDICAL EDUCATION (GME): RESIDENT & INTER-DISCIPLINARY EDUCATION LEADERSHIP & TEACHING Active in GME leadership and teaching activities, including progression of leadership roles to AVC / Chief Academic Officer (all Health Sciences’ School of Medicine Departments), Department Chair (Psychiatry), Addiction Psychiatry Residency Program Director, faculty mentor, and teacher, including for medical residents, fellows, psychology interns, and post-docs. Experience in ACGME accreditation reviews; and developing ACGME approved and non-ACGME GME programs.

University of California, San Diego (2017 – present) Associate Vice Chancellor

• Oversight of Academic Resource Center to support all SOM Departments on resident employment matters, in Chief Academic Officer role had oversight of GME (2017-2018), and focus on inter-professional education, well-being, and work with UCSD Health DIO.

• Coordinate education across medical, pharmacy, and public health studies with an emphasis on inter-professional education and team education.

University of Massachusetts Medical School: 2007-2017

Department Chair of Psychiatry Oversight of 6 residency programs and Psychology Pre-Doctoral Interns-Residents and Post-Doctoral Programs and Students.

• Oversight of American Psychological Association accreditation process and updates. • Sponsor of new educational initiatives in milestones project, Psychiatry library resource

guide, educational technology innovation integration, new international electives (AMPATH), creation of addiction psychiatry fellowship, expansion of Child Psychiatry residency program, development of management training, and a Leadership College.

• Inter-disciplinary partnerships with UMass medical school, graduate nursing school, and graduate school in Basic Biomedical Sciences and Clinical & Translational Sciences

• Lead on Teaching / Curriculum for Residents: Chair’s Case Conference with Residents & Service Lines

Biological Psychiatry Seminar for PGYIII and IV Residents Didactic Seminar Series for Psychiatry Residents Addiction Psychiatry Seminar for Residents / Fellows Clinical Supervision – Addiction Psychiatry Clinical Program Psychology Interns Lecture of Co-occurring Disorders Leadership and Management Seminar for Residents Research Career Writing Group mentorship group

UMass Addiction Psychiatry Residency Training Program PGY-5 Leadership Group Faculty Development Group Addiction Psychiatry Residency Program Development Work Group Addiction Psychiatry Residency Program / Fellows - Supervisor

Graduate School of Biomedical Sciences – Neuroscience Program – graduate student sponsor

48

GSBS - Clinical & Population Health Research Program – graduate student sponsor UMass Graduate School of Nursing – IPE training and faculty sponsor

Robert Wood Johnson Medical School (1998-2006): Addiction Psychiatry PGY-V Residency Program, Director, 1998-2006

- developed Addiction Psychiatry Fellowship and ACGME approval (1999,) with 3 Residents / Fellows per year

Substance Abuse Seminar for Child and Adolescent Psychiatry Fellows, 1999-2006 Clinical Supervisor for Psychiatric Residents, Addiction Psychiatry Fellows, and Psychology Interns

within the University Behavioral Health Care System, 1998-2006 Substance Abuse Seminar for Second Year Psychiatry Residents, 1998-2006 Substance Abuse Seminar for Fourth Year Psychiatry Residents, 1998-2006 Second Year Residents Psychopharmacology Seminar, 1999-2006 Rutgers University / Rutgers School of Public Health (Tobacco Treatment Specialists) Tobacco Treatment Specialist (TTS) certification training program Princeton Theological Seminary Courses (seminary graduate students): Faith and Addiction, 1999-2000 Spirituality and Health, 2000-2005 Yale University (residents, psychologists, and public health students): Psychiatric Emergency Room Seminar Series for Residents, Faculty Lecturer, 1990-1993

Substance Abuse Treatment Unit Seminar Series, Coordinator and Faculty, 1990-1993 Psychopharmacology Seminar for Second Year Psychiatry Residents, Faculty Lecturer, 1990-1998 Yale's Comprehensive National Boards Review Course, Faculty Lecturer, 1992-1995 Psychiatric Epidemiology Seminar, School of Public Health, Faculty Lecturer, 1994 to 1998 Introduction to Substance Abuse Seminar - 10 week seminar, Coordinator and Faculty, 1994-1998 Seminar on Family Study Methodology, Genetic Epidemiology Research Unit, Faculty, 1994-1998 Substance Abuse / Dual Diagnosis Seminar for CMHC Outpatient Division (weekly seminar,

September through April), Seminar Coordinator and faculty, 1994-1998 Clinical Supervisor for Psychiatric Residents and Substance Abuse Fellows, 1990-1998

University of California Los Angeles (UCLA): Assessment and Interview Course for Second Year Psychiatry Residents, Coordinator, 1989 Substance Abuse Seminar Course for Second Year Psychiatry Residents, Coordinator, 1989

Substance Abuse Seminar: Instructor, 1989 Substance Abuse Fellowship – developed the Fellowship Program and secured funding 1989 – 1990

49

CONTINUING MEDICAL EDUCATION (CME):

CURRICULUM & LEADERSHIP ACTIVITIES – Health Sciences, Department, National, and Global: University of California, San Diego (2017 – present) Associate Vice Chancellor (2017 – present) Coordinating role across schools (pharmacy, medicine, and public health); have had oversight of UCSD CME Office in Chief Academic Officer role (2017 – 2018) including hiring of new Associate Dean for CME and Faculty Teaching Development. Executive Director, UCSD Center for Mindfulness (2019 – present) Oversight of our CFM’s Mindfulness-Based Professional Training Institute which provides continuing education programs locally, nationally, and globally. There are teacher certification training programs in: Mindfulness Based Stress Reduction (MBSR), Mindfulness Based Cognitive Therapy (MBCT), Mindful Eating – Conscious Living (MB-CL), and Mindful Self Compassion (MSC). Additional Training Programs: mPEAK CTI: Mindful Performance Enhancement, Awareness & Knowledge Coach Training Intensive, MFY: Making Friends with Yourself: A Mindful Self-Compassion Program for Teens & Young Adults Teacher Training, and MBCP: Mindfulness-Based `Childbirth and Parenting. University of Massachusetts Medical School (2007 -2017)

Chair oversight of CME activities for the Department of Psychiatry.

Sponsored an active program across the Department with many faculty involved. Every year led several CME events in my specific content areas of expertise (Addiction, Tobacco, Wellness, Compulsive Overeating / Food Addiction, Mindfulness, Co-Occurring Mental Illness and Addiction, etc). Sponsor our weekly Psychiatry Grand Rounds and annual Public Sector Conference, annual Research Day, and annual DMH Center of Excellence Conference.

National and State Level Organizations CME Activities: Lead / Co-leader for National, State, Professional Organizations annual CME events, including numerous years with the American Academy of Addiction Psychiatry, American Society of Addiction Medicine, Departments of Mental Health / Public Health (CT, NJ, MA), etc American Academy of Addiction Psychiatry (AAP): Lead consultant in developing Performance in Practice (PIP) for certification for Maintenance of Certification. PIP is entitled: “Improving Patient-Centered Outcomes in Treating Patients with Substance Use Disorders Who Are Also Tobacco Users: Performance in Practice (PIP). ” Sponsored by the AAAP to help psychiatrists fulfill the American Board of Psychiatry and Neurology (ABPN) Part 4 PIP requirement, which requires a quality improvement project to improve their practice.

50

Global & National Continuing Medical Education Programs: Leader and Developer / Co-Developer of curriculum, trainings, and evaluations for CME and in Dissemination & Implementation Science research projects. Topics include:

• Co-occurring mental illness and addiction o Dual Recovery Therapy; Motivation Based Treatments; MISSION model,

• Addressing tobacco addiction o Learning About Healthy Living, Treating Addiction to Nicotine in Schizophrenia,

ATTOC, and UMDNJ Tobacco Treatment Specialist (TTS) certificate program. • Mindfulness / Compassion Based Interventions & Wellness and Resiliency

o Mindful leadership, Mindfulness Based Interventions, & Joy of Medicine. • Family / support network based interventions

o Open Dialogue, Couples Therapy This work required developing training manuals, training programs, fidelity scales, and evaluating the impact of the teaching and the outcomes from integrating into practice. Training methods include didactic seminars, small group discussion, ongoing supervision / trainings, train-the-trainer approaches, flipped-classroom, and use of educational technology.

Training and Developing Curriculum for Clinical Skills, Train-the-Trainer, and Fidelity: Co-Occurring Disorders & Homelessness: Dual Recovery Therapy / MISSION model Training Curriculum and Training Developer of curriculum and training programs for co-occurring disorders (Dual Recovery Therapy and Motivation Based Treatment approach), and co-led development of MISSION model approach which integrates these co-occurring disorder treatments in addressing homelessness (8 MISSION training manuals and two translated into Spanish with needed cultural adaptations). Training is inter-professional and multi-disciplinary, including, psychiatry, psychology, nursing, counseling, and primary care. MISSION training was implemented into numerous VA Medical Centers. Tobacco Use Disorders (TUD) & Addressing Tobacco Through Organizational Change (ATTOC): Led the development of the ATTOC organizational change approach and have integrated TUD training based on work from Tobacco Treatment Specialist certification program that I co-developed at Rutgers / UMDNJ and other curriculum for lower and higher motivated patients (Learning About Healthy Living, Treating Addiction to Nicotine in Schizophrenia, etc). CME and organizational consultation trainings have occurred locally, regionally, nationally, and globally. Mindful Leadership Program Training for Health Care Workers Leader and Developer of curriculum and training programs on mindful leadership for health care workers and also integrate training for peer support and mindfulness-based interventions for addiction, mental illness, and pain patients. CME local, regional, national, and global.

Family / Support Network Interventions (Open Dialogue, Couples & Family Therapy): Leader and Co-Developer of curriculum and fidelity materials for Open Dialogue model, including couples and family therapy intervention training and curriculum development in Open Dialogue and Dual Recovery Therapy. CME local, regional, national, and global.

51

FACULTY MATTERS: ACADEMIC AFFAIRS & FACULTY AFFAIRS (INCLUDING CAREER DEVELOPMENT & RESEARCH MENTORSHIP PROGRAMS): University of California, San Diego Associate Vice Chancellor (AVC) for Health Sciences * Oversee Academic Affairs Office (AA), which provides oversight and assistance for academic appointments and advancement, faculty compensation, and interpretation of UC policies. The Office provides expert, objective guidance to faculty, departments and health sciences schools in the advancement and retention of faculty academic appointees and in support of the Health Sciences mission of exceptional teaching, research, and patient care.

• Office has an Academic Resource Center (ARC) with staff who function as a shared service to all Health Sciences Departments to support Department functions for faculty (paid and voluntary), staff physicians (non-faculty), project and research scientists, post docs & visiting scholars, graduate student researchers, including Recruitment Process, Scholars, Personnel Administration, Reviews and New Appointments, and Compensation.

• ARC provides the project management to launch new software to support faculty academic and personnel matters (examples include UC Path, AP Next, OATS, etc).

• Office provides centralized support for Voluntary/Non-Salaried Clinical Faculty (CLIFF), Department of Labor / Fair Labor Standards Act, Endowed Chairs, Faculty Relocation Assistance Program (FRAP), HS Clinical 1-Year Renewals, Interagency Personnel Agreement, Interfolio, Layoffs, Leaves, Mortgage Origination Program (MOP), Multi-Location Agreements, Return to Active Duty (RTAD). Also work with American Federation of Teachers (UC-AFT) - Unit 18s and United Autoworkers (UAW/Professional Researchers).

* Oversee Office of Faculty Affairs (OFA), which provides a variety of professional development activities designed to support and enhance Health Sciences faculty success. Professional development activities include Faculty Development Workshops, Leadership Development Programs, HRSA Hispanic Center for Excellence, Research Mentoring Grants that are funded by the NIH and focus on URM faculty, and numerous Special Events. Activities I personally initiated and lead are:

o K Award Career Development Award Writing Group (AVC) o Faculty Engagement & Wellness Group (AVC) o Medical Staff PMO: Faculty and Physician Management Committee – AVC lead

• Career Development Coordination across Health / Health Sciences – with medical staff & Experience Office included

o Onboarding & Support for Chairs (AVC) University of Massachusetts Medical School

The UMass Department of Psychiatry: Developed and sponsored numerous faculty mentorship programs and mentored many faculty on all aspects of their careers / mission areas, including on research career development awards. Developed the Department’s Career Development and Research Office (CDRO) which is recognized as a “best practice” model within the University of Massachusetts Medical School and was presented at the Association of American Medical Colleges (AAMC) annual meeting. Faculty Affairs & Academic Affairs were collocated in the CDRO.

52

Related personal awards at UMass for Mentoring and Career Development: • Women’s Faculty Award for Outstanding Mentoring to Women Faculty at UMass. • Named and established a “Doug Ziedonis Career Development Mentoring Award”

named in my honor for which I am humbled by their thoughtfulness.

Examples of mentorship programs developed and implemented since 2007: 2007 – 2017 Career Development & Research Office (CDRO) – UMass

• Developed & Sponsored – individual & group mentoring programs, Academic Interest Groups, Awards (all mission areas), on-boarding; and Protected Time Program.

• Developed mentoring programs, including training of mentors, annual evaluations, & specialized programs for women, Under Represented Minorities, junior & senior faculty.

• Created and sponsored Annual Research Day & Annual Women’s Faculty Retreat. • CDRO training on grant writing, clinical recruitment, and developing project directors. • Created a Vice Chair of Academic Affairs and Career Development position

2007 – Present K Award Writing Group for Research Career Development (Developer / Co-leader)

• At UMass and UC San Diego, with over 60 faculty members receiving a Research Career Development Award, including NIH K Awards & VA CDAs.

2013 – 2017 Leadership College for UMass Faculty (Developer and Co-leader)

• Developed Internal Coaching Program (individual and peer coaching models) • Developed Team Coaching Program to enhance teamwork and address issues

2014 – 2017 Quality Improvement Training Program for Faculty

• As Black Belt Certified and trained in Lean and other QI methods, developed and sponsor a QI training program for faculty, trainees, and staff.

2014 – 2018 Mindful Physician Leadership Program (MA statewide initiative)

o Developer & Grant PI (Physicians Foundation)

2012 – 2017 Collaborative Partnerships with other Universities - Joint Grant Programs for Faculty Research Collaboration

o Assumption College / UMass Medical School o Tuft’s Veterinary School / UMass Medical School

2008 – 2017 Ethics in Psychiatry Program

• Co-developed and sponsor the Ethics in Psychiatry program. Provided education and training, mentoring, policy development, web-site resources, consultation, international visiting professor series, discussions at Department Meetings, and research on ethics.

2016 – 2017 Faculty Engagement “Champions” Coaching Program

• Developed and lead coaching program for all 18 Champions from each clinical Department who are leading their Department’s Faculty Engagement Initiative

2005 – 2010 American Psychiatric Association’s Senior Mentor Research Colloquium for Junior

Investigators - National program for junior faculty investigators: 2005, 2009 & 2010

53

PUBLICATIONS: Summary: 324 publications / scholarly works: With 142 original research articles, 3 major reviews (NIH, IOM, RCP), 6 practice guidelines, 37 review articles, 1 letter, 21 invited articles, 9 books, 42 chapters, 20 behavioral therapy manuals, 12 organizational change & leadership development manuals, 25 refereed published conference proceedings (NIDA Research Monograph Series & Journals), 1 CD, 2 computer programs, and 1 video Original Research Articles:

1. Townsend, J.B., Ziedonis, D.M., Bryan, R.M., Brennan, R.W., and Page, R. Choroid Plexus Blood Flow: Evidence of Dopaminergic Control. Journal of Cerebral Blood Flow and Metabolism 3:216-7, 1983.

2. Townsend, J.B., Ziedonis, D.M., Bryan, R.M., Brennan, R.W., and Page, R. B. Choroid Plexus Blood Flow: Evidence for Dopaminergic Influence. Brain Research 290:165-9, 1984.

3. Ziedonis, D.M., Servers, W.B., Brennan, R.W., and Page, R.B. Blood Flow and Functional Responses

Correlate in the Ovine Neural Lobe. Brain Research 373:27-34, 1986. 4. Ziedonis, D.M., Ungerleider, J.T., and Noble, E.P. Teaching Substance Abuse Using an Interactive Teaching

Model. Substance Abuse 10(2):97-102, 1989. 5. Ziedonis, D.M. and Kosten, T.R. Depression as a Prognostic Factor for Pharmacological Treatment of

Cocaine Dependence. Psychopharmacology Bulletin 27:337-343, 1991. 6. Ziedonis, D.M. and Kosten, T.R. Pharmacotherapy Improves Treatment Outcome In Depressed Cocaine

Addicts. Journal of Psychoactive Drugs 23(4):417-425, 1991. 7. Kosten, T.R., Rosen, M., Schottenfeld, R., and Ziedonis, D.M. Buprenorphine for Cocaine and Opiate

Dependence. Psychopharmacology Bulletin 28(1):15-19, 1992.

8. Jenkins, S.W., Warfield, N.A., Blaine, J.D., Cornish, J., Ling, W., Rosen, M., Urschel, H., Wesson, D., and Ziedonis, D.M. A Pilot Trial of Gepirone versus Placebo in the Treatment of Cocaine Dependence. Psychopharmacology Bulletin 28(1), 1992.

9. Ziedonis, D.M., Richardson, R., Lee, E., Petrakis, I., and Kosten, T. Adjunctive Desipramine in the

Treatment of Cocaine Abusing Schizophrenics. Psychopharmacology Bulletin 28(3):309-314, 1992. 10. Ungerleider, J.T, Pechnick R., Wallbom, A.S., Siegal, N., Fairbanks, L., Ziedonis, D.M. Interactive

Teaching, Medical Students and Substance Abuse: University and Community Join Together in New Endeavor. Academic Psychiatry 16(3):160-169, 1992.

11. Carroll, K., Ziedonis, D.M. O'Malley, S., McCance-Katz E, Gordon, L., and Rounsaville, B.J.

Pharmacological Interventions for Abusers of Alcohol and Cocaine: Disulfiram versus Naltrexone. The American Journal on Addictions 2(1): 77-79, 1993.

. 12. Schottenfeld, R.S., Pakes, J.R., Ziedonis, D.M., and Kosten, T.R. Buprenorphine: Dose-Related Effects on

Cocaine and Opioid Use in Cocaine Abusing Opioid-Dependent Humans. Biological Psychiatry 34:66-74, 1993.

54

13. Kosten, T.R., Schottenfeld, R., Ziedonis, D.M., and Falcioni, J. Buprenorphine versus Methadone Maintenance for Opioid Dependence. Journal of Nervous and Mental Disease 181:358-364, 1993.

14. Oliveto, A., Kosten, T.R., Schottenfeld, R.S., and Ziedonis, D.M. Cocaine Abuse Among Methadone-

Maintained Patients. American Journal of Psychiatry 150:1755, 1993. 15. Ziedonis, D.M., Rayford, B.S., Bryant, K., and Rounsaville, B.J. Psychiatric Comorbidity in White and

African-American Cocaine Addicts Seeking Substance Abuse Treatment. Hospital and Community Psychiatry 45:43-49, 1994.

16. Oliveto, A., Kosten, T.R., Schottenfeld, R., Ziedonis, D.M., and Falcioni, J. Cocaine Use in Buprenorphine

versus Methadone Maintained Patients. American Journal of Addictions 3:43-48, 1994. 17. Ziedonis, D.M., Kosten, T.R., Glazer, W.M., and Frances, R.J. Nicotine Dependence and Schizophrenia.

Hospital and Community Psychiatry 45:204-206, 1994. 18. Leal, J., Ziedonis, D.M., and Kosten, T.R. Antisocial Personality Disorder as a Prognostic Factor for

Pharmacotherapy of Cocaine Dependence. Drug and Alcohol Dependence 35:31-35, 1994.

19. George, T., Sernyak, M.J., Ziedonis, D.M., and Woods, S.W. Effects of Clozapine on Smoking In Chronic Schizophrenic Outpatients. Journal of Clinical Psychiatry 56:344-346, 1995.

20. Farren, C.K., Ziedonis, D.M., Clare, A.W., Hameedi, F.A., and Dinan, T.G. D-Flenfluramine induced prolactin response in post-withdrawal Alcoholics and Controls. Alcoholism: Clinical and Experimental Research 19:1578-1582, 1995.

21. Farren, C.K., Clare, A.W., Ziedonis, D.M., Hammeedi, F.A., and Dinan, T.G. Evidence for reduced dopamine D2 receptor sensitivity in post-withdrawal alcoholics. Alcoholism: Clinical and Experimental Research 19:1520-1524. 1995.

22. Oliveto, A., Kosten, T., Schottenfeld, R., Falcioni, J., and Ziedonis, D.M. Desipramine, Amantadine, or

Fluoxetine in Buprenorphine Maintained Cocaine Users. Journal of Substance Abuse Treatment 12:423-428, 1995.

23. Schottenfeld, R.S., Pakes, J., Ziedonis, D.M., and Kosten, T.R. Buprenorphine: Dose-Related Effects on

Cocaine and Opioid Use in Cocaine Abusing Opioid-Dependent Humans. Yearbook of Psychiatry and Applied Mental Health, 5:160-161, 1995

24. Ziedonis, D.M. and Kosten, T.R. Nicotine Dependence and Schizophrenia. Italian Journal of the Addictions 4:44-47, 1996.

25. Ziedonis, D.M. and George, T.P. Schizophrenia and Nicotine Use: Report of a Pilot Smoking Cessation

Program and Review of Neurobiological and Clinical Issues. Schizophrenia Bulletin 23(2):247-254, 1997. 26. Ziedonis, D.M. and Trudeau, K. Motivation to Quit Using Substances Among Individuals With

Schizophrenia: Implications for a Motivation-Based Treatment Model. Schizophrenia Bulletin 23(2):229-238, 1997.

55

27. Schottenfeld, R.S., Pakes, J.R., Oliveto, A., Ziedonis, D.M., and Kosten, T.R. Buprenorphine versus Methadone Maintenance For Concurrent Opioid Dependence and Cocaine Abuse. Archives of General Psychiatry 54(8):713-720, 1997.

28. Kraus, M.L., Ziedonis, D.M., Feinberg, M.A., Segal, S.R., Israel, L., and Kraus, M. A Community

Hospital’s Ambulatory Addiction Medicine Program. Connecticut Medicine 62:89-93, 1998. 29. Smelson, D.A., Roy, M., Roy, A., Engelhart, C., Williams, J., and Ziedonis, D. Relationship between

Electroretinogram, Blue Cone Amplitude, and Cue Elicited Cocaine Craving. In L. Harris (Ed), Problems of Drug dependence, 1999. National Institute on Drug Abuse Research Monograph. Washington DC: USGPO, 2000.

30. Woods, S., Ziedonis, D.M., Sernak, M., Diaz E., and Rosenheck R. Characteristics of Participants and

Non-participants in Medication Trials for Treatment of Schizophrenia. Psychiatric Services 51:79-84, 2000.

31. George, T.P., Ziedonis D.M., Feingold A., Pepper W.T., Satterburg C.A., Winkel J., Rounsaville B.J., and

Kosten T.R. Nicotine Transdermal Patch and Atypical Antipsychotic Drugs for Smoking Cessation in Schizophrenia. American Journal of Psychiatry 157 (11):1835-1842, 2000.

32. Carol, G., Smelson, D., Losonczy, M.F., Ziedonis, D. A preliminary investigation of cocaine craving

among persons with and without schizophrenia. Psychiatric Services 52:1029-1031, 2001. 33. Ziedonis, D. and Stern, R. Dual Recovery Therapy for Schizophrenia and Substance Abuse. Psychiatric

Annals 31(4):255–264, 2001. 34. Smelson, D.A., Davis, C.W., DiPano, R., Johnson, V., Losonczy, M.F., Ziedonis, D.M. Executive and

motor skill functioning among cocaine-dependent schizophrenics and non-drug-abusing schizophrenics. Journal of Nervous Mental Disorders 190(3):200-202, 2002.

35. Smelson, D.A., Losonczy, M., Kaune, M., Williams, J., Davis, C., Ziedonis, D.M. Risperidone

decreases cue-elicited craving and relapses in withdrawn cocaine-dependent schizophrenics. Schizophrenia Research 53:160, 2002.

36. Roeloffs, C., Wells, K., Ziedonis, D.M., Tang, L., Unutzer J. Problem substance use among depressed

patients in managed primary care. Psychosomatics 43(5):405-12, 2002.

37. Smelson, D.A., Losonczy, M.F., Davis, C.W., Kaune, M., Williams J., Ziedonis, D. Risperidone decreases craving and relapses in individuals with schizophrenia and cocaine dependence. Canadian Journal of Psychiatry 47(7):671-5, 2002.

38. Smelson, D.A., Starosta A., Losonczy M.F., Kind J., Williams J., and Ziedonis D. An Analysis of Cue

Reactivity Among Individuals With Schizophrenia Compared to Cocaine Addicts Without Schizophrenia. Psychiatric Services 53:1612-1616, 2002.

39. Krejci, J., Steinberg, M.L., and Ziedonis, D.M. Smoking status and substance abuse severity in a

residential treatment sample. Drug and Alcohol Dependence 72, 249-254, 2003.

56

40. Smelson, D.A., Davis, C., Eisenstein, N., Engelhart, C., Williams, J., Losonczy., M.F. and Ziedonis, D.M. Cognitive disparity in schizophrenics with and without cocaine dependency. Journal of Substance Abuse Treatment 24(1) 75-79, 2003.

41. Williams, J.M. and Ziedonis, D. Naltrexone-bupropion combination therapy for protracted

abstinence dysphoria. The American Journal on Addictions 2(3):270-272, 2003.

42. Kampov-Polevoy, A.B., Ziedonis, D.M., Steinberg, M.L., Pinsky, I., Krejci, J.A., Eick, C., Boland, G., Khalitov, E., and Crews, F.T. Association between sweet preference and paternal history of alcoholism in psychiatric and substance abuse patients. Alcoholism: Clinical and Experimental Research 27(12):1929-1936, 2003.

43. Smelson, D.A., Ziedonis, D.M., Losonczy, M.F., Williams, J., and Kaune, M. A double-blind study

comparing olanzapine to haloperidol for reducing cue-elicited craving in individuals with schizophrenia and cocaine dependence. Schizophrenia Research 60(1):303, 2003.

44. Steinberg, M.L., Ziedonis, D.M., Krejci, J.A., and Brandon, T.H. Motivational Interviewing With

Personalized Feedback: A Brief Intervention for Motivating Smokers with Schizophrenia To Seek Treatment for Tobacco Dependence. Journal of Consulting and Clinical Psychology 72(4):723-728, 2004.

45. Williams, J.M., Ziedonis, D.M., Foulds, J. Case Series of Nicotine Nasal Spray in the Combination

Treatment of Tobacco Dependence among Patients with Schizophrenia. Psychiatric Services 55(9):1064-1066, 2004.

46. Smelson, D.A., Williams, J., Ziedonis, D.M., Sussner, B.D., Losonczy, M.F., Engelhart, C., and Kaune,

M. A double-blind placebo-controlled pilot study of risperidone for decreasing cue-elicited craving in recently withdrawn cocaine dependent patients. Journal of Substance Abuse Treatment 27:45-49, 2004.

47. Steinberg, M.L., Williams, J.M., and Ziedonis, D.M. Financial Implications of Cigarette Smoking

Among Individuals with Schizophrenia. Tobacco Control 13(2):206, 2004.

48. Amass, L., Ling, W., Freese, T.E., Reiber, C., Annon, J.J., Cohen, A.J., McCarty, D., Reid, M., Brown, L.S., Clark, C., Ziedonis, D.M., Krejci, J., Stine, S., Winhusen, T., Brigham, G., Babcock, D., Muir, J., Buchan, B., Horton T. Bringing Buprenorphine-Naloxone Detoxification to Community Treatment Providers: The NIDA Clinical Trials Network Field Experience. American Journal on Addictions 13:S42-S66, 2004.

49. Steinberg, M.L., Williams, J.M., Steinberg, H.R., Krejci, J.A., Ziedonis, D.M. Applicability of the

Fagerström Test for Nicotine Dependence in Smokers with Schizophrenia. Addictive Behaviors 30(1):49-59, 2005.

50. Boudreaux, E.D., Baumann, B.M., Friedman, K., Ziedonis, D.M. Smoking Stage of Change and Interest

in an Emergency Department-based Intervention. Academic Emergency Medicine 12(3):211-18, 2005.

57

51. Ling, W., Amass, L., Shoptaw, S., Annon, J.J., Hillhouse, M., Babcock, D., Brigham, G., Harrer, J., Reid, M., Muir, J., Buchan, B., Orr, D., Woody, G., Krejci, J., Ziedonis, D.M. Buprenorphine Study Protocol Group. A multi-center randomized trial of buprenorphine-naloxone versus clonidine for opioid detoxification: findings from the National Institute on Drug Abuse Clinical Trials Network. Addiction 100(8):1090-100, 2005.

52. Williams, J.M., Foulds, J., Dwyer, M., Order-Connors, B., Springer, M., Gadde, P., Ziedonis, D.M. The Integration of Tobacco Dependence Treatment into Residential Addictions Treatment in New Jersey. Journal of Substance Abuse Treatment 28:331–340, 2005.

53. Walters, S.T., Matson, S.A., Baer, J.S., Ziedonis, D.M. Effectiveness of workshop training for

psychosocial addiction treatments: A systematic review. Journal Substance Abuse Treatment. 29(4):283-93, 2005.

54. Smelson, D.A., Losonczy, M., Castles-Fonseca, K., Stewart, P., Kaune, M., and Ziedonis, D.M.

Preliminary Outcomes from a booster case management program for individuals with a co-occurring substance abuse and a persistent psychiatric disorder. Journal of Dual Diagnosis 13:47–59, 2005.

55. Williams, J.M., Ziedonis, D.M., Abanyie, F., Steinberg, M.L., Foulds, J., Benowitz, N.L. Increased nicotine and cotinine levels in smokers with schizophrenia and schizoaffective disorder are not a metabolic effect. Schizophrenia Research 15;79(2-3):323-35, 2005.

56. Sussner, B.D., Smelson, D.A., Rodrigues, S., Kline, A., Losonczy, M., Ziedonis, D.M. The validity and

reliability of a brief measure of cocaine craving. Drug and Alcohol Dependence 2006. 27;83(3):233-7.

57. Smelson, D.A., Ziedonis, D.M., Williams, J., Losonczy, M.F., Williams, J., Steinberg, M.L., Kaune, M. The efficacy of olanzapine for decreasing cue-elicited craving in individuals with schizophrenia and cocaine dependence: a preliminary report. J Clinical Psychopharmacology 26(1):9-12, 2006.

58. Hu, H.M., Kline, A., Huang, F.Y., Ziedonis, D.M. Detection of co-occurring mental illness among adult

patients in the New Jersey substance abuse treatment system. American Journal of Public Health 96(10):1785-93, 2006.

59. Foulds, J., Williams J, Order-Connors, B., Edwards N., Dwyer, M., Kline A., Ziedonis, D.M. Integrating

tobacco dependence treatment and tobacco-free standards into addiction treatment: New Jersey’s experience. Alcohol Research Health 29(3):236-240, 2006.

60. Steinberg, M.L., Krejci, J.A., Collett, K., Brandon, T.H., Ziedonis, D.M., Chen, K. Relationship between

self-reported task persistence and history of quitting smoking, plans for quitting smoking, and current smoking status in adolescents. Addictive Behavior. 32(7)1451-1460, 2007.

61. Fuller, B.E., Guydish, J., Tsoh, J., Reid, M.S., Resnick, M., Zammarelli, L., Ziedonis, D.M., Sears, C.,

McCarty, D. Attitudes toward the integration of smoking cessation treatment into drug abuse clinics. Journal Substance Abuse Treatment 32(1):53-60, 2007.

62. Gerwe, C.F. and Ziedonis, D.M. Using the Orchestration Group Process of the Gerwe-Orchestration

Method in Group Therapy for Addiction and Recovery. Journal of Groups in Addiction and Recovery 2(1): 41-66 2007.

http://www.umassmed.edu/globalassets/psychiatry/opendialogue/keyelementsv1.109022014.pdf?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=16384655&query_hl=16&itool=pubmed_docsum

http://www.missionmodel.org/manuals-1/?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17125931&query_hl=1&itool=pubmed_docsum

https://public.era.nih.gov/grantfolder/piAppDetails/genericStatus.do?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17175398&query_hl=1&itool=pubmed_docsum

https://public.era.nih.gov/grantfolder/piAppDetails/genericStatus.do?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17175398&query_hl=1&itool=pubmed_docsum

58

63. Epstein, E.E., McCrady, B., Morgan, T.J., Cook, S.M., Kugler, G., Ziedonis, D.M. The Successive Cohort

Design: A Model for Developing New Behavioral Therapies for Drug Use Disorders and Application to Behavioral Couple Treatment. Addictive Disorders and Their Treatment, 6(1):1-19, 2007.

64. Epstein, E.E., McCrady, B., Morgan, T.J., Cook, S.M., Kugler, G., Ziedonis, D.M. Couples Treatment for

Drug Dependent Males: Preliminary Efficacy of a Stand Alone Outpatient Model. Addictive Disorders and Their Treatment, 6(1):21-37, 2007.

65. Smelson, D.A., Losonczy, M.F., Ziedonis, D.M., Sussner, B.D., Castles-Fonseca, K., Rodrigues, S., and

Kline, S. A brief community linkage intervention for veterans with a persistent mental illness and a co-occurring substance abuse disorder. European Journal of Psychiatry 21(2), 143-152, 2007.

66. Kim S.S., Ziedonis, D., Chen, K. Tobacco Use and Dependence in Asian American and Pacific Islander

Adolescents: A Review of the Literature. Journal of Ethnicity in Substance Abuse. 6(3/4):113-142, 2007.

67. Ziedonis, D.M, Zammarelli, L., Seward, G., Oliver, K., Guydish, J., Hobart, M., Meltzer, B. Addressing

Tobacco Use Through Organizational Change: A Case Study of an Addiction Treatment Organization. Journal of Psychoactive Drugs, 39 (4), 451-459, 2007.

68. Williams, J.M., Gandhi, K.K., Steinberg, M.L., Foulds, J., Ziedonis, D.M., Benowitz, N.L. Higher nicotine and carbon monoxide levels in menthol cigarette smokers with and without schizophrenia. Nicotine & Tobacco Research, 9 (8), 873-881, 2007.

69. Boudreaux, E.D., Baumann, B.M., Camargo, C.A., Jr., O’Hea, E.L., Ziedonis, D.M. Changes in smoking

associated with an acute health event: Theoretical and practical implications. Annals of Behavioral Medicine, 33:189-199, 2007.

70. Huang, F.Y., Ziedonis, D.M., Hu, H.M., and Kline, A. Using Information Technology to Evaluate the

Detection of Co-Occurring Substance Use Disorders Amongst Patients in a State Mental Health System: Implications for Co-Occurring Disorder State Initiatives, Community Mental Health Journal 44:11-27, 2008.

71. Ross, S., Cidambi, I., Dermatis, H., Weinstein, J., Ziedonis, D.M., Roth, S., Galanter, M. Music

Therapy: A Novel Motivational Approach for Dually Diagnosed Patients. Journal of Addictive Diseases, 27:(1) 41-53, 2008

72. Kim, S., Kwon, M-S., Klessig, Y.C., and Ziedonis, D.M. Adapting Tobacco Dependence Group Therapy

Treatment for Korean Americans: A Case Report of Pilot Treatment Program. Journal of Groups in Addiction & Recovery Therapy 2008. 3(1-2), 93-108.

73. Boudreaux, E.D., Baumann, B.M., Perry, J., Marks, D., Francies S., Camargo, C..A., Jr., Ziedonis, D.M.

Emergency Department Initiated Treatments for Tobacco (EDITT): A pilot study. Annals of Behavioral Medicine, 2008. 36(3):314-25.

74. Williams, J.M., Ziedonis, D.M., Vreeland, B., Speelman-Edwards, N., Zechner, Michelle R., Williams,

M.T., Rahim, R., Karmi, L., Molnar, M., and Eilers, R. A Wellness Approach to Addressing Tobacco in

59

Mental Health Settings: Learning About Healthy Living. American Journal of Psychiatric Rehabilitation 12:4, 352-369, 2009

75. Gonzalez, G., Romero-Gonzalez, M., Desai, R., Randall, M., Patwa, H., Tokuno, H., Petrakis, I.,

Ziedonis, D. M. Myoclonus Cases Associated with Tiagabine Treatment for Cocaine and Opioid Dependent Patients. American Journal on Addictions; 2009; 18(4):324-324.

76. Ziedonis, D.M., Amass, L., Steinberg, M.L., Krejci, J., Woody, G., Annon, J., Cohen, A.J., Waite-

O’Brien, N., Stine, S., McCarty, D., Reid, M., Brown, L., Maslansky, R., Winhusen, T., Babcock, D., Brigham, G., Muir, J., Orr, D., Buchan, B.J., Horton, T., and Ling, W. Predictors of Outcome For Short-Term Medically Supervised Opioid Withdrawal during a Randomized, Multi Center Trial of Buprenorphine-Naloxone and Clonidine in the NIDA Clinical Trials Network Drug and Alcohol Dependence. Drug & Alcohol Dependence. 2009. 99:28-36.

77. Williams, J.M, Steinberg, M.L., Zimmermann, M.H., Gandhi, K.K., Stipelman, B, Budsock, P.D.,

Ziedonis, D.M. Comparison of two intensities of tobacco dependence counseling in schizophrenia and schizoaffective disorder. Journal Substance Abuse Treatment. 38(4): 384-93, 2010.

78. Chen, K.W., Comerford, A., Shinnick P., Ziedonis, D.M. Introducing qigong meditation into

residential addiction treatment: a pilot study where gender makes a difference. Journal of Alternative Complementary Medicine 2010. 16(8):875-82.

79. DiFranza, J., Ursprung, W.W., Lauzon, B., Bancej, C., Wellman, R.J., Ziedonis, D., Kim, S.S., Gervais, A.,

Meltzer, B., McKay, CE., O'Loughlin, J., Okoli, C.T., Fortuna, L.R., Tremblay, M. A systematic review of the diagnostic and statistical manual diagnostic criteria for nicotine dependence. Addictive Behaviors. 2010. 35(5):373-82.

80. Boudreaux, E.D., Moon, S., Baumann, B.M., Camargo, C.A., Jr., O’Hea, E., Ziedonis, D.M. Intentions

to Quit Smoking: Causal Attribution. Perceived Illness Severity, and Event-Related Fear During an Acute Health Event. Annals of Behavioral Medicine. 2010. 40:350-355.

81. Guydish, J., Tajima B., Chan, M., Delucchi, K.L., Ziedonis, D. Measuring smoking knowledge, attitudes

and services (S-KAS) among clients in addiction treatment. Drug & Alcohol Dependence 2011. 114(2-3):237-41.

82. Ozhathil, D., Abar, B., Baumann, B.M., Camargo, C.A., Ziedonis, D., & Boudreaux, E.D. The effect of

removing cost as a barrier to treatment initiation with an outpatient tobacco dependence clinic among emergency department patients. Academic Emergency Medicine. 2011. 19(6): 662-664.

83. Guydish, J., Ziedonis, D., Tajima, B., Seward, G., Passalacqua, E., Chan, M., Delucchi, K., Zammarelli,

L., Levy, M., Kolodziej, M., Brigham, G. Addressing Tobacco Through Organizational Change (ATTOC) in residential addiction treatment settings. Drug & Alcohol Dependence. 2012. 121(1-2):30-7.

84. Byatt, N., Biebel, K., Lundquist, R., Moore Simas, T., Debourdes-Jackson, G., Ziedonis, D. Patient,

Provider and System-level Barriers and Facilitators to Addressing Perinatal Depression. Journal of Reproductive and Infant Psychology. 2012. 30(5): 436-439.

60

85. Guydish, J., Tajima,.B., Kulaga, A., Zavala, R., Brown, L.S., Bostrom, A., Ziedonis, D, Chan M. The New York Policy on Smoking in Addiction Treatment: Findings After 1 Year. American Journal of Public Health. 2012. 102(5):e17-e25.

86. Smelson, D., Kalman, D., Losonczy, M.F., Kline, A., Sambamoorthi, U., Hill, L.S., Castles-Fonseca, K.,

Ziedonis, D. A brief treatment engagement intervention for individuals with co-occurring mental illness and substance use disorders: results of a randomized clinical trial. Community Mental Health J. 2012. 48(2), 127-132. doi: 10.1007/s10597-010-9346-9.

87. Kim, S.S., Chen, W., Kolodziej, M., Wang, X., Wang, V.J., Ziedonis, D. A Systematic Review of Smoking Cessation Intervention Studies in China. Nicotine & Tobacco Research. 2012, 14(8):891-899. doi: 10.1093/ntr/ntr289.

88. Boyer, E.W., Fletcher, R., Fay, R.J., Smelson, D., Ziedonis, D., Picard, R.W. Preliminary efforts

directed toward the detection of craving of illicit substances: the iHeal project. Journal of Medical Toxicology. 2012. 8(1):5-9.

89. Ziedonis, D., Wang, X., Li, T., Kim, S. S., Tonelli, M., Li, S., & Kalman, D. Addressing tobacco through

organizational change in West China Hospital’s Mental Health Center: The intervention and lessons learned in an implementation study. Journal of Dual Diagnosis. 2012. 8(2): 148-57. DOI:10.1080/15504263.2012.672116

90. Ziedonis, D. & Kolodziej, M. E. Introduction to the Special Issue: Innovative Interventions for Treating

Tobacco Addiction amongst Persons with Co-occurring Mental Illness and Addiction: New Approaches to Improve Outcomes. Journal of Dual Diagnosis. 8(2), 85-88, 2012 DOI 10.1080/15504263.2012.672159

91. Kim, S. S., Fang, H., DiFranza, J., Ziedonis, D., & Ma, G. Gender differences in the Fagerström Test for

Nicotine Dependence in Korean Americans. Journal of Smoking Cessation. 2012. 7(1), 1-6. DOI: 10.1017/jsc.2012.5

92. Kim, S.S., Kim, S.H., Ziedonis, D. Tobacco dependence treatment for Korean Americans: preliminary

findings. J Immigrant & Minority Health. 2012. 14(3), 395-404.

93. Smelson, D., Yu, L., Buyske, S., Gonzalez, G., Tischfield, J., Deutsch, C. K., & Ziedonis, D. Genetic association of GABA-A receptor alpha-2 and mu opioid receptor with cocaine cue-reactivity: evidence for inhibitory synaptic neurotransmission involvement in cocaine dependence. American J Addiction. 2012. 21(5): 411-415.

94. Byatt, N., Biebel, K., Debourdes-Jackson, G., Lundquist, R., Moore Simas, T., Weinreb, L., Ziedonis, D.

Community Mental Health Provider Reluctance to Provide Pharmacotherapy May Be a Barrier to Addressing Perinatal Depression: A Preliminary Study. Psychiatric Quarterly. 2013. 84(2), 169-174.

95. Smelson, D., Chen, K.W., Ziedonis, D., Andes, K., Lennox, A., Callahan, L., Rodrigues, S., Eisenberg, D.: A pilot study of Qigong for reducing cocaine craving early in recovery. J Alternative Complement Medicine. 2013. 19(2): 97-101.

61

96. Abar, B. Baumann, B.M., Rosenbaum, C., Boyer, E., Ziedonis, D., Boudreaux, E.D. Profiles of importance, readiness, and confidence in quitting tobacco use. Journal of Substance Use, 2013. 18(2):75-81.

97. Song, X., Fan, X., Song, X., Zhang, J., Zhang, W., Li, X., Gao, J., Harrington, A., Ziedonis, D., & Lv, L.

Elevated levels of adiponectin and other cytokines in drug naïve, first episode schizophrenia patients with normal weight. Schizophrenia Research 2013 150(1): 269-73.

98. Kim, S., Seongho, K., McKay, C., Ziedonis, D.M. Comparison of characteristics among Korean American

male smokers between survey and cessation studies. Open Journal of Preventive Medicine. 2013. 3(3): 293-300.

99. Byatt, N., Biebel, K., Friedman, L., Debordes-Jackson, G., Pbert, L., Ziedonis, D. Patient’s Views on

Depression Care in Obstetric Settings: How Do They Compare to the Views of Perinatal Health Care Professionals? General Hospital Psychiatry. 2013; 35(6):598.

100. Huang W1, DiFranza JR, Kennedy DN, Zhang N, Ziedonis D, Ursprung S, King JA. Progressive

levels of physical dependence to tobacco coincide with changes in the anterior cingulum bundle microstructure. PLoS One. 2013 8(7):e67837-44. doi: 10.1371/journal.pone.0067837

101. Kim, S.S., Chung, S., Park, J.I., Jung, A.J., Kalman, D., Ziedonis, D.M. Smoking among individuals

with schizophrenia in Korea: Gender differences. Archives of Psychiatric Nursing. 2013. 27(5):241-5. doi: 10.1016/j.apnu.2013.06.002

102. Ding ,M., Song, X., Zhao, J., Gao, J., Li, X., Yang, G., Wang, X., Harrington, A., Ziedonis, D., Fan, X.,

Lv, L. Activation of Th17 cells in drug naïve, first episode schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry, 2014; 51: 78-82. PMID: 24447943.

103. Kim, S., Lee, H., Kiang, P., Kalman, D., Ziedonis, D.M. Factors associated with alcohol problems

among Asian American college students: Gender, ethnicity, smoking and depressed mood. Journal of Substance Use. 2014. (1-2): 12-17.

104. Byatt, N., Biebel, K., Friedman, L., Debordes-Jackson, G., Ziedonis, D.M. Women’s perspectives

on postpartum depression screening in pediatric settings: a preliminary study. Archives of Women’s Mental Health. 2013. 16(5):429-32.

105. Song, X., Fan, X., Li, X., Zhang,W., Gao, J., Zhao, J., Harrington, A., Ziedonis, D., Lv, L. Changes in

pro-inflammatory cytokines and body weight during 6-month risperidone treatment in drug naïve, first-episode schizophrenia. Psychopharmacology (Berl). 2014. 231(2):319-25.

106. Anderson, M.L., Ziedonis, D.M., & Najavits, L.M. Posttraumatic stress disorder and substance

use disorder comorbidity among individuals with physical disabilities: Findings from the National Comorbidity Survey Replication. Journal of Traumatic Stress. 2014; 27(2), 182-191.

107. Kim, S.S., Fang, H., McKee, S.A., & Ziedonis, D.M. Prospective Evaluation of Factors Predicting

Nicotine Withdrawal symptoms Among Korean Americans. Journal of Smoking Cessation. 2014; 11(3), 154-162.

62

108. Song, X., Fan, X., Zhang, J., Zheng, H., Li, X., Pang, L., Chen, X., Zhang, W., Harrington, A., Ziedonis, D., Lv, L. Prolactin serum levels correlate with inflammatory status in drug-naïve first-episode schizophrenia. World J Biological Psychiatry, 2014 15(7):546-52. doi: 10.3109/15622975.2014.922699. PMID:24959913

109. Huang, W., King, J., Ursprung, S., Zheng, S., Zhang, N., Kennedy, D., Ziedonis, D., & DiFranza, J.

The Development and Expression of Physical Nicotine Dependence Corresponds to Structural and Functional Alterations in the Anterior Cingulate-Precuneus Pathway. Brain and Behavior, 2014; 4: 408–417. doi: 10.1002/brb3.227.

110. Song, X., Quan, M., Lv, L., Li X., Pang, L., Kennedy, D., Hodge, S., Harrington, A., Ziedonis, D., Fan, X.

Decreased cortical thickness in drug naïve first episode schizophrenia: in relation to serum levels of BDNF. Journal Psychiatric Research, 2015. 60, 22-8.

111. Byatt, N., Levin, L.L., Ziedonis, D., Moore Simas, T.A., Allison, J. Enhancing participation in

depression care in outpatient perinatal care settings: A systematic review. Obstetrics and Gynecology. 2015; 126(5):1048-58.

112. Kelly, M., Sido, H., Forsyth, J., Ziedonis, D., Kalman, D., Cooney, J. Acceptance and commitment

therapy smoking cessation treatment for veterans with posttraumatic stress disorder: A pilot study. J Dual Diagnosis. 2014. 11(1), 50-55.

113. Kim, S.S., Kim, S.H., Fang, H., Kwon, S., Shelley, D., & Ziedonis, D.M. A culturally adapted smoking

cessation intervention for Korean Americans: A mediating effect of perceived family norm toward quitting. Journal of Immigrant and Minority Health. 2015. 17(4): 1120-9.

114. Li, M., Wei, D., He, Z., Wang, Q., Huang, C., Jiang, L., Ziedonis, D.M., King, J.A., Ma, X., Zhang, N.,

Li, T. A splitting brain: Imbalanced neural networks in schizophrenia. Psychiatry Research Neuroimaging. 2015. 232 (2): 145-153.

115. Chung, S., Kim, S.S., Kini, N., Fang, H.J., Kalman, D., & Ziedonis, D.M. Smoking Topography in

Korean American and White Men: Preliminary Findings. J Immigrant Minority Health. 2015. 17: 860 - 66.

116. Du, J., Quan, M., Zhuang, W., Zhong, N., Juang, H., Kennedy, D., Harrington, A., Ziedonis, D., Fan,

X., Zhao, M. Hippocampal volume reduction in female but not male recent abstinent methamphetamine users. Behavioural Brain Research, 2015. 289: 78-83.

117. Byron, G., Ziedonis, D., McGrath, C., Frazier, J., deTorrijos, F. & Fulwiler, C. Implementation of

Mindfulness Training for Mental Health Staff: Organizational Context and Stakeholder Perspectives. Mindfulness. 2015: 6(4):861-872.

118. Wang, X., Peng, Z., Ziedonis, D.M., Wang, C., Yu, B., Li, T. Evaluation of tobacco use on Chinese

population through ATTOC model: a cross-sectional survey on hospitalized psychiatric patients. In J Clin Exp Med. 2015; 8(4), 6008-6015.

63

119. Gonzalez, G., DiGirolamo, G., Romero-Gonzalez, M., Smelson, D., Ziedonis, D. Kolodziej, M. Memantine improves buprenorphine/naloxone treatment for opioid dependent young adults. Drug Alcohol Depend. 2015 156: 243-253.

120. Anderson, M.L., Wolf Craig, K.S., Hall, W.C., Ziedonis, D.M. A Pilot Study of Deaf Trauma

Survivors Experiences, Early Traumas Unique to Being Deaf in a Hearing World. Journal of Child and Adolescent Trauma. 2016 9 (4): 353 – 358.

121. Anderson, M.L., Sortwell, A., Wolf Craig, K.S. & Ziedonis, D.M. Symptom Patterns of

Posttraumatic Stress Disorder among Deaf Trauma Survivors. JADARA. 2016; 50(1): 1-21. Retrieved from http://repository.wcsu.edu/jadara/vol50/iss1/3

122. Byatt, N., Pbert, L., Hosein, S., Swartz, H., Weinreb, L., Allison, J. Ziedonis, D. Program In Support

of Moms (PRISM); Development and Beta Testing. Psychiatric Services. 2016; 67(8), 824-826; doi: 10.1176/appi.ps.201600049.

123. Murphy, K.M. & Ziedonis, D.M. (2016). Group Guided Imagery and Music for adults in addiction

treatment: A pilot randomized control trial feasibility study. Journal of the Association for Music and Imagery, 2016. 15, 43-65.

124. Gordon, C., Gidugu, V., Rogers, E.S., DeRonk, J., Ziedonis, D. Adapting Open Dialogue for early

onset psychosis into the U.S. healthcare environment: A feasibility study. Psychiatric Services. 2016. 67(11):1166-1168. doi: 10.1176/appi.ps.201600271.

125. Kim, S., Sitthisongkram, S., Bernstein, K., Fang, H., Choi, W., Ziedonis, D. A randomized

controlled trial of a videoconferencing smoking cessation intervention for Korean American women: preliminary findings. International Journal of Women’s Health. 2016 (8), 453-462. DOI https://doi.org/10.2147/IJWH.S109819

126. Chen, L., Baker, T., Brownson, R., Carney, R., Jorenby, D., Hartz, S., Smock, N., Johnson, M.,

Ziedonis, D., Bierut, L. Smoking cessation and electronic cigarettes in community mental health centers: Patient and provider perspectives. Community Mental Health Journal. 2016 Nov 30. [Epub ahead of print] DOI: 10.1007/s10597-016-0065-8 PMID:27900650

127. Anderson, M. L., Wolf Craig, K. S., & Ziedonis, D. M. Deaf people’s help-seeking following

trauma: Experiences with and recommendations for the Massachusetts behavioral healthcare system. Psychological Trauma: Theory, Research, Practice, and Policy. 2017. 9(2):239-248.

128. Brunette MF, Ferron JC, Robinson D, Coletti D, Geiger P, Devitt T, Klodnick V, Gottlieb J, Xie H, Greene MA, Ziedonis D, Drake RE, McHugo GJ. Brief Web-Based Interventions for Young Adult Smokers With Severe Mental Illnesses: A Randomized, Controlled Pilot Study. Nicotine & Tobacco Research. 2017 Oct 14. doi: 10.1093/ntr/ntx190. [Epub ahead of print]

129. Byatt N, Moore Simas TA, Biebel K, Sankaran P, Pbert L, Weinreb L, Ziedonis D, Allison J.

PRogram In Support of Moms (PRISM): a pilot group randomized controlled trial of two approaches to improving depression among perinatal women. J Psychosomatics Obstetric Gynaecology. 2017 Oct 10:1-10. doi: 10.1080/0167482X.2017.1383380. [Epub ahead of print]

http://www.umassmed.edu/psychiatry/globalini-tiatives/

http://www.umassmed.edu/psychiatry/globalinitiatives/chinaconnectionwelcome.aspx

64

130. Kim SS, Fang H, Bernstein K, Zhang Z, DiFranza J, Ziedonis D, Allison J. Acculturation, Depression, and Smoking Cessation: a trajectory pattern recognition approach. Tob Induced Disorders. 2017 Jul 24;15:33. doi: 10.1186/s12971-017-0135-x.

131. Anderson, M. L., Wolf Craig, K. S., & Ziedonis, D. M. Barriers and facilitators to deaf trauma

survivors’ help-seeking behavior: Lessons for behavioral clinical trials research. Journal of Deaf Studies and Deaf Education. 2017. 1:118-130.

132. Ivanovs R, Kivite A, Ziedonis D, Mintale I, Vrublevska J, Rancans E. Association of Depression and

Anxiety With the 10-Year Risk of Cardiovascular Mortality in a Primary Care Population of Latvia Using the SCORE System. Front Psychiatry. 2018 Jun 26;9:276. doi: 10.3389/fpsyt.2018.00276.

133. Thornton JD, Dwibedi N, Scott V, Ponte CD, Ziedonis D, Sambamoorthi N, Sambamoorthi U. Predictors of Transitioning to Incident Chronic Opioid Therapy Among Working-Age Adults in the United States. Am Health Drug Benefits. 2018 Feb;11(1):12-21.

134. Wu C, Chiang M, Harrington A, Kim S, Ziedonis D, Fan X. Racial disparity in mental disorder diagnosis and treatment between non-hispanic White and Asian American patients in a general hospital. Asian J Psychiatr. 2018 Apr;34:78-83. doi: 10.1016/j.ajp.2018.04.019. Epub 2018 Apr 9.

135. Ivanovs R, Kivite A, Ziedonis D, Mintale I, Vrublevska J, Rancans E. Association of depression and

anxiety with cardiovascular co-morbidity in a primary care population in Latvia: a cross-sectional study. BMC Public Health. 2018 Mar 6;18(1):328. doi: 10.1186/s12889-018-5238-7.

136. Kim, S. S., Bernstein, K., Olivia, H., Fang, H., McKee, S., & Ziedonis, D. Remote biochemical verification of smoking abstinence via a mobile-phone video call with Korean American women. Journal of Mobile Technology in Medicine, 2018. 7(1), 1-7.

137. Vilardaga R, Rizo J, Ries RK, Kientz JA, Ziedonis DM, Hernandez K, McClernon FJ.Formative,

multimethod case studies of learn to quit, an acceptance and commitment therapy smoking cessation app designed for people with serious mental illness. Transl Behav Med. 2018 Nov 16. doi: 10.1093/tbm/iby097. PMID: 30445507

138. Flitter, A., Lubitz, S., Ziedonis, D., Stevens, N., Leone, F., Mandell, D., Kimberly, J., Lopez, O., Beidas, R., & Schnoll, R. A cluster-randomized clinical trial testing the effectiveness of the addressing tobacco through organizational change (ATTOC) model for improving the treatment of tobacco use in community mental healthcare: preliminary study feasibility and baseline findings. Nicotine and Tobacco Research. 2019 Apr 17;21(5):559-567. doi: 10.1093/ntr/nty239. PMID: 30388273

139. Wachholtz A, Gonzalez G, Ziedonis D. Psycho-physiological response to pain among individuals with comorbid pain and opioid use disorder: Implications for patients with prolonged abstinence. Am J Drug Alcohol Abuse. 2019;45(5):495-505. doi: 10.1080/00952990.2019.1620260.

140. Lubitz SF, Flitter A, Wileyto EP, Ziedonis D, Stevens N, Leone F, Mandell D, Kimberly J, Beidas R, Schnoll RA. History and Correlates of Smoking Cessation Behaviors among Smokers with Serious Mental Illness. Nicotine Tob Res. 2019 Dec 9. pii: ntz229. doi: 10.1093/ntr/ntz229.

65

141. Rancans E, Vrublevska J, Kivite-Urtane A, Ivanovs R, Ziedonis D. Prevalence of major depression and associated correlates in Latvian primary care population: results from the National Research Program BIOMEDICINE 2014-2017. Nordic Journal of Psychiatry. 2020 Jan;74(1):60-68. doi: 10.1080/08039488.2019.1668961

142. Rancans E, Renemane L, Kivite-Urtane A, Ziedonis D. Prevalence and associated factors of mental disorders in the nationwide primary care population in Latvia: a cross-sectional study. Annals of General Psychiatry. 2020 Apr 7;19:25. doi: 10.1186/s12991-020-00276-5.

Major Reviews: NIH, IOM, and Royal College of Physicians 1. Ziedonis, D., Hitsman, B., Beckham, J.C., Zvolensky, M., Adler, L.E., Audrain-McGovern, J., Breslau,

N., Brown, R.A., George, T.P., Williams, J., Calhoun, P.S., Riley, W.T. Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health Report. Nicotine & Tobacco Research, 2008. 10(12):1691-715.

2. Committee on Smoking Cessation in Military Veteran Populations. Combating Tobacco Use in Military and Veteran Populations. Institute of Medicine of the National Academies: Washington, DC. (Committee members: Bondurant S, Benowitz N, Curry, S, Gritz E, Jacobson P, Kizer K, Klesges, R, Koh H, Mariner W, Martinez-Donate A, Meara E, Peterson A, Stillman F, Wyatt E, Ziedonis D). 2009.

3. Royal College of Physicians, Royal College of Psychiatrists. Smoking and mental health. London: RCP.

Royal College of Psychiatrists. Council Report CR178. (Contributors: Howard L, Huang Y, Jarvis M, Kalman D, Leonardi-Bee J, MacAskill S, Mei-See Man S, McNally L, McNeill SA, Munafò M, Newlove-Delgado T, Parker C, Parrott S, Piné-Abata H, Ratschen E, Rowe M, Szatkowski L, Shorter G, Stewart R, Whittington C, Williams J, Wu Q, & Ziedonis DM). 1-201, 2013.

Reviews: Clinical Practice Guidelines in Journal Supplements and Publications 1. Hughes, J.R., Fiester, S., Goldstein, M., Resnick, M., Rock, N., and Ziedonis, D.M. American Psychiatric

Association ‘s Practice Guidelines for the Treatment of Patients With Nicotine Dependence. American Journal of Psychiatry 153 (10, entire supplement), 1 – 31. 1996.

2. Work Group on Substance Use Disorders: Kleber, H.D., Weiss, R.D., Anton, R.F., Rounsaville, B.J., George, T.P., Strain, E.C., Greenfield, S.F., Ziedonis, D.M., Kosten, T.R., Hennessy, G., O’Brien, C.P., Connery, H.S. American Psychiatric Association Steering Committee on Practice Guidelines; McIntyre, J.S., Charles, S.C., Anzia, D.J., Nininger, J.E., Cook, I.A., Summergrad, P., Finnerty, M.T., Woods, S.M., Johnson, B.R., Yager, J., Pyles, R., Lurie, L., Cross, C.D., Walker, R.D., Peele, R., Barnovitz, M.A., Gray, S.H., Shemo, J.P., Saxena, S., Tonnu, T., Kunkle, R., Albert, A.B., Fochtmann, L.J., Hart, C., Regier, D.. Treatment of patients with substance use disorders, second edition. American Psychiatric Association. American Journal of Psychiatry. 2006. 163(8, Supplement):5-82.

3. Kleber, H.D., Weiss, R.D., Anton Jr., R.F., George, T.P., Greenfield, S.F., Kosten, T.R., O'Brien, C.P.,

Rounsaville, B.J., Strain, E.C., Ziedonis, D.M., Hennessy, G., Connery, H.S., McIntyre, J.S., Charles, S.C., Anzia, D.J., Cook, I.A., Finnerty, M.T., Johnson, B.R., Nininger, J.E., Summergrad, P., Woods,

66

S.M., Yager, J., Pyles, R., Cross, C.D., Peele, R., Shemo, J.P., Lurie, L., Walker, R.D., Barnovitz, M.A., Gray, S.H., Saxena, S., Tonnu, T., Kunkle, R., Albert, A.B., Fochtmann, L.J., Hart, C., Regier, D. Treatment of patients with substance use disorders, second edition. American Psychiatric Association. The American Journal of Psychiatry. 2007: 164 (4 Suppl), pp. 5-123

4. Center for Substance Abuse Treatment. Substance Abuse Treatment for Persons With Co-Occurring

Disorders. Treatment Improvement Protocol (TIP) Series 42. DHHS Publication No. (SMA) 05-3992. Rockville, MD: Substance Abuse and Mental Health Services Administration, (Authors / Panelists: Sacks, S., Ries, R., McNelis, D.M., Mee-Lee, D., Sorenson, J.L., Ziedonis, D.M., Zweben, J.E., Blackmon, B., Cantu, S., Chichester, C.S., Clark, C., Cline, C.A., Daw, R., Ekleberry, S.C., Fujita, B.N., Gallant, L.E., Harle, M., Kirby, M.W., Minkoff, K., Najavits, L.M., and Soto, T.A.). 2005.

5. SAMHSA. Pharmacologic Guidelines for Treating Individuals with Post-Traumatic Stress Disorder and Co-Occurring Opioid Use Disorder (Ziedonis, D – Member – Pharmacotherapy Expert Consensus Panel) HHS Pub. No. SMA-12-4688. 2012.

6. SAMHSA. General Principles for the Use of Pharmacological Agents to Treat Individuals with Co-

Occurring Mental and Substance Use Disorders (Ziedonis, D – Member – Pharmacotherapy Expert Consensus Panel) HHS Pub. No. SMA-12-4689. 2012.

Review Articles 1. Cadieux, R.J. and Ziedonis, D.M. Dementia: Differential Diagnosis and Evaluation. Family Practice

Recertification 7(12):55-90, 1985.

2. Ziedonis, D.M. and Kosten, T.R. Behavioral Pathology (Substance use disorder classification and subtyping). Annual Review of Addictions Research and Treatment 2:109-123, 1992.

3. Ziedonis, D.M. Diagnosing and Treating Comorbid Psychosis and Substance Abuse. Current Approaches

to Psychoses 2:6-12, 1993. 4. Ziedonis, D.M., Rao, S., and Preisig, M. Comorbidity Blues: Diagnosing and Treating Depression among

Substance Abusers. Employee Assistance 6:6-34, 1994. 5. Ziedonis, D.M. and Fischer, W. Assessment and Treatment of Comorbid Substance Abuse in Individuals

with Schizophrenia. Psychiatric Annals 24:477-483, 1994. 6. Rao, S., Ziedonis, D.M., and Kosten, T.R. The Pharmacotherapy for Cocaine Dependence. Psychiatric

Annals 25:363-368, 1995. 7. Ziedonis, D.M. and Fisher, W. Motivation Based Assessment and Treatment of Substance Abuse in

Patients with Schizophrenia. New Directions in Psychiatry 16:1-8, 1996.

8. Kosten, T. and Ziedonis, D.M. Substance Abuse and Schizophrenia. Schizophrenia Bulletin 23(2):181-186, 1997.

67

9. Ziedonis, D.M. and Brady, K. Dual Diagnosis in Primary Care. Medical Clinics of North America 81(4):1017-1036, 1997.

10. Ziedonis, D., Williams, J. Corrigan, P., and Smelson, D. Management of Substance Abuse in

Schizophrenia. Psychiatric Annals. 2000. 30(1):67–75, 2000. 11. McCrady, B. and Ziedonis, D. American Psychiatric Association Guideline for Substance Use Disorders.

Journal of Behavioral Therapy. 32:309-336, 2001.

12. Krejci, J. and Ziedonis, D.M. Medications in the treatment of addiction: workplace issues. Occupational Medicine. 17(1):91-104, 2002.

13. Boyarsky, B.K., Dilts, S., Frances, R.J., Frosch, W.A., Galanter, M., Levin, F., Lewis, C., Loomis, E.,

Menninger, J.A., Nace, E.P., Suchinsky, R., Sullivan, M., Tamerin, J., Westermeyer, J., Wolkoff, D., Ziedonis, D. Responsibility and choice in addiction (2002) Psychiatric Services. 2002. 53 (6): 707-713.

14. Ziedonis, D.M. and Williams, J. Management of Smoking in People with Psychiatric Disorders. Current

Opinion in Psychiatry. 16 (3):305-315, 2003.

15. Ziedonis, D.M. and Williams, J. Addressing Tobacco Use in Mental Health and Addiction Settings. Psychiatric Annals. 33(7):425-426, 2003.

16. Stuyt, E.B., Order-Connors, B., and Ziedonis, D.M. Addressing Tobacco through Program and System

Change in Mental Health and Addiction Settings. Psychiatric Annals. 33(7):446-456, 2003.

17. Ziedonis, D.M. Williams, J.M. Smelson, D.A. Serious Mental Illness and Tobacco Addiction: A Model Program to Address this Common but Neglected Issue. American Journal of the Medical Sciences 326(4):223-30, 2003

18. Foulds, J., Burke, M., Steinberg, M., Williams, J.M. and Ziedonis, D.M.. Advances in

Pharmacotherapy for Tobacco Dependence. Expert Opinion in Emerging Drugs. 9(1):39-51, 2004.

19. Williams, J.M. and Ziedonis, D.M. Addressing Tobacco among Individuals with a Mental Illness or an Addiction. Addictive Behaviors. 29(6):1067-1083, 2004.

20. Ziedonis, D.M., Smelson, D.A., Rosenthal, R.N., Batki, S.L., Green, A.I., Henry, R.J., Montoya, I., Parks,

J., Weiss, R.D. Improving the care of individuals with schizophrenia and substance use disorders: consensus recommendations. J Psychiatric Practice 11(5):315-39, 2005.

21. Yanos, P.T., Ziedonis, D.M. The patient-oriented clinician-researcher: advantages and challenges of

being a double agent. Psychiatric Services 57(2):249-53, 2006.

22. Ziedonis, D.M., Williams, J.M., Steinberg, M., Foulds, J. Addressing tobacco addiction in office-based management of psychiatric disorders: practical considerations. Primary Psychiatry 13(2):51-63, 2006.

68

23. Ziedonis, D.M., Haberstroh, S., Hanos Zimmermann, M., Miceli, M., Foulds, J. Adolescent tobacco use and dependence: assessment and treatment strategies. Adolescent Medicine Clinics 17(2):381-410, 2006.

24. Ziedonis, D.M., Guydish, J., Williams, J., Steinberg, M., Foulds, J. Barriers and Solutions to Addressing

Tobacco Dependence in Addiction Treatment Programs. Alcohol and Tobacco, Alcohol Research and Health, 29(3), 228-235, 2006.

25. Kim, S.S., Ziedonis, D.M. and Chen, K.W. Tobacco use and dependencies in Asian Americans: A review

of the literature. Nicotine and Tobacco Research 9:169-184, 2007.

26. Ziedonis, D.M., Parks, J., Hanos Zimmermann, M., McCabe, P. Program and System Level Interventions to Address Tobacco Amongst Individuals with Schizophrenia. Journal of Dual Diagnosis 3(3/4): 151-175, 2007.

27. Ziedonis, D.M., Montoya, I.D. Tobacco dependence amongst individuals with schizophrenia: A public

health crisis and an opportunity for bidirectional translational research. Journal of Dual Diagnosis, 2007. 3 (3-4): 3-7.

28. Gardner, P.D, Tapper, A.R., King, J.A., Ziedonis, D.M. The Neurobiology of Nicotine Addiction: Clinical

and Public Policy Implications. Journal of Drug Issues. 39: 1045-1067, 2009.

29. Kalman ,D., Kim, S. DiGirolamo, G., Smelson, D., Ziedonis, D. Addressing tobacco use disorder in smokers in early remission from alcohol dependence: The case for integrating smoking cessation services in substance use disorder treatment programs. Clinical Psychology Review 2010. 30 (1):12-24.

30. Boyer, E.W., Smelson, D., Fletcher, R., Ziedonis, D.M., Picard, R.W. Wireless Technologies,

ubiquitous Computing and Mobile Health: Application to Drug Abuse Treatment and compliance with HIV Therapies. Journal of Medical Toxicology. 2010 6(2): 212-6.

31. Wachholtz, A., Ziedonis, D., Gonzalez, G. Comorbid Pain and Opioid Addiction: Psychosocial and

Pharmacological Treatments. Substance Use & Misuse, 2011; 46(12):1536-52.

32. Wachholtz, A., Gonzalez, G., Boyer, E., Naqvi, Z., Rosenbaum, C., & Ziedonis, D. The intersection of chronic pain treatment and opioid analgesic misuse: A review of the causes, treatments, and policy strategies. Substance Abuse and Rehabilitation Review. 2011; 2: 145-162.

33. Byatt, N. Moore Simas, T. A. Lundquist, R. S., Johnson, J. V., & Ziedonis, D. M. Strategies for

improving perinatal depression treatment in North American outpatient obstetric settings. Journal of Psychosomatic Obstetrics & Gynecology. 2012. 33(4), 143–161

34. Pating, D.R., Miller, M.M., Goplerud, E., Martin, J., Ziedonis, D.M. New systems of care for substance use

disorders: treatment, finance, and technology under health care reform. Psychiatric Clinics North America. 2012. 35(2), 327-356. doi: 10.1016/j.psc.2012.03.004

69

35. Mistler, L.A., Brunette, M.F., Ferron, J.C., & Ziedonis, D. Shared Decision Making and Tobacco Dependence Treatment for People with Severe Mental Illnesses. Journal of Dual Diagnosis. 2012. 8(2), 99-103. DOI: 10.1080/15504263.2012.671093

36. Ziedonis, D., Das, S., Tonelli, M. Smoking and mental illness: Strategies to increase screening, assessment, and treatment. FOCUS. 2015: 13(3) 290-306.

37. Mitra S, Natarajan R, Ziedonis D, Fan X. Antioxidant and anti-inflammatory nutrient status, supplementation, and mechanisms in patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2017 Aug 1;78:1-11. doi: 10.1016/j.pnpbp.2017.05.005. Epub 2017 May 9.

Letters:

1. Kosten, T.R., Schottenfeld, R., Ziedonis, D., Falcioni, J. Comparing Buprenorphine and Methadone

Maintenance: Reply to Dr. Newman. Journal of Nervous and Mental Disease, 1994. 182 (4), 246. Invited Articles: 1. Brewster, T., Farentinos, C., Ziedonis, D. Response: the neurobiological model in community

treatment programs. Sci Pract Perspect. 2002. 1(1):21.

2. Ziedonis, D.M. and Williams, J. When Psychosis and substance use coincide in the emergency service. Psychiatric Issues in Emergency Care Settings. Summer Issue: 3–13, 2002.

3. Williams, J. and Ziedonis, D.M. Emergency management of psychosis and substance abuse.

Psychiatric Issues in Emergency Care Settings. 2002: 2: 14–19.

4. Brewster, T., Farentinos C., Ziedonis, D. Response: implementing motivational stepped care. Sci Pract Perspect. Jul 1(1):47-8, 2002.

5. Ziedonis, D.M. Integrated treatment of co-occurring mental illness and addiction: clinical

intervention, program, and system perspectives. CNS Spectrum 9(12):892-904, 2004.

6. Foulds, J., Steinberg, M.B., Williams, J.M., Ziedonis, D.M. Developments in pharmacotherapy for tobacco dependence: past, present and future. Drug Alcohol Rev 25(1):59-71, 2006.

7. Williams, J.M., Ziedonis, D.M. Snuffing out tobacco dependence. Ten reasons behavioral health

providers need to be involved. Behavioral Healthcare 26(5):27-31, 2006. 8. Ziedonis, D.M., Dual Diagnosis: The Evolving Conceptual Framework. Psychiatric Services, 58(3): 416,

March 2007.

9. George, T. and Ziedonis, D. Addressing tobacco dependence in psychiatric practice: Promises and pitfalls. Canadian Journal of Psychiatry, 2009. 54(6): p. 137-139.

70

10. McKay, C., Ziedonis, D., Seward, G., Williams, V., Bradley, K., Colburn, J., & Rocheleau, David. Addressing Tobacco Use in Adult Mental Health Service Programs. Psychiatry Information in Brief 2009. 6(2): 1.

11. Guydish, J. and Ziedonis, D. Introduction to the Theme Issue on Smoking and Substance Abuse. Journal

of Drug Issues. 2009. 9: 245-256.

12. Ziedonis, D. and Baker, S. Addressing Tobacco through Organizational Change (ATTOC). Psychiatry Information in Brief. 2011. 8(5): 1.

13. Ziedonis, D. and Olson, M. Preparing the Open Dialogue Approach for Implementation in the United

States. Psychiatry Information in Brief. 9(10):1, 2012.

14. Ziedonis, D. M., & Kolodziej, M. E. Introduction to the Special Issue on innovative interventions for treating tobacco addiction among persons with co-occurring mental illness and addiction: new approaches to improve outcomes. Journal of Dual Diagnosis. 2012. 8:85-88.

15. Ziedonis, D.M., Fulwiler, C, Tonelli, M: Integrating Mindfulness Into Your Daily Routine. Vital Signs,

a publication of the Massachusetts Medical Society. 2014. 19(2): 6.

16. Grimes-Smith, B. and Ziedonis, D. Implementing Wellness into Mental Health and Addiction Recovery: The Addressing Wellness Through Organizational Change (AWTOC) Approach. Psychiatry Information in Brief 12(4), 1, 2015.

17. Das, S., Tonelli, M., Ziedonis, D. Update on Smoking Cessation: E-Cigarettes, Emerging Tobacco

Products Trends, and New Technology-Based Interventions. Current Psychiatry Rep. 2016. 18(5):51. doi: 10.1007/s11920-016-0681-6.

18. Tonelli, M.., Fulwiler, C., de Torrijos, F., Ziedonis, D. Mindfulness in psychiatry program and emerging

initiatives at the University of Massachusetts & UMass Memorial Health Care. Worcester Medicine, 2016. 80(2), 14 - 15.

19. Ziedonis, D., Larkin, C. and Apassani, R. Dignity in mental health practice and research: Time to unite

on innovation, outreach and education. Indian Journal of Medical Research. 2016. 144: 491-495. DOI: 10.4103/0971-5916.200885.

20. Ziedonis D, Das S, Larkin C. Tobacco use disorder and treatment: new challenges and opportunities.

Dialogues in Clinical Neuroscience. 2017 Sep;19(3):271-280.

21. Ziedonis D. Looking for the healthy aging pathways to subjective well-being: the road to personal empowerment and enhanced self-care. International Psychogeriatrics. 2019 Apr;31(4):451-453.

22. Ahn MS, Ziedonis D. Coaching Health Care Leaders and Teams in Psychiatry. Psychiatric Clinics of North America. 2019 Sep;42(3):401-412. doi: 10.1016/j.psc.2019.05.010.

23. Ziedonis D, Ahn MS. Professional Development for Clinical Faculty in Academia: Focus on Teaching, Research, and Leadership. Psychiatric Clinics of North America. 2019 Sep;42(3):389-399. doi: 10.1016/j.psc.2019.05.009.

71

Books / Monographs: 1. Coombs, R.H. and Ziedonis, D.M. (eds). Handbook on Drug Abuse Prevention: A Comprehensive

Strategy to Prevent the Abuse of Alcohol and Other Drugs. Allyn and Bacon. Boston. 1995.

2. American Psychiatric Association. Practice Guidelines for the Treatment of Patients With Nicotine Dependence. American Psychiatric Press Inc. Washington DC, 1996. (Work Group on Nicotine Dependence co-authors: Hughes, J.R., Fiester, S., Goldstein, M., Resnick, M., Rock, N., and Ziedonis, D.M.), 1996.

3. Krauss, M.L., Segal, S.R., Frantz, A.H., and Ziedonis, D.M. The Governor’s Blue Ribbon Task Force on

Substance Abuse Report. Hartford, CT. 1996. 4. Ziedonis, D.M. and Simsarian, J. Department of Mental Health and Addiction Services Dual Diagnosis

Task Force Report. DMHAS: Hartford, CT. 1997. 5. Group for the Advancement of Psychiatry: Substance Abuse Work Group. Addiction Treatment: A Case

Approach to Avoiding Pitfalls. APPI Press: Washington, DC, 1998. 6. Slade, J., Ziedonis, D.M., Lindberg, D., Order-Connors B, and Hoffman A. New Jersey Guidelines for

Tobacco Dependence Treatment. DAS: Trenton, NJ. 2000. 7. Westermeyer, J., Weiss, R., and Ziedonis, D.M. Integrated Treatment for Mood and Substance Use

Disorders. John Hopkins University Press, Baltimore, MD. 2003.

8. Ziedonis D. Foreword. Rewriting Life Scripts: Transformational Recovery for Families of Addicts. by Desjardins L, Oelklaus N, and Watson I. Life Scripts Press. Ann Arbor, MI. 2010. pp. ix – xii

9. Ziedonis D. Foreword. The Imprint Journey: A Path of Lasting Transformation Into Your Authentic

Self. by Desjardins L. Life Scripts Press. Ann Arbor, MI. 2012. pp. vii – x Chapters: 1. Ziedonis, D.M. Family Assessment and Therapy. UCLA Handbook of Psychiatry, Year Book Medical

Publishers Inc., Chicago, 538-551, 1990.

2. Ziedonis, D.M. Comorbid Psychopathology and Cocaine Addiction. In Kosten TR and Kleber HD (eds). Clinician's Guide to Cocaine Addiction: Theory, Research and Treatment. Guilford Press, New York, NY, 337-360, 1992.

3. Sullivan, M. and Ziedonis, D.M. Treatment for Substance Abuse. In Sullivan EJ (ed.) Nursing Care of

Clients With Substance Abuse. Mosby-Year Book, Inc., St. Louis, 71-101, 1995.

4. Ziedonis, D.M. Substance Abuse Prevention Strategies for Psychiatric Patients. In Coombs RH and Ziedonis DM (eds.) Handbook on Drug Abuse Prevention: A Comprehensive Strategy to Prevent the Abuse of Alcohol and Other Drugs. Allyn and Bacon, Boston 445-469. 1995.

72

5. Ziedonis, D.M. and Fisher, W. Motivation Based Assessment and Treatment of Substance Abuse in Patients with Schizophrenia. In The Hatherleigh Guide to Treating Substance Abuse (Part II). Hatherleigh Press, New York, NY 269-287, 1996.

6. Ziedonis, D.M. and D’Avanzo, K. Schizophrenia and Substance Abuse. In Kranzler HR and Rounsaville BJ

(eds.) Dual Diagnosis and Treatment: Substance Abuse and Comorbid Medical and Psychiatric Disorders. Marcel Deker: New York, N.Y. 427-465, 1998.

7. Ziedonis, D.M., Wyatt, S.A. and George, T.P. Current Issues in Nicotine Dependence and Treatment.

In: McCance-Katz, E. and Kosten, T.R. New Treatments for Chemical Addictions. American Psychiatric Press Inc: Washington, D.C. 1-34, 1998.

8. Wyatt, S. and Ziedonis, D.M. Psychological and Psychiatric Consequences of Amphetamine Use. In

Tarter, R.S., Ammerman, R.T., Ott, P.J. (eds.) Sourcebook on Substance Use and Abuse. Plenum Press, New York, NY: 1998.

9. Ziedonis, D.M., Farren, C.K., and George, T. Depression and Substance Abuse. In Tohen M (ed.)

Comorbidity in Affective Disorders, Marcel Dekker, New York, NY, 27-56, 1999.

10. Ziedonis, D.M. and Wyatt, S.A. Psychosis and the Addicted Patient. In Miller N (ed.) Principles of Addiction Medicine, 2nd Edition. New York, NY: American Society of Addiction Medicine, 1999.

11. O’Connor, P.G. and Ziedonis, D.M. Linkages Between Substance Abuse, Primary Care, and Mental

Health Services. In Miller N (ed.) Principles of Addiction Medicine. New York, NY: American Society of Addiction Medicine. 1999.

12. Ziedonis, D.M. and Nickou, C. Substance Abuse in Patients with Schizophrenia. In Hwang M. (ed.)

Schizophrenia and Co-morbid Conditions: Diagnosis and Treatment. Washington, DC: American Psychiatric Press Inc., 187-222, 2001.

13. Ziedonis, D.M., Krejci, J., and Atdjian, S. Integrating Medications and Psychotherapy in the

Treatment of Alcohol, Tobacco and Other Drug Addictions. In Kay J (ed.) Integrated Treatment of Psychiatric Disorders (Volume 20). Washington DC: American Psychiatric Press Inc., 79-111, 2001.

14. Ziedonis, D.M. and Krejci, J. Pharmacotherapy in the treatment of Substance Use Disorders: One Tool

in the Toolbox. In Robert Coombs (ed.) Addiction Recovery Tools: A Practical Handbook. Thousand Oaks, CA: Sage Publications, 81-98, 2001.

15. Krejci, J. and Ziedonis, D.M. Medications in the treatment of addiction: Workplace issues. In J.

Zweben and S. Lambert (eds.) Addiction in the Workplace, Occupational Medicine: State of the Art Reviews. Philadelphia: Hanley and Belfus, 2002.

16. Ziedonis, D.M., Steinberg, M.L., Smelson, D.A. and Wyatt, S. Co-occurring addictive and psychotic

disorders. In A.W. Graham, T.K. Schultz, M.F. Mayo-Smith, R.K. Ries and B.B. Wilford (eds.) Principles of Addiction Medicine, Third Edition. Chevy Chase, MD: American Society of Addiction Medicine, 1297-1320, 2003.

73

17. Ziedonis, D.M. and Krejci, J. Dual Recovery Therapy: Blending Psychotherapies for Depression and Addiction. In Westermeyer, J., Weiss, R., and Ziedonis, D.M. (eds.) Integrated Treatment for Mood and Substance Use Disorders. John Hopkins University Press, Baltimore, MD, 90–121, 2003.

18. Ziedonis, D.M. and Fiester, S. Substance Abuse: Nicotine Dependence (Chapter 59). In Tasman A (ed.)

Psychiatry (2nd Edition). John Wiley and Sons, London, UK. 2003.

19. Ziedonis, D.M., Steinberg, M.L., D’Avanzo, K. and Smelson, D.A. Schizophrenia and substance abuse. In Kranzler, H.R. and Rounsaville, B.J. (eds.) Dual diagnosis and treatment: Substance abuse and comorbid medical and psychiatric disorders 2nd Edition. Marcel Deker: New York, NY, 387-436, 2004.

20. Ziedonis, D.M., Williams, J., Steinberg, M.L., Smelson, D.A., Sussner, B., Foulds, J., Krejci, J., and

Violette, N. Addressing Tobacco Dependence Amongst Individuals with a Psychiatric Disorder: A Neglected Epidemic of Major Clinical and Public Health Concern. In Isaacs SL (ed.) VA In the Vanguard: Building on Success in Smoking Cessation. Department of Veterans Affairs. 141-170, 2005.

21. Ziedonis, D., Yanos, P.T., Silverstein, S.M. Relapse Prevention for Schizophrenia. Therapist’s Guide to

Evidence-Based Relapse Prevention, Elsevier, 2007.

22. Foulds, J., DeInevo, C., Ziedonis, D.M., Steinberg, M.B. Health Effects of Tobacco, Nicotine, and Exposure to Tobacco Smoke Pollution (Chapter 13). In Brick, J. (ed.) Handbook of the Medical Consequences of Alcohol and Drug Abuse (2nd Edition). The Haworth Press, Taylor & Francis Group, New York and London, 423-460, 2008.

23. Ziedonis, D.M., Day, E., O’Hea, E.L., Krejci, J., Berman, J.A., Smelson, D.A. Treatment of Co-Occurring

Psychiatric and Substance Use Disorders. In Tyrer, P. and Silk, K. (eds.) Cambridge Handbook for Effective Treatments in Psychiatry, Cambridge University Press. 442-458, 2008.

24. Ziedonis, D.M., Berman J., Lehn, M.D., Coameco, S. Support Groups and Twelve-Step Programs in

the Treatment of the Chronic Pain Patient. In Smith and Passik (eds.) Pain and Chemical Dependency, Oxford University Press, USA; 2008.

25. Ziedonis, D.M., Steinberg, M., Smelson, D.A., and Wyatt, S.A. Co-Occurring Addiction and Psychotic

Disorders. In Ries, R., Fiellin, D., Miller, S., Saitz, R. (eds). Principles of Addiction Medicine, 4th Edition. New York, NY: American Society of Addiction Medicine, 1193-1209, 2009

26. Gonzalez, G., Miozzo, R. and Ziedonis, D. Substance Use Disorders. In Rothschild AJ (ed), for the

Evidence-Based Guide to Antipsychotic Medications, American Psychiatric Publishing, Inc., Washington, DC, 125-144, 2010.

27. Kim, S.S., Kalman, D., Gonzalez, G., Ziedonis, D. Substance Use disorder among Immigrants in the United

States. In Sher, L. and Vilens A. (eds.) Immigration and Mental Health: Stress, Psychiatric Disorders and Suicidal Behavior Among Immigrants and Refugees. New York: Nova Science Publishers, 243 – 65, 2010.

28. Ziedonis, Kalman, Johnson, Mistler. Nicotine Dependence Management. Chapter 36 in Lowinson and

Ruiz’s Substance Abuse: A Comprehensive Textbook. 5th Edition. Editors: Pedro Ruiz, Eric C. Strain. Lippincott Williams and Wilkins. Philadelphia. 2011.

74

29. Ziedonis, D., Bizamcer, A.N., Steinberg M.L., Wyatt, S.A. Smelson, D.A. Vaiana, A.D. Co-Occurring

Addiction and Psychotic Disorders. In Cavacuita, C.A. (ed). Principles of Addiction Medicine: The Essentials, 4th Edition, Chapter 86, 2011

30. Williams JM, Delnevo C, & Ziedonis DM. The Unmet Needs of Smokers with Mental Illness or Addiction.

In After Tobacco: What Would Happen If Americans Stopped Smoking? Bearman, Neckerman and Wright (Eds). Columbia University Press, 2011.

31. Ziedonis, D.M., Kalman, D., Kolodziej, M., Johnson, C.W., Kim. S. Tobacco Addiction and

Psychological Co-morbidities. In Pagoto, Sherry (ed) Psychological Co-morbidities of Physical Illness: A Behavioral Medicine Perspective. 207-232, 2011

32. Ziedonis, D.M., Fan, X., Bizamcer, A. N., Wyatt, S. A., Tonelli, M. E., Smelson, D.A. Co-Occurring

Addiction and Psychotic Disorders. In R. Ries et al. (eds), Principles of Addiction Medicine, Fifth Edition. New York, NY: American Society of Addiction Medicine. 1346-1364, 2014.

33. Kalman, D., Hayes, R., Ziedonis, D: Tobacco Use Disorder. In M Galanter, et al. (eds), Textbook of

Substance Abuse Treatment. Arlington, VA: American Psychiatric Publishing. 223-237, 2015.

34. Ziedonis, D.M., Fan, X., Bizamcer, A., Wyatt, S., Tonelli, M., Smelson, D. Co-Occurring Addiction and Psychotic Disorders. In A. Herron, T. Koehler Brennan (eds.). The ASAM Essentials of Addiction Medicine, 2nd edition. Philadelphia, PA: Wolters Kluwer. 505-511, 2015.

35. Ziedonis, D., Cimpeanu, C., Tonelli, M. Substance-Related and Addictive Disorders: Tobacco-Related

Disorders. In A. Tasman, J. Kay, J.A. Lieberman, M.B. First, M.B. Riba (eds.). Psychiatry, Volume 2, 4th Edition. Wiley-Blackwell. pp. 1615-1637, 2015.

36. Kalman, D., Harrington, A., DiFranza, J., Pbert, L., and Ziedonis, D. M. Nicotine Dependence. In A.

Mack, R. Frances, K. Brady, S. Miller (eds). Clinical Textbook of Addictive Disorders, 4th Edition. New York, NY: Guilford Publications, Inc., 2016.

37. Ziedonis, D, Tonelli, M, Das, S. Tobacco-Related Disorder. In B. Sadock, V. Sadock, P. Ruiz (eds.).

Kaplan & Sadock's Comprehensive Textbook of Psychiatry, 10th edition. (2017).

38. Ziedonis, D.M., Fan, X., Larkin, C., Wyatt, S., Smelson, D. Co-Occurring Addiction and Psychotic Disorders. In Miller,S.C. Fiellin, D.A., Rosenthal, R.N., and Saitz. R. (eds.). The ASAM Principles of Addiction Medicine, 6th edition. Philadelphia, PA: Wolters Kluwer. (2018)

39. Ziedonis, D.M. and Iflund, J. Introductions to Recovery from Processed Food Addiction. In: Ifland, J., Marcus, M.T., Preuss, H.G. (eds.) Processed Food Addiction: Foundations, Assessment, and Recovery. CRC Press, Boca Raton, FL, 307-320, 2018.

40. Ziedonis, D.M. and Iflund, J. Premises of Recovery for Adults. In: Ifland, J., Marcus, M.T., Preuss, H.G. (eds.)Processed Food Addiction: Foundations, Assessment, and Recovery. CRC Press, Boca Raton, FL, 321-340, 2018.

75

41. Ziedonis, D.M. and Iflund, J. Avenues to Success for the Practitioner. In: Ifland, J., Marcus, M.T., Preuss, H.G. (eds.). Processed Food Addiction: Foundations, Assessment, and Recovery. CRC Press, Boca Raton, FL, 341-353, 2018.

42. Ziedonis D., Larkin, C., Fan, X, Wyatt, S.A., Smelson, D. Co-occurring addiction and psychotic disorders. In Essentials of Addiction Medicine 3rd Ed. Eds. Herron, A., Brennan, T. Philadelphia: Wolters Kluwer Health. 2019.

Behavioral Therapy Manuals: 1. Ziedonis, D.M. and D’Avanzo, K. Dual Recovery Therapy for Schizophrenia and Cocaine Addiction.

National Institute of Drug Abuse Behavioral Therapy Development Study Manual. Yale University. New Haven CT. 1998.

2. Ziedonis, D.M. and Krejci, J. Dual Recovery Therapy: Supporting Integrated Recovery from Co-occurring Substance Abuse and Mental Disorders in Outpatient Substance Abuse Treatment Settings. Substance Abuse Mental Health Service Agency (SAMHSA). UMDNJ. Piscataway NJ. 2004

3. Krejci, J.A., Steinberg, M.L. and Ziedonis, D.M. Motivational interviewing in tobacco dependence

Manual. NIDA Behavioral Therapy Development Study Manual. UMDNJ. Piscataway NJ. 2004 4. Krejci, J.A. and Ziedonis, D.M. Adapting Motivational Enhancement Therapy for Poly-Drug Addiction:

A Therapist Manual for Addiction Counselors. NIDA Behavioral Therapy Development Study Manual. UMDNJ. Piscataway NJ. 2004

5. Smelson, D., Kline, A., Hills, S., Ziedonis, D. The MISSION Treatment Manual. Substance Abuse and

Mental Health Service Administration. (2007). http://www.missionmodel.org/manuals-1/ 6. Williams, J., Ziedonis, D.M., Krejci, J.A., Steinberg, M.L., and Zimmerman, M. Medication

Management For Schizophrenia and Tobacco Dependence. NIDA Behavioral Therapy Development Study Manual. UMDNJ. Piscataway NJ. 2005

7. Ziedonis, D.M., Krejci, J.A., Steinberg, M.L., and Williams, J.M. Treatment of Addiction to Nicotine In

Schizophrenia: A Tobacco Dependence Treatment Manual for Therapists. NIDA Behavioral Therapy Development Study Manual. UMDNJ. Piscataway, NJ 2005

8. Ziedonis, D.M., Krejci, J.A., O’Hea, E.L., and Boudreaux, E.D. Motivation-Based Recovery Oriented

Therapy: A Therapist Manual for Addiction Counselors Treating Poly-drug Addiction. NIDA Behavioral Therapy Development Study Manual. UMDNJ. Piscataway NJ. 2005

9. Fortuna, LR, Jankowski, MK, Rosenberg, H, Mueser, K, Vallejo, Z, Rosenberg, S, Ziedonis, D. Cognitive

Behavioral Therapy Integrated for PTSD and Substance Abuse for Adolescents NIDA Behavioral Therapy Development Study Manual. University of Massachusetts Medical School, Worcester MA. 2010


76

10. Kelly M, Ziedonis D. Acceptance and Commitment Therapy for PTSD and Tobacco Addiction Treatment Manual. Veterans Health Administration Behavioral Therapy Development Study.VISN1. Bedford, MA. 2010

11. Smelson, D., Sawh, L, Kane, V., Kuhn, J, Ziedonis, D. The MISSION Treatment Manual: Veterans

Edition. Veterans Health Administration. (2011). http://www.missionmodel.org/manuals-1/

12. Williams, J., Ziedonis, D., Speelman, N., Vreeland, B., Zechner, M.R., Rahim, R., O’Hea, E.L. Learning About Healthy Living. Tobacco and You. New Jersey Division of Mental Health Services. 2005. (edited and revised, 2012) http://www.njchoices.org/LAHL/2012%20lahl.pdf

13. Smelson, D., Sawh, L, Harter, J., Siegfriedt, J., & Ziedonis, D. The MISSION Treatment Manual: Second

Edition. University of Massachusetts Medical School. (2014). http://www.missionmodel.org/manuals-1/

14. Smelson, D., Sawh, L., Harter, J., & Ziedonis, D. The MISSION Participant Workbook Second Edition.

Substance Abuse and Mental Health Service Administration. (2014). http://www.missionmodel.org/manuals-1/

15. Pinals, D., Smelson, D., Sawh, L., Harter, J., & Ziedonis, D. The MISSION Criminal Justice Treatment Manual. University of Massachusetts Medical School. (2014). http://www.missionmodel.org/manuals-1/

16. Smelson, D., Pinals, D. Harter, J., Sawh, L., & Ziedonis, D. The MISSION Criminal Justice Participant

Workbook. Substance Abuse and Mental Health Service Administration. (2014). http://www.missionmodel.org/manuals-1/

17. Smelson, D., Sawh, L., Harter, J., & Ziedonis, D. The MISSION Participant Workbook Second Edition,

Spanish Edition. Substance Abuse and Mental Health Service Administration. (2014). http://www.missionmodel.org/manuals-1/

18. Olson M, Seikkula J, and Ziedonis D. The Key Elements of Dialogic Practice in Open Dialogue:

Fidelity Criteria. University of Massachusetts Medical School. (available online since 2014). www.umassmed.edu/globalassets/psychiatry/opendialogue/keyelementsv1.109022014.pdf

19. Smelson, D., Sawh, L., Harter, J., & Ziedonis, D. The MISSION Participant Workbook Second Edition,

Spanish Edition. Substance Abuse and Mental Health Service Administration. (2015). http://www.missionmodel.org/manuals-1/

20. Smelson, D., Pinals, D., Harter, J., Sawh, L., and Ziedonis, D. The MISSION Criminal Justice Treatment

Manual, Spanish Edition. Substance Abuse and Mental Health Service Administration. (2015). http://www.missionmodel.org/manuals-1/


http://www.ncbi.nlm.nih.gov/entrez/query.fcgi

http://repository.wcsu.edu/jadara/vol50/iss1/3



https://youtu.be/jr1IlMZb55I

https://doi.org/10.2147/IJWH.S109819



http://www.njchoices.org/LAHL/2012%20lahl.pdf

77

Organizational Change & Leadership Development Manuals 1. Ziedonis, D.M., Comerford, T., Violette, N., and Krejci, J. Addressing Mental Health Problems in

Substance Abuse Treatment: A Guide to Developing Consultant-Integrated and Fully-Integrated Programs Manual. Substance Abuse and Mental Health Service Administration (SAMHSA). UMDNJ. Piscataway NJ. 2004.

2. Ziedonis, D.M. and Krejci, J. Addressing Mental Health Problems in Substance Abuse Treatment: A

Guide to Assessment and Treatment Planning for Substance Abuse Counselors - Clinician Guide. Substance Abuse and Mental Health Service Administration (SAMHSA). UMDNJ. Piscataway, NJ. 2004.


Guide to Assessment and Treatment Planning for Substance Abuse Counselors - Instructor Guide. Substance Abuse and Mental Health Service Administration (SAMHSA). UMDNJ. Piscataway, NJ. 2004.


Guide to Assessment and Treatment Planning for Substance Abuse Counselors - Self-study Clinician Guide. Substance Abuse and Mental Health Service Administration (SAMHSA). UMDNJ. Piscataway, NJ. 2004.

5. Ziedonis, D.M. and Krejci, J. A Guide for Supervisors of Substance Abuse Counselors Using the Self-

Study Clinician Guide. Substance Abuse and Mental Health Service Administration (SAMHSA). UMDNJ. Piscataway NJ 2004

6. Ziedonis DM, et al. Addressing Tobacco Through Organizational Change. NIDA Organizational Change

Study Manual. University of Massachusetts. Worcester MA. 2011. 7. McKay, C., Ziedonis, D., Seward, G., Bradley, K. Sawyer, E., Williams, V., Adams, J., Letourneau, P.,

Rocheleau, D., & Perkins, L. Promoting Healthy Lifestyles Clubhouse Toolkit. Legacy Foundation. The University of Massachusetts Medical School: Worcester, MA. 1-280. 2011.

8. Ziedonis D, Olson M, & Seikkula. Adapting Open Dialogue & Dialogic Practice: Organizational & Therapeutic Methods and Fidelity Criteria Manual. Foundation for Excellence in Mental Health Care. 2015

9. Ziedonis D & Lorberg B. Mindful Physician Leadership Program Introductory Curriculum Guidebook.

Physician’s Foundation. The University of Massachusetts Medical School: Worcester, MA. 2018.

10. Ziedonis D & Lorberg B. Mindful Physician Leadership Program Foundational Level Guidebook. Physician’s Foundation. The University of Massachusetts Medical School: Worcester, MA. 2018.

11. Ziedonis D & Lorberg B. Mindful Physician Leadership Program Teleconference Call Group Guidebook. Physician’s Foundation. The University of Massachusetts Medical School: Worcester, MA. 2018.

12. Ziedonis D & Lorberg B. Mindful Physician Leadership Program Advanced Level Guidebook. Physician’s Foundation. The University of Massachusetts Medical School: Worcester, MA. 2018.

78

Refereed Published Conference Proceedings (NIDA Research Monograph Series & Journals): 1. Ziedonis D and Kosten T. Depression as a Treatment Matching Factor in Cocaine Dependence

Treatment. . In Harris editor, Problems of Drug Dependence 1991. NIDA Research Monograph Series. DHHS Washington D.C.; USGPO. 1992: (119), 365.

2. Kosten T, Schottenfeld RS, Morgan CH, Falcioni J, and Ziedonis D. Buprenorphine vs. Methadone for Opioid and Cocaine Dependence. In Harris editor Problems of Drug Dependence 1991. NIDA Research Monograph Series, DHHS Washington D.C.; USGPO.1992: (119), 359.

3. Margolin A, Avants SK, Ziedonis D, Petrakis I, and Kosten TR. Pre- and Post-Treatment Cue-Reactivity in Cocaine Addicts Treated with Bupropion. In Harris editor Problems of Drug Dependence 1991. NIDA Research Monograph Series, DHHS Washington D.C.; USGPO.1992: (119), 463.

4. Ziedonis, D.M., Kosten, T.R., Glazer, W. The impact of drug abuse on psychopathology and movement disorders in chronic psychotic outpatients. In Harris editor, Problems of Drug Dependence 1992. NIDA Research Monograph Series, DHHS Washington D.C.; USGPO.1993: (132), 153.

5. Schottenfeld, R.S., Ziedonis, D., Pakes, J., Kosten, T.R. Buprenorphine dose ranging for combined

cocaine and opiate dependence. In Harris editor, Problems of Drug Dependence 1992. NIDA Research Monograph Series, DHHS Washington D.C.; USGPO.1993. (132), 311.

6. Kosten, T.R., Schottenfeld, R.S., Ziedonis, D.M., Falcioni, J. Six month trial of buprenorphine versus methadone for opioid use. . In Harris editor Problems of Drug Dependence 1992. NIDA Research Monograph Series, DHHS Washington D.C.; USGPO.1993. (132), 100.

7. Schottenfeld RS, Kosten TR, Pakes J, Ziedonis D, and Oliveto A. Buprenorphine versus Methadone

Maintenance for Combined Cocaine and Opioid Dependence. In Harris editor Problems of Drug Dependence 1993, Vol II. NIDA Research Monograph Series, DHHS Washington D.C.; USGPO.1994 (141), 142.

8. Ziedonis DM, Kosten T, and Glazer W. Nicotine Dependence and Schizophrenia: The Relationship to

Psychopathology and Neuroleptic Medication Dosage and Side Effects. Problems of Drug Dependence 1993, Vol II. NIDA Research Monograph DHHS Washington D.C.; USGPO.1994 (141). 236.

9. Leal J, Ziedonis D, and Kosten T. The Prognostic Significance of Antisocial Personality Disorder in the

Treatment of Cocaine Dependence Using Pharmacotherapy. Problems of Drug Dependence of 1993. Vol II. NIDA Research Monograph Series, DHHS Washington D.C.; USGPO.1994. (141), 434.

10. Sikowitz D, Ziedonis DM, Hayes M, and Kosten T. Prolonged Adjunctive Clonidine Usage Improves

Treatment Outcomes for Opioid Addicts Given Naltrexone. Problems of Drug Dependence of 1993. Vol II. NIDA Research Monograph Series, DHHS Washington D.C.; USGPO.1994. (141), 452.

11. Oliveto A, Kosten TR, Schottenfeld R, and Ziedonis D. Effects of Desipramine, Amantadine, or Fluoxetine on Cocaine and Opioid Use in Buprenorphine-Maintained Patients: A Pilot Study.

79

Problems of Drug Dependence 1994. NIDA Research Monograph Series. DHHS Washington D.C.; USGPO. 1995 (153) 25.

12. Gill TS, Ziedonis DM, Farren CK, Wallace EA, and Schottenfeld RS. A Survey of Sleep Problems in a Substance Abuse Population. In Harris editor, Problems of Drug Dependence 1994. NIDA Research Monograph Series. DHHS Washington D.C.; USGPO.1995 (153) 100.

13. Ziedonis DM, Farren C, and Kosten TR. Depression in Cocaine Abusing Opioid Addicts Treated with Either Buprenorphine or Methadone. In Harris editor, Problems of Drug Dependence 1994. NIDA Research Monograph Series. DHHS Washington D.C.; USGPO.1995 (153) 211.

14. Farren CK, McDougle C, Price L, Ziedonis D, Hameedi F, and Kosten T. Growth Hormone Responses

to Dopamine Antagonists in Cocaine Addicts and Alcoholics. In Harris editor, Problems of Drug Dependence 1994. NIDA Research Monograph Series. 1995 (153) 323.

15. Ziedonis D, Fisher W, Harris P, Trudeau K, Rao S, and Kosten T. Adjunctive Selegiline in the

Treatment of Cocaine Abusing Schizophrenics. In Harris editor, Problems of Drug Dependence 1995. NIDA Research Monograph Series, DHHS Washington D.C.; USGPO.1996. (162), 325.

16. Ziedonis D; D’Avanzo K; Kasuba B; Cosentino W, Trudeau K, Harris P, and Harmon L. Dual Diagnosis

Relapse Prevention (DDRP): A Preliminary Outcome Report. In Harris editor, Problems of Drug Dependence 1996. NIDA Research Monograph Series. DHHS Washington D.C.; USGPO. 1997 (174) 127.

17. Smelson, D., Roy, M., Roy, A., Harter, J., Engelhart, C., & Ziedonis, D. Relationship between the electroretinogram blue cone amplitude and cue-eliciting cocaine craving. In Harris editor, College of Problems of Drug Dependence, 1999. National Institute of Drug Abuse Research Monograph. DHHS Washington D.C.; USGPO. 2000.

18. Mordan, E., Weeks, A., Geffrard, M., Baumann, B.M., Camargo, C.A., Jr., Ziedonis, D.M., Boudreaux,

E.D. Expired carbon monoxide validation of self-reported smoking among ED patients. Academic Emergency Medicine 12(5):45, 2005.

19. Boudreaux, E.D., Baumann, B.M., Camargo, C.A., Foulds, J., Ziedonis, D.M. Smoking among adult

emergency department patients: Abstinence and stage of change one month post-visit. Annals of Behavioral Medicine 29S:29, 2005.

20. Boudreaux, E.D., Baumann, B.M., Foulds, J., Camargo, C.A. Jr., Perry, J., Ziedonis, D.M. An

exploratory study of ED-initiated tobacco interventions: Deriving parameter estimates to plan randomized trials. Academic Emergency Medicine S309, 2006.

21. Boudreaux, E.D., Baumann, B.M., Foulds, J. Camargo, C.A., Jr., Ziedonis, D. The effect of removing

cost as a barrier to treatment initiation with an outpatient tobacco dependence clinic among emergency department patients. Academic Emergency Medicine 13:S373, 2006.

22. Boudreaux, E.D., Baumann, B., Perry, J., Marks, D., Francies S., Velazaquez, M., Reinglass, A, Camargo,

C., Ziedonis, D. Emergency department initiated tobacco interventions. Annals of Behavioral Medicine, 33:S098, 2007.

80

23. Boudreaux, E.D., Baumann, B.M., Marks, D., Francies, S., Ziedonis, D. Polysubstance abuse, readiness to

quit, and interest in ED-initiated interventions among adult emergency department patients. Academic Emergency Medicine, 2008. 15:S166.

24. Haskins B, Le R, Terrian L, Grissom G, Ziedonis D, Boudreaux ED. Evaluation of websites and web-

based applications targeting alcohol and drug use. Annals of Behavioral Medicine, 2014; 47: s139.

25. Murphy KM & Ziedonis DM. Group Guided Imagery and Music for Adults in Addiction Treatment: A Pilot Randomized Control Trial Feasibility Study. Research Symposium Proceedings: 24th International Association for Music & Imagery Conference. 2017; 19-22.

OTHER WORK

Music CD

1. Ziedonis, D.M. and Clottey, K. The Journey. Mindfulness Music. (www.cdbaby.com/cd/ziedonis). World

Music – Native American Flute, African Hand drums, Balafon, and Latvian Kokle. 2004.

Computer Programs 1. Krejci, J.A., Steinberg, M.L. and Ziedonis, D.M. Motivating Ambivalent Smokers to Quit (MASQ) for

MS Excel 97 [computer program]. Piscataway, NJ, University of Medicine and Dentistry of New Jersey/ Robert Wood Johnson Medical School. 2001.

2. Steinberg, M.L., Krejci, J.A., Ziedonis, D.M., and Williams, J.M. A Personalized Assessment Feedback

Report for Smokers with Schizophrenia for MS Excel and MS Word [computer program]. Piscataway, NJ, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Division of Addiction Psychiatry. 2003.

Video Products:

1. Hall, W. C., Anderson, M. L., Elliott, M. E., & Ziedonis, D. M. (2014). Engaging the deaf community in

behavioral health research: Insider, outsider, and ally perspectives. Available at https://youtu.be/jr1IlMZb55I

Summary: 324 publications / scholarly works: With 142 original research articles, 3 major reviews (NIH, IOM, RCP), 6 practice guidelines, 37 review articles, 1 letter, 21 invited articles, 9 books, 42 chapters, 20 behavioral therapy manuals, 12 organizational change & leadership development manuals, 25 refereed published conference proceedings (NIDA Research Monograph Series & Journals), 1 CD, 2 computer programs, and 1 video


curriculum vitae - executivesearch.unm.educurriculum vitae . name: douglas michael ziedonis, md,...

Documents